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Many epithelial barriers are constitutively populated by large numbers of organ-
specific γδ T cells that collectively make up a substantial proportion of the body’s T 
cells. In mice, these intraepithelial lymphocytes (IEL) display striking site-specific T 
cell receptor (TCR) Variable (V)γ chain usage, such that Vγ5+, Vγ6+ and Vγ7+ T 
cells form lifelong associations with the murine epidermis, uterine and the small 
intestinal epithelium, respectively. The maintenance of IEL composition is critically 
important to host physiology and its disruption in murine epidermis is associated 
with dysregulated cutaneous inflammation and heightened susceptibility to 
carcinogenesis. Furthermore, tumour-associated γδ T cell gene-expression 
signatures were recently found to be the greatest correlate with overall survival in a 
genome-wide expression analysis of ~18,000 human tumours. Thus, there is 
considerable interest in identifying molecules that regulate infiltration, composition 
and activation of tissue-resident γδ T cells. 
Skint1 is a Butyrophilin-like (Btnl) gene expressed by thymic medullary epithelium 
and suprabasal keratinocytes, which shapes DETC composition. However, as 
neither Skint1 nor DETC are conserved, a general mechanism by which epithelia 
shape IEL composition remains unelucidated. Here we show that enterocyte Btnl1 
expression shapes small intestinal IEL composition by driving extrathymic 
maturation and expansion of Vγ7+ IEL in trans upon their arrival in the gut. 
Uninfluenced by microbial or solid food antigens, this mechanism evokes the Major 
Histocompatibility Complex-driven selection of αβ T cell repertoires. Consistent with 
this, we show that Btnl1 together with Btnl6 elicits specific TCR-dependent 
responses of intestinal Vγ7+ cells in vitro. From these data, a generalizable 
mechanism emerges whereby organ-specific expression of Btnl molecules enables 
epithelial cells to actively shape the lifelong composition of their signature IEL 
compartments. Moreover, by identifying selection elements that regulate signature 
γδ IEL, our models also provide novel avenues to study the unique contributions of 
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Chapter 1. Introduction 
The study of immunology stems from the earliest observations of immune memory 
and the potent prophylactic properties of vaccination against infectious disease. In 
seeking to better understand the biology underlying these observations, seminal 
work from several groups has outlined a sequence of cellular and molecular 
interactions that describe the host response to microbial challenge. Such pathways 
are now described in some detail in all immunology textbooks and their study has 
uncovered numerous molecular targets for pharmacological immunomodulation in 
the clinic. While the immune system has evolved under considerable selection 
pressure to respond to microbial challenge, it is increasingly acknowledged that 
non-microbial challenges such as mechanical tissue perturbation, genotoxic stress 
and cellular transformation can also activate immune cells. Such responses to 
dysregulated or stressed ‘self’ may contribute to the exacerbation or initiation of 
autoinflammatory pathology and are directly implicated in tumour 
immunosurveillance. In order to better understand the contribution of these 
emerging immunological pathways to host defence and host pathology, research 
has focussed on identifying key cellular effectors and characterising their 
development; their functional potential(s); and the molecular interactions that 
govern their effector function(s).  
1.1 The immune responses to environmental challenge 
1.1.1 Microbial Challenge 
The immune response to microbial challenge is the best-studied system in 
mammalian immunology and is subdivided into innate and adaptive phases. During 
the innate phase, myeloid-derived antigen-presenting cells (APC) such as dendritic 
cells (DCs) employ germline-encoded pattern recognition receptors (PRRs) to 
mount rapid responses to pathogen-associated molecular patterns (PAMPs) and 
danger-associated molecular patterns (DAMPs) (Janeway, 1989; Janeway and 
Medzhitov, 2002; Matzinger, 2002; Zelenay and Sousa, 2013) (Figure 1.1). Upon 
activation, DCs deploy local effector responses, recruit additional leukocytes and 
migrate to local lymphoid tissues to prime the adaptive phase of the immune 
response. Adaptive immunity is antigen-specific and driven by T and B cells that 
Chapter 1 Introduction 
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utilise recombination-activating-gene (RAG)-mediated somatic gene rearrangement 
to generate a vast repertoire of antigen-specific immune receptors (Davis and 
Bjorkman, 1988; Hozumi and Tonegawa, 1976). At the lymphoid tissue, DCs 
present processed microbial antigens via major histocompatibility complex (MHC) 
to naïve antigen-specific αβ T cells (Figure 1.1).  
The engagement of cognate antigen via the T cell receptor (TCR) drives clonal 
expansion and functional differentiation of naïve T cells into mature effector T cells. 
Effector T cells home to affected tissues and drive the adaptive immune response 
(Banchereau and Steinman, 1998). Upon resolution of infection, some antigen-
specific lymphocytes persist as long-lived memory cells that can be rapidly 
mobilized to provide symptomatic immunity to re-infection by the same pathogen 
(Sallusto et al., 1999; Zinkernagel et al., 1996). Thus, while innate immunity 
comprises rapid responsiveness to conserved molecular patterns associated with 
microbial invasion, adaptive immunity is delayed, antigen-specific and can generate 
long lasting immunological memory. 





Figure 1.1 The immune response to microbial challenge 
Innate - Locally resident myeloid-derived APCs rapidly detect microbial invasion by 
engaging PAMPs and DAMPs via germline-encoded PRRs (Janeway and 
Medzhitov, 2002; Matzinger, 2002; Zelenay and Sousa, 2013). Microbial 
components are internalised, processed into smaller peptides and presented on 
cell surface MHC molecules. Activated APCs migrate to local draining lymph nodes 
to prime the adaptive response. Antigens derived from cytosolic (intracellular) 
pathogens are presented via MHC class I to naïve CD8+ αβ T cells. Antigens 
derived from extracellular pathogens are presented via MHC class II to naïve CD4+ 
αβ T cells. 
Adaptive - TCR engagement of cognate antigen presented on cell surface MHC 
drives a process of clonal expansion and differentiation, whereby a naïve T cell 
acquires its mature effector function (e.g. IFNγ versus IL-17 production). CD4+ 
helper T (Th) cells promote the activation of CD8+ cytotoxic T cells (Tc), which 
comprise antigen-specific effectors of cell-mediated adaptive immunity. Th cells 
also promote activation of naïve B cells, which differentiate into antibody-secreting 
plasma cells. While T cells home to affected tissues to clear the infection, plasma 
cells secrete antigen-specific antibodies into the circulation, where they opsonise 
target pathogens. As clonal expansion, functional maturation and tissue homing 
takes time, adaptive immune responses are often delayed by several days. 
However, following resolution of infection, some antigen specific T cells and B cells 
persist as memory cells, providing symptomatic immunity to re-infection by the 
same pathogen. 
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1.1.2 Tissue-resident T cells with innate-like response modes 
Whilst the textbook model for immune activation (Figure 1.1) provides an 
extremely useful frame of reference, it sequesters the contribution of myeloid-
derived and lymphoid-derived cells to the afferent arm of the innate response and 
the efferent arm of the adaptive response, respectively. As such, the model fails to 
ascribe specific roles to the myriad populations of lymphocytes that are 
constitutively enriched for in non-lymphoid barrier tissues such as the skin and the 
gut, where they are optimally positioned to contribute to the earliest phases of the 
innate immune response. Prominent among these are large populations of T cells 
that exist in a functionally pre-activated state, enabling them to deploy effector 
functions in response to innate stimuli (e.g. inflammatory cytokines), in the absence 
of concomitant TCR engagement, functional differentiation and clonal expansion 
(Brennan et al., 2013; Fan and Rudensky, 2016; Lanier, 2013; Shires et al., 2001; 
Strid et al., 2008). The description of these cells as innate-like T cells reflects their 
expression of an Rag-rearranged TCR and their capacity for unconventional innate 
activation, via signals delivered through non-clonally distributed germ-line encoded 
receptors (Wencker et al., 2013). In other words, while these cells are designated 
as T cells, they may participate in both innate and adaptive immunity.  
Tissue-resident T cells with innate response capabilities include ‘conventional’ 
MHC-restricted αβ tissue-resident memory (TRM) cells (Fan and Rudensky, 2016; 
Guo et al., 2012) but also include several subsets of ‘unconventional’ αβ and γδ T 
cells (Godfrey et al., 2015). ‘Unconventional’ T cells are named as such because 
they are not restricted to classical MHC, display restricted TCR repertoires and 
home directly to non-lymphoid tissue following their development in the thymus. 
They include intraepithelial T lymphocytes (IEL) that occupy various human and 
murine epithelia, invariant natural killer T (iNKT) cells and mucosa-associated 
invariant T (MAIT) cells, both of which are enriched for in the liver and the intestinal 
mucosa (Chandra and Kronenberg, 2015; Cheroutre et al., 2011; Godfrey et al., 
2015; Shires et al., 2001).  
TRM cells and unconventional T cell subsets differentiate via discreet developmental 
pathways, but their acquisition of mature effector function, innate responsiveness 
and tissue-residency shares a requirement for strong or agonist-mediated TCR 
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stimulation. Hence, TRM cells are the differentiated products of a naïve T cells that 
have engaged a TCR agonist antigen in a peripheral lymphoid organ (Guo et al., 
2012; Schenkel et al., 2016; Schenkel and Masopust, 2014; Sheridan and 
Lefrançois, 2011); and ‘Unconventional’ T cells are the differentiated products of 
cells that acquire their mature effector potential, innate responsiveness and tissue 
homing phenotype following strong TCR-mediated signalling in the thymus (so 
called ‘agonist-selection’ Figure 1.2) (Baldwin et al., 2004; McDonald et al., 2014; 
Moran et al., 2011; Stritesky et al., 2012; Wencker et al., 2013). Although for MAIT 
cells this may occur shortly after thymic egress in a non-lymphoid tissue 
(Leeansyah et al., 2014).  
In summary, non-lymphoid barrier tissues are constitutively populated by multiple 
subsets of ‘conventional’ and ‘unconventional’ T cells that share a legacy of TCR-
driven maturation and a capacity to rapidly respond to innate stimuli. While some of 
these subsets achieve functional maturation in the thymus and home directly to 
their tissue of residence, other subsets are the products of antigen-specific clonal 
expansion and functional differentiation of naïve T cells into TRM cells. Collectively, 
these T cells are hypothesized to be key drivers of immunological stress response 
pathways and their enrichment in non-lymphoid tissue optimally positions them to 
serve as sentinels of tissue stress (Figure 1.3). 





Figure 1.2 Developmental pathways of tissue-resident T cells with innate 
response capabilities 
Classical MHC-restricted - Thymocytes are positively selected by weak TCR 
signalling in the thymus, as strong TCR signalling is associated with their negative 
selection and clonal deletion. Positively selected cells differentiate into naïve CD4+ 
or CD8+ T cells and home to peripheral lymphoid organs. Here they await a rare 
encounter with cognate antigen during microbial infection. Strong cognate antigen-
driven TCR signalling is associated with acquisition of mature effector function and 
tissue-homing capabilities, enabling these cells to migrate to affected tissues and 
deploy adaptive immunity. Following resolution of infection, the adaptive immune 
response contracts but some antigen-specific T cells persist, do not recirculate and 
are peripherally maintained as TRM cells. 
Non-classical MHC-restricted - Thymocytes experience strong TCR signalling 
during agonist selection in the thymus. Thymic differentiation of these cells is 
associated with acquisition of mature effector function, tissue-homing and innate 
response capabilities. Many such cells are peripherally maintained (see later). 
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1.1.3 The lymphoid stress surveillance response 
The immune response that ensues downstream of stress-induced innate activation 
of tissue-resident T cells is described as the Lymphoid Stress Surveillance 
Response (LSSR) (Hayday, 2009). Much like PAMP/DAMP-driven activation of 
myeloid-derived APCs, the LSSR drives rapid deployment of pro-inflammatory and 
cytotoxic effector functions, recruitment of additional leukocytes and modulation of 
adaptive immune responses (Hayday, 2009; Nitahara et al., 2006; Strid et al., 
2011). By positioning T cell activation in the afferent arm of innate immunity, the 
LSSR challenges the textbook model of immune responsiveness and broadens the 
contribution of T cells to host immunity (Figure 1.3) (Hayday, 2009). 
Tissue dysregulation can be directly communicated to tissue-resident innate-like T 
cells via germ-line encoded receptors such as toll-like receptors (TLRs), which 
engage PAMPs during microbial invasion (Martin et al., 2009); receptors for 
inflammatory cytokines  (Gray et al., 2011; Sutton et al., 2009; Wencker et al., 
2013); and natural killer receptors (NKR) such as NKG2D (Shafi et al., 2011; Strid 
et al., 2008). Ligands for NKG2D are MHC Class-I-related molecules of the 
MICA/MICB and ULBP families in humans and Rae1, H60 and Mult1 in mice. 
These ligands are up-regulated during cellular stress and are expressed on primary 
tumours (Girardi et al., 2001; Vantourout et al., 2014); on mechanically perturbed 
epithelia (Strid et al., 2011); and in sites of on-going inflammation (Groh et al., 
1996).  
The NKG2D axis is a model for the LSSR and is likely to represent one of many 
stimulatory trans-cellular interactions that occur between tissue-resident T cells and 
their epithelial or stromal neighbours (Chodaczek et al., 2012; Strid et al., 2008; 
Swamy et al., 2010; Witherden et al., 2010; 2012). NKG2D is constitutively 
expressed by CD8+ TRM cell compartments (Hüe et al., 2004; Xing et al., 2014) and 
by a large proportion of ‘unconventional’ T cells, of which intraepithelial γδ T cells 
are the prototype (Hayday, 2009; Strid et al., 2011; 2008). 
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Figure 1.3 The lymphoid stress surveillance response 
The lymphoid stress surveillance response (LSSR) describes the rapid activation of 
tissue-resident T cells in response to various forms of barrier perturbation that 
occur during microbial or non-microbial challenge. Their activation can take place 
independently of TCR engagement, via receptors for stress-inducible ligands (e.g. 
NKG2D), cytokine receptors or PRRs. The LSSR has been directly implicated in 
the maintenance of barrier integrity; in leukocyte recruitment; in tumour 
immunosurveillance; and in modulating down-stream adaptive immune responses. 
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1.2 γδ  T cells: Prototypic mediators of lymphoid stress 
surveillance 
1.2.1 Evolutionary conservation 
γδ T cells, αβ T cells and B cells comprise a tripartite of antigen-specific 
lymphocytes that utilize somatic gene rearrangement to generate their defining 
antigen receptors (Hayday, 2000). Discovery of the TCRγ gene locus was 
unanticipated (Hayday et al., 1985; Saito et al., 1984) and was made prior to the 
identification of tissue-resident lymphocytes that express them (Borst et al., 1987; 
Brenner et al., 1986; Jitsukawa et al., 1987; Stingl et al., 1987). Whilst a consensus 
has yet to be reached regarding the precise role of γδ T cells in human 
immunology, their conservation across ~450 million years of vertebrate evolution 
would attest to a significant contribution (Chen et al., 2009; Rast et al., 1997). 
Furthermore, recent studies of adaptive immunity in the Lamprey, a primitive extant 
jawless vertebrate, have identified 3 families of lymphocyte-like cells expressing 
somatically rearranged ‘variable lymphocyte receptors’ (VLR-A, -B, or -C) 
(Kasamatsu et al., 2010). While VLR-B is secreted much like B cells secrete 
immunoglobulin, VLR-A and VLR-C are expressed at the cell surface, evoking 
thought-provoking parallels with αβ and γδ T cells. Indeed, the enrichment of VLR-
C+ cells in barrier tissues (e.g. the epidermis) and of VLR-A+ cells in the circulation 
mirrors the anatomical distribution of most γδ and αβ T cells, respectively (Hirano et 
al., 2013). Taken together, these studies provide compelling arguments that the 
three families of antigen-specific lymphocytes carry out critical, non-overlapping 
functions that merit their conservation across the evolution of vertebrates. 
1.2.2 Highly ordered development and site-specific TCR usage 
In all vertebrates that have been analysed, γδ T cells are among the first T cells to 
emerge from the embryonic thymus, with rearrangement of TCRγδ genes 
detectable by embryonic day (E)13 in the mouse, E10 in the chicken and by 
gestational week 8 in the human (Hayday, 2000). Emergence of these T cells 
during embryogenesis is highly ordered and characterized by the sequential 
appearance of thymocytes bearing specific TCRs. In humans, the foetal circulating 
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γδ T cell compartment is initially dominated by Vγ9+Vδ2+ cells, which progressively 
decrease in representation as Vδ1+ and Vδ3+ T cells emerge (Dimova et al., 2015). 
Subsequently, Vγ9+Vδ2+ T cells persist in the adult circulation, whereas Vδ1+ and 
Vδ3+ T cells home to tissues such as the intestinal mucosa and skin (Holtmeier et 
al., 2001; Pang et al., 2012).  
Highly ordered development is also observed in mice, where distinct waves of γδ T 
cells characterised by TCRVγ chain usage sequentially emerge from the embryonic 
thymus. First to appear at embryonic day (E)13 are progenitors for Vγ5+Vδ1+ 
dendritic epidermal T cells (DETC), which exclusively populate the murine 
epidermis (Asarnow et al., 1988; Havran and Allison, 1988; Kuziel et al., 1987; 
Stingl et al., 1987). These are shortly followed by Vγ6+Vδ1+ thymocytes, which 
predominantly home to epithelia in the reproductive tract and tongue (Itohara et al., 
1990); and Vγ7+ thymocytes, that are mostly found as IEL in the small intestinal 
epithelium (Asarnow et al., 1988; Kyes et al., 1989). Henceforth, Vγ5+ DETC, Vγ6+ 
uterine IEL and Vγ7+ small intestinal IEL are considered to be the signature γδ ΙΕL 
compartments of the mouse (Figure 1.4).  
Vγ5+ DETC and Vγ6+ IEL are exclusively generated from foetal thymic progenitors 
and so must be peripherally maintained in their respective tissues (Ramond et al. 
2013; Haas et al. 2012; Muñoz-Ruiz et al. 2016). As their development precedes 
detectable expression of terminal deoxynucleotidyl transferase (TdT), they express 
canonical TCRs lacking junctional diversity that is normally generated via random 
nucleotide addition during Rag-mediated gene rearrangement (Haas et al., 2012; 
Muñoz-Ruiz et al., 2016; Ramond et al., 2013; Y. Zhang et al., 1995). By contrast, 
small intestinal Vγ7+ IEL arise from bone marrow progenitors and accordingly, can 
be reconstituted in adult bone marrow chimeras (Schluns et al., 2004). While they 
do display somewhat greater TCR diversity, their repertoire does not overlap with 
and is significantly less diverse than systemic γδ T cell subsets (Hayday, 2000; 
Kyes et al., 1989).  
Signature DETC compartments with restricted or monoclonal TCR repertoires also 
exist in rats, cows, and cynomolgus macaques (Hayday, 2000; Hein and Dudler, 
1997; Mohamed et al., 2015; Van Rhijn et al., 2007). Likewise, intra-epidermal 
VLR-C+ lymphocyte-like cells of the lamprey are reported to display a restricted 
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antigen receptor repertoire that does not overlap with that of circulating cells 
(Hirano et al., 2013). Humans also have γδ IEL, which are thought to comprise 
~40% of the intestinal IEL compartment and mostly express a Vγ4+ TCR, evoking a 
similarity with site-specific TCRVγ chain usage observed in mice (Figure 1.4) (Di 
Marco Barros et al., 2016; Landau et al., 1995). In summary, γδ T cells deploying 
site-specific TCRs, including signature IEL compartments, are both abundant and 
conserved across jawed vertebrates. The presence of similarly oligoclonal IEL-like 
cells in jawless vertebrates attests to the significance of site-specific antigen-
receptor specificity within these enigmatic immune compartments. 
The generation of an invariant or oligoclonal T cell compartment via RAG-mediated 
somatic gene rearrangement was unprecedented prior to the characterization of 
murine dendritic epidermal Vγ5+Vδ1+ T cells (DETC) (Asarnow et al., 1988). Such 
IEL are poorly suited to the antigen-sampling requirements of conventional 
adaptive immunity but are optimally positioned to serve as sentinels for barrier 
stress. Indeed, the signature associations of specific γδTCRs with particular 
epithelia has led to suggestions that these cells recognise antigens from a 
commonly encountered site-specific pathogen, or self-encoded molecules that are 
indicative of barrier dysregulation (Janeway et al., 1988; Vantourout and Hayday, 
2013). This hypothesized feature, along with the capacity of these cells to be 
activated independently of TCR engagement via bona fide innate receptors 
represents a significant crossover of innate and adaptive immunity. Thus, the 
biology of γδ IEL strongly supports their designation as prototypic innate-like tissue-
resident effectors of LSS (Hayday, 2009). 





Figure 1.4 γδ  IEL development and composition is tightly regulated 
γδ IEL progenitors emerge from the embryonic thymus in iconic waves 
characterized by TCRVγ chain usage. Vγ5+ and Vγ6+ thymocytes home directly to 
the epidermis and uterine epithelium, respectively. Vγ7+ thymocytes emerge in late 
embryonic/early post-natal stages. Notably Vγ7+ IEL can also develop in athymic 
NU/NU mice, so is not clear whether Vγ7+ thymocytes and/or an extrathymic pool of 
progenitors give rise to Vγ7+ IEL in vivo (this will be discussed in subsequent 
sections). Schematic adapted from: (Carding and Egan, 2002) 
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1.2.3 γδ  IEL composition is critical for lymphoid stress surveillance 
The striking evolutionary conservation of site-specific IEL compartments indicates 
that their composition is tightly regulated and may be important to host physiology. 
Whilst there are no mouse models exclusively deficient in IEL, perturbation of γδ 
IEL composition has been experimentally achieved in TCRδ-/- mice, which carry a 
genetic disruption in the TCR Cδ gene segment (Itohara et al., 1993); and in Vγ5-/-
Vδ1-/- mice, which carry targeted disruptions in TCRVγ5 and TCRVδ1 gene loci 
(Hara et al., 2000; Mallick-Wood et al., 1998). TCRδ-/- mice globally lack γδ T cells 
and their epithelia are populated by polyclonal αβ T cells. Vγ5-/-Vδ1-/- mice lack 
canonical DETC, but carry polyclonal γδ T cells in their place. Studies using these 
mutant mice have implicated signature γδ IEL as a critical component of the LSSR 
(Figure 1.3). 
1.2.3.1 Tumour immunosurveillance 
TCRδ-/- and Vγ5-/-Vδ1-/- mice are both reported to display increased susceptibility to 
chemically-induced cutaneous carcinogenesis, by cutaneous application of 
dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylephorbol (TPA) 
(Dalessandri et al., 2016; Girardi et al., 2001; Strid et al., 2008). TCRδ-/- mice have 
also been shown to display increased susceptibility to colorectal carcinoma, 
following intraperitoneal injection of azoxymethane (AOM) (Matsuda et al., 2001). 
Given that the IEL compartments of TCRδ-/- and epidermis T cells of Vγ5-/-Vδ1-/- 
mice are populated by polyclonal αβ and γδ T cells, respectively, these studies 
suggest that signature or canonical γδ IEL subsets perform critical and non-
redundant roles in tumour immunosurveillance.  
1.2.3.2 Cross-talk with adaptive immunity 
The LSSR has been implicated in modulating adaptive immune responses, via 
cellular and molecular pathways that are contingent on intact γδ IEL compartments. 
In support of this, a common phenotype reported during epithelial challenge of 
TCRδ-/- mice manifests as αβ T cell-mediated immunopathology at mucosal sites 
(Hayday et al., 2000). In the gut, it has been shown that TCRδ-/- but not TCRβ-/- or 
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TCRδ-/-β-/- mice display enhanced intestinal bleeding during infection with the 
natural coccidian parasite, Eimeria Vermiformis (Roberts et al., 1996). In the skin, 
TCRδ-/- but not TCRδ-/-β-/- display spontaneous and augmented hypersensitivity 
responses upon cutaneous application of TPA (Girardi et al., 2002). These adverse 
phenotypes could be rescued in the skin by adoptively reconstituting signature Vγ5+ 
DETC (Girardi et al., 2002), and could be rescued in the gut by adoptive transfer of 
intestinal IEL (Roberts et al., 1996). Additional studies have also implicated 
intestinal γδ IEL in the regulation of intestinal immunopathology during 2,4,6-
trinitrobenzene sulfonic acid (TNBS)-induced colitis (Inagaki-Ohara et al., 2004), 
and during infection with Nippostronglyus brasiliensis, a gastrointestinal nematode 
parasite (Inagaki-Ohara et al., 2011). Thus, the signature γδ IEL compartments of 
the skin and the gut are thought to be critical for effective regulation of barrier 
immune responses. 
More recently, the LSSR in the skin was shown to be involved in the induction of 
antigen-specific atopy (Strid et al., 2011). DETC can be activated by acute up-
regulation of NKG2D ligands (e.g. Rae-1) in neighbouring keratinocytes, which 
commonly occurs in response to mild cutaneous abrasion (Strid et al., 2011; 2008). 
When such mechanical perturbation was accompanied by exposure to ovalbumin, 
wild-type (WT) but not Vγ5-/-Vδ1-/- or NKG2D-deficient mice generated ova-specific 
immune responses, characterised by significant increases in serum ova-specific 
IgE (Strid et al., 2011). Altogether, these studies demonstrate that activation of 
LSSR can elicit highly pleiotropic downstream effects on adaptive immunity and 
that each of these are contingent on the presence of a signature γδ IEL 
compartment. 
1.2.3.3 Maintenance of barrier integrity 
Signature γδ IEL are increasingly becoming recognised for their role in the 
maintenance of effective barrier function. Vγ5+ DETC have been shown to display 
constitutive and stress-inducible up-regulation of IL-13 expression, which is thought 
to promote the transition of keratinocytes through the epidermis (Dalessandri et al., 
2016). In their absence, the epidermis of TCRδ-/- mice display a greater degree of 
trans-epidermal water loss and enhanced expression of Rae-1, indicative of 
steady-state barrier dysregulation (Dalessandri et al., 2016). Given that IL-13-
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deficient mice also display increased sensitivity to chemically-induced cutaneous 
carcinogenesis, it is possible that its selective production by canonical DETC is 
required for their role in tumour immunosurveillance (Dalessandri et al., 2016; 
Girardi et al., 2001; Strid et al., 2008).  
Following a full thickness punch biopsy of mouse skin, DETC are also thought to 
promote timely wound healing, possibly through their stress-inducible production of 
keratinocyte growth factor-1 and insulin-like growth factor 1 (Boismenu and Havran, 
1994; Sharp et al., 2004). However, although TCRδ-/- mice do display marked delay 
in re-epithelialization, these studies have not specifically identified canonical DETC-
deficiency to be the cause (Havran and J. M. Jameson, 2010).  
In the gut, it is possible that γδ IEL fulfil a similar role to DETC in the promotion of 
epithelial integrity. Indeed, TCRδ-/- mice have been shown to display increased 
systemic translocation of Salmonella typhimurium ≤4 hours after oral inoculation 
(Edelblum et al., 2015; Hirano et al., 2013; Ismail et al., 2011). Further studies have 
also shown rescue of this phenotype by adoptively transferring Vγ7+ IEL into TCRδ-
/- mice, whereas non-signature Vγ7- IEL were insufficient (Dalton et al., 2006; 
Walker et al., 2013). However, as intestinal γδ IEL do not constitutively express IL-
13, their promotion of barrier integrity appears to be driven via alternative undefined 
mechanisms (Fahrer et al., 2001; Shires et al., 2001). 
The various studies of mice with perturbed γδ IEL compartments have identified a 
multitude of potential contributions that these cells could make to host physiology. 
Furthermore, they have often been able to show, particularly in the skin, that such 
contributions are highly dependent on a single signature γδ T cell subset (e.g. 
Vγ5+Vδ1+ DETC). How such monoclonal or oligoclonal T cell compartments are 
able to regulate such pleiotropic functions is not fully understood, nor is it well 
understood how signature γδ T cell compartments are selected for maintenance at 
a particular anatomical site. 
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1.3 The development and maintenance of IEL composition 
1.3.1 Intestinal IEL composition 
Intestinal IEL are found at a density of approximately 1 lymphocyte per 5-10 
epithelial cells (Cheroutre et al., 2011). Given the extensive surface area of the 
small intestine, this may be one of the largest T cell compartments in the body. 
Unlike the epidermis where >90% of T cells express the canonical Vγ5+Vδ1+ TCR, 
the small intestinal epithelium is jointly occupied by γδ and αβ IEL, in roughly equal 
proportion. Most γδ IEL express CD8αα homodimers and can be subdivided 
according to TCRVγ chain usage. The majority (~60%) of γδ IEL express TCRVγ7, 
whereas the remainder express TCRVγ1 (~30%) or TCRVγ4 (~10%) (Cheroutre et 
al., 2011; Kawaguchi et al., 1993). By contrast, Vγ1+ and Vγ4+ T cells comprise 
~70% of the systemic γδ T cell compartment (Haas et al., 2012).  
αβ IEL include non-MHC restricted innate-like T cells that express the CD8αα 
homodimer and MHC-restricted T cells that express CD8αβ or CD4, although CD4+ 
cells are usually a minor subset (Hayday et al., 2001). Collectively, CD4+ and 
CD8αβ+ IEL constitute an intestinal TRM compartment that accumulates throughout 
life, following repeated exposure to foreign antigens (Figure 1.2) (Bandeira et al., 
1990; Sheridan and Lefrançois, 2011; Sheridan et al., 2014). A small proportion of 
TRM cells may also acquire co-expression of CD8αα homodimers, which is thought 
to arise during strong TCR signalling in the presence of cytokines such as TGFβ 
and retinoic acid, both of which are present in the gut microenvironment (Y. Huang 
et al., 2011; Mucida et al., 2013; Reis et al., 2013). In summary, the small intestinal 
epithelium is predominantly occupied by Vγ7+, TCRβ+CD8αα+ or TCRβ+CD8αβ+ 
IEL, alongside smaller subsets of γδ and αβ T cells. 
Intestinal IEL are not uniformly distributed as IEL density is greatest in the proximal 
small intestine and progressively decreases towards the caecum (H. Suzuki et al., 
2000). Furthermore, while γδ and TCRβ+CD8αα+ IEL display their greatest 
abundance in the proximal small intestine, TCRβ+CD4+ and TCRβ+CD4+CD8αα+ 
IEL are more abundant in the distal small intestine, which could suggest these cells 
perform site-specific functions (H. Suzuki et al., 2000). Unlike the small intestine, 
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colonic IEL are predominantly (>80%) αβ T cells (Kuo et al., 2001). In considering 
how signature γδ IEL subsets may develop and persist in a given anatomical site, it 
is necessary to briefly review γδ and αβ T cell and IEL development. 
1.3.2 Thymic development of αβ  and γδ  T cells 
T cell development conventionally occurs in the thymus where bone marrow-
derived haematopoietic lymphoid progenitors differentiate into naïve or innate-like 
αβ or γδ T cells. It is generally accepted that a common thymic progenitor has the 
capacity to generate both αβ and γδ T cells, however this does not rule out the 
possibility that some subsets of T cells derive from distinct progenitor pools (Haks 
et al., 2005; Hayes et al., 2005; Kreslavsky et al., 2008; Ramond et al., 2013; Zarin 
et al., 2014). T cell progenitors infiltrate the thymus at the cortico-medullary junction 
as TCR-, CD4-CD8- double negative cells and their differentiation can be divided 
into 4 stages (DN1àDN4) according to their cell surface expression of CD25 and 
CD44 (DN1-CD44+CD25- à DN2-CD25+CD44+ à DN3-CD25+CD44low à DN4-
CD25loCD44lo) (Rothenberg et al., 2008). RAG-mediated rearrangement of the 
TCRβ, γ and δ gene loci begins at DN2 and is largely completed by DN3 (Ciofani 
and Zúñiga-Pflücker, 2010). Cells that productively rearrange a γδ TCR adopt a DN 
γδ T cell fate, whereas cells that fail to do so can assemble a pre-TCR, composed 
of TCRβ and pre-TCRα. The pre-TCR delivers weak ligand-independent signals 
and drives DN thymcoytes to adopt a CD4+CD8+ double positive (DP) αβ T cell fate 
(Dudley et al., 1995; Prinz et al., 2006). 
1.3.2.1 Conventional αβ  T cell selection 
Several experimental systems have demonstrated that TCR signalling is a key 
regulator of T cell lineage commitment. While strong signals delivered through a γδ 
TCR drive thymocytes to a DN γδ T cell fate, weak ligand-independent signals 
delivered through a pre-TCR drive thymocytes to a DP αβ T cell fate (Haks et al., 
2005; Hayes et al., 2005; Kreslavsky et al., 2008; Zarin et al., 2014). DP 
thymocytes rearrange the TCRα gene locus in order to assemble mature TCRαβ 
heterodimers that serve as substrates for MHC-mediated positive and negative 
selection (Figure 1.5) (Germain, 2002). During selection, highly self-reactive cells 
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experience strong TCR signalling and die by apoptosis, whereas non self-reactive 
cells die by neglect. Positively selected cells are weakly self-reactive, experience 
intermediate levels of TCR signalling and adopt a CD4+ or CD8+ single positive 
(SP) αβ T cell fate in accordance with their restriction to MHC class II or class I, 
respectively. 
1.3.2.2 Developmental pre-programming of γδ  T cells 
The role of negative selection during γδ T cell development is poorly defined 
(Hayday, 2009; Vantourout and Hayday, 2013). However, several subsets of 
innate-like γδ T cell progenitors are understood to require agonist selection 
downstream of strong TCR signals, driven by their engagement of largely 
undefined TCR ligands (Jensen et al., 2008; Muñoz-Ruiz et al., 2016; Turchinovich 
and Hayday, 2011; Wencker et al., 2013). Agonist selection describes the selection 
of γδ and αβ thymocytes that developmentally engage agonist TCR ligands, 
experience a strong TCR signal but are not negatively selected (Figure 1.5) 
(Baldwin et al., 2004; Hogquist and S. C. Jameson, 2014). Many agonist-selected 
γδ T cells (e.g. DETC and Vγ6+ IEL) are thought to derive exclusively from foetal 
thymic progenitors and are developmentally pre-programmed with pre-defined 
effector functions (e.g. IFNγ versus IL-17 production) and tissue-homing capabilities 
(Figure 1.5) (Ribot et al., 2009; Turchinovich and Hayday, 2011).  
Developmental pre-programming is mediated via TCR signalling, in conjunction 
with co-stimulation via a range of germ-line encoded receptors (Ribeiro et al., 2015). 
This pathway is best described for IFNγ-producing γδ T cells, which critically 
depend on TCR stimulation; trans-conditioning from DP thymocytes; and co-
stimulation through CD27 and lymphotoxin (LT) receptor, both of which are 
members of the tumour necrosis factor (TNF) receptor superfamily (Figure 1.5) 
(Muñoz-Ruiz et al., 2016; Pennington et al., 2003; Ribot et al., 2009; Silva-Santos 
et al., 2005; Turchinovich and Hayday, 2011). 
Because of developmental pre-programming, IFNγ-producing γδ T cells and 
thymocytes can be distinguished from IL-17-producing γδ T cells and thymocytes 
by their constitutive cell surface expression of CD27 and by their distinct gene 
expression signature. This gene expression signature includes regulators of G 
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protein signalling, Rgs1 and 2; Tbx21; the inducible cAMP early repressor of 
transcription (ICER); and various transcription factors from the nerve growth factor-
induced B family (e.g. Nr4a1) (Malhotra et al., 2013; Narayan et al., 2012; 
Pennington et al., 2003; Ribot et al., 2009; Silva-Santos et al., 2005). This gene 
expression signature is also shared with intestinal TCRαβCD8αα+ and γδ IEL, 
which also express CD27 and produce IFNγ upon stimulation (Malinarich et al., 
2010; Montufar-Solis et al., 2007; Pennington et al., 2003). By contrast, these 
genes are not highly expressed by intestinal TCRβCD8αβ+ TRM IEL, which do 
produce IFNγ but develop via conventional MHC-mediated selection and antigen-
dependent peripheral activation (Figure 1.2) (Masopust et al., 2006; Pennington et 
al., 2003; Schenkel and Masopust, 2014; Yamagata et al., 2004). Given their 
similar gene expression signatures, it is possible that signature intestinal γδ IEL, 
TCRβ+CD8αα+ IEL and innate-like CD27+ γδ T cells receive similar signals (e.g. 
agonist selection) during their development. 




Figure 1.5 Model for thymic development of γδ /αβ  T cells 
αβ  T cell selection - Cells that fail to productively rearrange TCRγ/δ gene loci can 
assemble the αβ TCR and undergo MHC-mediated positive and negative selection. 
Due to selection, it is estimated that <5% of the αβTCRs generated through Rag-
mediated rearrangement in the thymus are represented in the periphery (Goldrath 
and Bevan, 1999). 
γδ  T cell differentiation - Some γδ T cells, including IL-17 producing subsets 
(γδ17) and DETC, exclusively derive from foetal thymic progenitors (Haas et al., 
2012; Ramond et al., 2013). However, other subsets, such as innate-like CD27+ 
IFNγ-producing cells may also derive from adult bone marrow (Muñoz-Ruiz et al., 
2016). Rearrangement of TCRγ/δ gene loci depends on IL-7 cytokine, which 
regulates chromatin accessibility at this site (Schlissel et al., 2000; Ye et al., 2001). 
The transcription factors Sox4 and Sox13 are known to promote γδ T cell 
differentiation (Melichar et al., 2007).  
γδ  T cell pre-programming - Signalling through the TCR, CD27 and the LT 
receptor (LTRβ) are each required for the developmental pre-programming of most 
IFNγ-producing γδ T cells (γδIFNγ).  Their thymocyte precursors interact with thymic 
medullary epithelial cells, which express CD70 (the TNF ligand for CD27) 
(Tesselaar et al., 2003); and DP thymocytes, which produce LT and mediate 
additional trans-conditioning (Silva-Santos et al., 2005). While CD27+ γδIFNγ cells 
down-regulate Sox13 and Sox4 and up-regulate genes such as Tbx21 and Egr3, 
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CD27- γδ17 cells maintain Sox13 and Sox4 expression and up-regulate Rorc. The 
curved arrows highlight the fact that many such γδ T cell subsets exclusively derive 
from the foetal thymus and are peripherally maintained. 
γδ  T cell agonist selection - It was originally postulated that TCR agonist ligand 
engagement drives γδ thymocytes towards an CD27+ γδIFNγ cell fate, whereas 
weaker ligand-independent signalling drives cells towards a ‘default’ CD27- γδ17 
cell fate (Jensen et al., 2008). While the requirement for strong TCR signalling in 
γδIFNγ cells has been substantiated in various studies (Muñoz-Ruiz et al., 2016; 
Turchinovich and Pennington, 2011; Wencker et al., 2013), recent reports have 
identified additional complexity in the developmental requirements for γδ17 cells 
(Muñoz-Ruiz et al., 2016; Wencker et al., 2013). In particular, these studies 
demonstrated that: a) all γδ17 cells depend on developmental TCR-associated 
signalling; and b) Vγ6+ (but not Vγ4+) CD27- γδ17 cells require high levels of cell 
surface γδ TCR expression to develop, suggesting they may require strong agonist-
mediated selection. Given these developments, further studies are now required to 
identify the contribution of TCR ligands (versus ligand-independent signalling) to 
the development of these discreet populations of γδ17 cells (Turchinovich and 
Pennington, 2011). 
An alternative pathway for γδ17 cells - It was recently shown that γδ17 cells can 
be derived from DN2 but not DN3 or DN4 foetal thymocytes in vitro (Shibata et al., 
2014). These data suggest that foetal-derived γδ17 cells could bi-pass the DN3 and 
DN4 stages of thymocyte development in vivo. In order to account for this 
possibility, a blue dashed arrow is included in the above model. Figure adapted 
from: (Vantourout and Hayday, 2013). 
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1.3.3  Thymic agonist selection of intestinal innate-like αβ  IEL 
T cells expressing the CD8αα homodimer are rare in the circulation but are 
abundant in the small intestinal epithelium. Their TCR repertoire is both oligoclonal 
and site-specific as it does not overlap with that of lymph node αβ T cells or with 
TCRβ+CD8αβ+ cells in the small intestinal epithelium or lamina propria (Arstila et 
al., 2000; Cheroutre et al., 2011; Mayans et al., 2014; McDonald et al., 2014; 
Regnault et al., 2016; Rocha et al., 1991). While TCRβ+CD8αα+ IEL are not 
restricted to classical MHC class I/II or CD1, they do depend on developmental 
interactions with non-classical MHC class Ib molecules. As such, β2m-/- but not 
CD1- or classical MHC class I/II-deficient mice are depleted for most 
TCRβ+CD8αα+ IEL (Capone et al., 2003; G. Das et al., 2000; Fujiura et al., 1996; 
Park et al., 1999). 
Because TCRβ+CD8αα+ IEL display such a restricted, site-specific TCR repertoire, 
they are thought to comprise self-reactive αβ T cells. Consistent with this, they 
develop independently of the microbiome and of diet-derived protein antigens, and 
in DBA/2 (M1sa IE+) mice, express TCRVβ (Vβ6, Vβ8.1 and Vβ11+) chains that are 
normally negatively selected by thymic super-antigens (Bandeira et al., 1990; 
Hayday et al., 2001; Rocha et al., 1991). Furthermore, mice transgenic for TCRs 
that display high but not low affinity for thymic ligands preferentially generate 
TCRβ+CD8αα+ cells in vivo (Leishman et al., 2002; Yamagata et al., 2004). Thus, it 
is generally considered that TCRβ+CD8αα+ IEL are generated from self-reactive 
thymocytes that are positively selected by strong, agonist-mediated TCR signalling 
(Baldwin et al., 2004). 
Consistent with this notion, co-stimulation-deficient CD28-/- or B7-/- mice display 
marked defects in the negative selection of super-antigen-reactive thymocytes, 
which instead develop into TCRβ+CD8αα+ IEL (Pobezinsky et al., 2012). Using this 
system, it was shown that the development of these thymocytes was characterized 
by their up-regulation of CD122, CD5, CD69 and PD-1, all of which are markers 
associated with agonist selection (Azzam et al., 2001; Hanke et al., 1994; Ishida et 
al., 1992; McDonald et al., 2014). Furthermore, their development was also 
characterized by their transition from the DP compartment, back into the DN 
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compartment, revealing a major divergence in the developmental pathways of 
conventional MHC-restricted αβ T cells versus agonist-selected TCRβ+CD8αα+ IEL 
(Figure 1.6).  
Because agonist ligands for TCRβ+CD8αα+ IEL are mostly unidentified, studies 
have sought to characterise the importance of αβ TCR specificity in their agonist 
selection and lineage commitment. By analysing the development of thymocytes 
bearing transgenic TCRs cloned from TCRβ+CD8αα+ (unconventional) and 
TCRβ+CD8αβ+ (conventional) IEL, it was shown that unconventional TCRs 
exclusively drove the development of innate-like CD8αα+TCRαβ+ or CD4-CD8-
TCRαβ+ IEL. By contrast, thymocytes expressing conventional TCRs gave rise to 
intestinal TCRαβ+CD8αβ TRM cells (Mayans et al., 2014; McDonald et al., 2014). 
Taken together, these data strongly attest to the importance of TCR specificity in 
determining the lineage determination of αβ thymocytes. The implication is that 
only thymocytes bearing agonist ligand-reactive TCRs develop into TCRβ+CD8αα+ 
IEL. 
The mechanism by which strong TCR signalling drives agonist selection of some 
αβ T cells and clonal deletion of others is poorly understood. Some studies have 
suggested that agonist-selection may take place within a tight perinatal window, 
prior to the establishment of efficient clonal deletion (Hayday et al., 2001; Lin et al., 
1999). However, this model would not accommodate the fact that TCRβ+CD8αα+ 
IEL can be reconstituted from adult bone marrow chimeras (Schluns et al., 2004). 
Other studies have proposed that TCRβ+CD8αα+ cells develop extrathymically, or 
avoid negative selection by exiting the thymus at the DN stage (Guy-Grand et al., 
1991; Lambolez et al., 2005; 2002; Naito et al., 2008). However, lineage tracing 
studies have shown that these cells uniformly transition through a DP status at 
some point of their development (G. Eberl and Littman, 2004). An alternative 
possibility is that TCRβ+CD8αα+ IEL derive from distinct haematopoietic 
progenitors that are intrinsically pre-programmed to survive agonist selection. 
Some evidence for this was provided by a study that showed TCRβ+CD8αα+ IEL to 
derive from a rare population of CD8αα-expressing DP thymocytes (so called triple 
positive; TP cells) (Gangadharan et al., 2006). As the CD8αα homodimer is 
thought to repress TCR signalling and promote T cell survival (Cheroutre and 
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Lambolez, 2008; Y. Huang et al., 2011; Leishman et al., 2001; Madakamutil et al., 
2004; Olivares-Villagómez et al., 2008), it was suggested that up-regulation of 
CD8αα in a subset of (possibly pre-committed) DP thymocytes serves to rescue 
them from clonal deletion during strong TCR signalling (Gangadharan et al., 2006). 
Although precise details regarding the development of TCRβ+CD8αα+ IEL remain 
under investigation, these various studies have outlined a prototypic pathway for 
the agonist selection of self-reactive IEL. This pathway differs from conventional 
MHC-mediated selection because it may require up-regulation of CD8αα at the DP 
stage (i.e. a TP stage) (Gangadharan et al., 2006); because it involves strong TCR 
signalling (Mayans et al., 2014; McDonald et al., 2014; Rocha et al., 1991; 
Yamagata et al., 2004); and because it may involve down-regulation of CD4 and 
CD8 prior to thymic export (Lambolez et al., 2005; McDonald et al., 2014) (Figure 
1.6). 
1.3.4 The extrathymic development of intestinal γδ  IEL 
Athymic NU/NU mice harbour no uterine or epidermal IEL and likewise have very 
few αβ T cells but their intestinal epithelium contains substantial numbers of γδ IEL 
(20-30% of that in euthymic mice) (Guy-Grand et al., 1991; Nonaka et al., 2005). 
The intestinal mucosa is thought to support extrathymic γδ T cell development in 
specialised lymphoid organs called cryptopatches that are found in the crypt lamina 
propria (Kanamori et al., 1996; Naito et al., 2008; Saito et al., 1998). These small 
lymphoid compartments are enriched in immature haematopoietic lin- cells 
expressing receptors for stem cell factor and IL-7 (c-kit+IL7R+), which reconstitute 
mature γδ IEL when adoptively transferred to thymectomized immunodeficient 
recipients (Lambolez et al., 2002; Saito et al., 1998). γδ IEL can also be 
reconstituted by transplantation of donor bone marrow into thymectomized lympho-
depleted recipients, and is associated with the sequential appearance of 
cryptopatch structures, CD3- and then CD3+ IEL (K. Suzuki et al., 2000). Consistent 
with the capacity of the intestinal mucosa to support γδ T cell development, 
enterocyte-specific expression of an IL-7 transgene alone can rescue γδ IEL 
development in IL-7-/- mice (Laky et al., 2000). Thus, there is a significant body 
evidence to suggest the small intestinal mucosa can support the extrathymic 
lymphopoiesis of γδ IEL (Figure 1.6). An extrathymic pathway of development 
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would represent a significant difference between γδ IEL and thymic agonist-
selected TCRβ+CD8αα+ IEL. 
Although extrathymic γδ T cell development clearly takes place in NU/NU mice, a 
number of studies have questioned this pathway and the extent to which it 
contributes to γδ IEL development in euthymic mice (Figure 1.6). For example, 
neonatal thymectomy is associated with a substantial depletion of both intestinal γδ 
and αβ IEL, suggesting that thymic transit may be a key component intestinal IEL 
development (Lefrançois and Olson, 1994). In support of this, sub-cutaneous re-
engraftment of thymic lobes into thyemectomized adults can rescue the intestinal 
IEL compartment (Lefrançois and Olson, 1994). Furthermore, as γδ IEL still develop 
in Rorγt-deficient mice that are significantly depleted of cryptopatches, the 
relevance of these lymphoid aggregates to IEL development has been questioned 
(G. Eberl, 2005; G. Eberl and Littman, 2004; Naito et al., 2008). Other studies have 
used transgenic mice expressing green fluorescent protein (GFP) downstream of 
the Rag2 promoter, to test whether TCR rearrangement is detectable amongst 
cryptopatch cells or IEL. Whilst GFPHI cells, indicative of recent or active Rag 
expression, were abundant in Peyer’s patches and mesenteric lymph nodes (MLN) 
of athymic mice, they were undetectable amongst IEL or cryptopatch cells of 
euthymic or athymic animals, which directly challenges the proposed pathway for 
extrathymic T cell development (Guy-Grand et al., 2003), although this too has 
been contested (Ishikawa et al., 2007).  
Most recently, it has been proposed that low frequencies of Vγ7+ intestinal IEL 
progenitors continuously emerge from the thymus and require prior activation in 
Peyer’s patches before infiltrating the gut epithelium (Guy-Grand et al., 2013). 
However, this model is difficult to reconcile with the virtually unimpaired 
development of Vγ7+ IEL in NU/NU alymphoplasia (aly/aly) mice that are athymic 
and lack all lymph nodes, Peyer’s patches and isolated lymphoid follicles (Nonaka 
et al., 2005). Hence, the developmental pathway and selection of signature γδ IEL 
remains largely unresolved (Hayday and Gibbons, 2008).  
The potential of the intestinal mucosa to support γδ T cell development has not 
been the focus of most recent studies, despite its potential relevance to the lifelong 
maintenance of γδ IEL. Indeed, extrathymic development may represent a critical 
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pathway by which signature tissue-resident immune compartments are replenished 
beyond thymic evolution. Hence these pathways could have profound implications 
for immunological senescence in the LSSR and merit further study. 
1.3.4.1 Agonist selection of intestinal γδ  IEL 
Although the developmental pathway of signature γδ ΙΕL remains unresolved, it is 
generally thought that these cells are also developmentally agonist-selected. In 
order to study the importance of γδ TCR specificity and test the contribution of 
agonist ligand engagement to the development of intestinal γδ IEL, various groups 
have analysed γδ TCR-transgenic (Tg) mouse models. The G8 γδ TCR is known to 
engage the non-polymorphic MHC class Ib molecule TLb (T22), which is normally 
expressed on thymic medullary and small intestinal epithelial cells of C57Bl/6 mice 
(Adams et al., 2005; 2008; Crowley et al., 2000; Shin et al., 2005). By comparing γδ 
IEL development in T22+ve versus T22-ve G8-TCR-Tg mice, it was shown that 
although intestinal γδ IEL can develop independently of T22, they require its 
expression to adopt the signature Thy1-CD8αα+ cell surface phenotype of most γδ 
IEL (Hayday et al., 2001; Lin et al., 1999). Furthermore, while G8-TCR-Tg 
thymocytes were abundant in the thymus of T22+ve neonates, they were largely 
undetectable in that of adults, suggesting that they had been negatively selected. 
Hence, G8-TCR-Tg IEL in T22+ve mice developed exclusively from neonatal 
progenitors and required TCR agonist ligand engagement in the thymus and/or gut 
in order to attain phenotypic maturity (Lin et al., 1999).  
Further substantiating these observations, the intestinal γδ IEL of mice rendered 
transgenic for the expression of non-gut IEL associated γδTCRs (e.g. the DETC 
Vγ5+Vδ1+ TCR) are also reported to display an unconventional Thy1+CD8αα- cell 
surface phenotype (Bonneville et al., 1990). Thus, studies of γδ IEL development in 
γδ TCR-Tg mice support the notion that signature intestinal γδ ΙΕL require agonist 
selection to attain phenotypic maturity. 
To further test this model outside of a TCR-Tg system, Jensen et al., (2009) 
analysed the cell surface phenotype of T10/T22-reactive intestinal γδ IEL in 
C57Bl/6 (T10/T22+) versus β2m-/- (T10/T22-deficient) mice. ~1% of all mouse γδ T 
cells have been shown to engage T10/T22 via their TCRδ chain. These T cells are 
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readily identified using fluorescently-conjugated T22 tetramers and have been 
shown to emerge from the thymus irrespective of whether or not their TCR ligands 
(T10/T22) are expressed (Jensen et al., 2008). Staining of intestinal γδ IEL with T22 
tetramers showed that T22-reactive cells displayed a CD122HI phenotype in 
C57Bl/6 mice and a CD122LO phenotype in β2m-/- mice (Jensen et al., 2009). As 
up-regulation of CD122 is a hallmark of agonist selection (Jensen et al., 2008; 
Lewis et al., 2006; Turchinovich and Hayday, 2011), this study attested to the 
importance of developmental agonist ligand-engagement in the phenotypic 
maturation of small intestinal γδ IEL. However, as these conclusions are based on 
data acquired in a very small subset (~1%) of γδ IEL, the extent to which it applies 
to the full γδ IEL compartment is unclear. 
1.3.5 Intestinal factors regulating γδ  IEL composition 
Following their putative agonist selection and migration to the gut epithelium, there 
are several factors that peripherally determine the mature composition of γδ IEL. 
These factors include self-expressed cytokines but also include exogenous diet-
derived components. Interestingly, each of these factors are equally critical for the 
peripheral maintenance of signature DETC (De Creus et al., 2002; Kadow et al., 
2011; Kawai et al., 1998).  
1.3.5.1 IL-15 signalling 
Several cytokines, including IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 engage distinct 
multimeric cytokine receptor complexes that each make use of the common γ chain 
receptor subunit (CD132). CD132 is constitutively expressed on most lymphocytes 
and has been implicated in several immune processes, including T cell 
development, maintenance, activation and memory generation (Schluns and 
Lefrançois, 2003; Waickman et al., 2015). Its critical role in immune function is 
illustrated by the syndrome of severe combined immunodeficiency (SCID) seen in 
individuals that carry a loss of function mutation in the γC gene (Noguchi et al., 
1993).  
IL-15 primarily exists in complex with IL15Rα and is trans-presented from intestinal 
enterocytes to IEL expressing CD132 and IL-2Rβ (CD122) (Stonier and Schluns, 
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2010). This trans-cellular interaction is critical for the peripheral expansion and 
maintenance of signature Vγ7+ IEL and TCRβ+CD8αα+ IEL (Lai et al., 2008). 
Consistent with this, IL-15Rα-/- and IL-15-/- mice are markedly depleted in 
TCRβ+CD8αα+ IEL and γδ IEL, the development of which can be rescued in IL-
15Rα-/- mice by enterocyte-specific expression of an IL15Rα transgene (Ma et al., 
2009; H. Suzuki et al., 1997). It has also been shown that haematopoietic 
expression of CD122 and stromal expression of IL-15 and IL-15Rα are critical for 
the reconstitution of Vγ7+ and TCRβ+CD8αα+ IEL from adult donor bone marrow 
(Schluns et al., 2004). Given that thymic lobes from IL-15Rα-/- mice can still give 
rise to γδ and TCRβ+CD8αα+ IEL when engrafted into WT hosts (Lai et al., 2008), it 
is the intestinal IL-15 that is critical for the establishment and long-term 
maintenance of signature IEL subsets. The impact of IL-15 signalling on intestinal 
IEL may be mediated by driving their proliferation (Lodolce et al., 1998) and/or by 
promoting their long-term survival via up-regulation of anti-apoptotic molecules 
such as Bcl-2 (Ma et al., 2009). 
As the up-regulation of CD122 is one hallmark of agonist selection, one could 
expect agonist-selected TCRβ+CD8αα+ or γδ IEL to have a selective survival 
advantage in the small intestinal epithelium (Hanke et al., 1994; Jensen et al., 
2008; Turchinovich and Hayday, 2011). In this regard, it is conspicuous that Vγ1+ 
IEL are not dependent on IL-15 signalling for their reconstitution in adult bone 
marrow chimeras (Schluns et al., 2004). Perhaps this suggests that Vγ7+ but not 
Vγ1+ cells are agonist-selected to up-regulate CD122 and henceforth preferentially 
survive in their shared small intestinal niche. Such a model could explain why Vγ7+ 
cells are the predominating γδ IEL subset in this location (Kawaguchi et al., 1993).  
1.3.5.2 Aryl hydrocarbon receptor  
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is 
probably best known for its role in mediating the toxic effects of dioxins, which 
include hazardous bi-products of industrial processes (Connor and Aylward, 2007). 
This receptor is expressed by various subsets of immune cells, including γδ IEL, but 
is also expressed by several non-lymphoid tissues (e.g. epithelia). AhR-deficiency 
is associated with several phenotypes, including a reduction in splenic and lymph 
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node lymphocytes, chronic liver fibrosis and a marked depletion in small intestinal 
γδ and TCRβ+CD8αα+ IEL (Fernandez-Salguero et al., 1995; Y. Li et al., 2011). The 
impact of AhR on intestinal IEL is independent of the epithelium as its expression 
was shown to be specifically required in RAG-dependent lymphoid cells for IEL 
development (Y. Li et al., 2011).  
Intestinal ligands for the AhR are thought to include tryptophan derivatives that are 
specific to plants (e.g. indole-3-carbinol). Such ligands are particularly enriched for 
in cruciferous vegetables such as cabbage and are found in the normal mouse diet. 
Synthetic diets deficient in such ligands were found to deplete intestinal γδ IEL, 
whereas diets containing these ligands were found to maintain them (Y. Li et al., 
2011). Thus, whilst the development of signature γδ IEL occurs independently of 
the microbiome (Bandeira et al., 1990; Kawaguchi et al., 1993), their maintenance 
in the small intestinal epithelium is contingent on their continued exposure to 
exogenous ligands for the AhR (Figure 1.6). 




Figure 1.6 Model for the development of γδ  and TCRβ+CD8αα+ IEL 
γδ  IEL development - Strong TCR signals downstream of agonist selection (yellow 
arrow) are thought to drive acquisition of a mature cell surface phenotype in γδ IEL 
precursors. Agonist selection may take place in the neonatal thymus (Lin et al., 
1999); mesenteric lymph node (MLN) or Peyer’s patch (PP) (Guy-Grand et al., 
2013); or during infiltration into the small intestinal epithelium (Lambolez et al., 
2002). γδ IEL may develop via a thymic (G. Eberl and Littman, 2004) or extrathymic 
(Guy-Grand et al., 1991; Lambolez et al., 2002; Naito et al., 2008) pathway. 
TCRβ+CD8αα  IEL development - A small subset of DP thymocytes express the 
CD8αα homodimer, which is thought to promote their survival during agonist ligand 
engagement (Gangadharan et al., 2006). Agonist selection is associated with 
acquisition of a CD122+CD5+CD69+ DN cell surface phenotype. These cells 
migrate to the small intestinal epithelium and adopt a CD8αα+CD5-CD69+ cell 
surface phenotype (Mayans et al., 2014; McDonald et al., 2014). 
IEL maintenance - Signalling through the IL-15 receptor expressed by agonist-
selected IEL and aryl hydrocarbon receptor (AhR) is critical for the peripheral 
maintenance of γδ and TCRβ+CD8αα+ IEL (Y. Li et al., 2011; Ma et al., 2009; 
Schluns et al., 2004). 
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1.3.6 Skint1: a tissue-restricted selecting element 
Studies of small intestinal IEL development have outlined a prototypic pathway 
through which signature intestinal γδ and αβ IEL compartments develop (Figure 
1.6). This pathway involves agonist selection, which drives up-regulation of CD122, 
and peripheral maintenance, which is at least partly mediated by signals received 
through CD122 and the AhR. Within this model, agonist-selection may serve to 
endow signature IEL subsets with the responsiveness to IL-15 (via up-regulation of 
CD122) that is required for their selective maintenance in a given epithelia. This 
could explain why Vγ7+ IEL predominate over Vγ1+ and Vγ4+ IEL in the small 
intestinal epithelium and could also explain why Vγ5+ IEL comprise >90% of 
epidermal T cells. However, it fails to explain how discreet compartments of γδ IEL 
establish and maintain their signature associations with specific epithelial tissues 
(i.e. Vγ7+ and TCRβ+CD8αα+ with gut; Vγ5+ with skin). While research has been 
successful in identifying a multitude of functional and phenotypic hallmarks of 
tissue-resident T cells, very little is actually known about the factors that 
constitutively regulate tissue-resident T cell composition (Fan and Rudensky, 
2016). In this regard, a singular insight has been provided by the discovery of 
Skint1. 
Skint1 is the founding member of a novel immunoglobulin superfamily of trans-
membrane proteins related to B7 and is exclusively expressed in thymic medullary 
epithelial cells and suprabasal keratinocytes (Boyden et al., 2008). Mice that carry 
a loss-of-function mutation in Skint1 lack canonical DETC and consequently display 
spontaneous and augmented cutaneous hypersensitivity responses (Lewis et al., 
2006). The ablation of canonical DETC in Skint1 mutant mice is primarily a 
developmental defect as DETC progenitors fail to acquire functional and 
phenotypic maturity in the thymus and fail to home to the skin (Barbee et al., 2011; 
Lewis et al., 2006; Turchinovich and Hayday, 2011). Consequently, DETC 
progenitors in Skint1 mutant mice carry a pre-agonist-selected 
CD27LOCD122LOTCRLO cell surface phenotype and produce IL-17 rather than IFNγ 
upon stimulation ex vivo (Figure 1.5) (Barbee et al., 2011; Lewis et al., 2006; 
Turchinovich and Hayday, 2011). Developmental interactions with Skint1-
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expressing thymic medullary epithelial cells are therefore critical for normal DETC 
development. 
While the receptor for Skint1 on DETC has not been identified, there is evidence to 
suggest that its impact is mediated via a TCR-associated pathway. Consistent with 
this, the phenotypic maturation of DETC in Skint1 mutant thymic lobes can be 
rescued in foetal thymic organ culture (FTOC) by providing soluble TCRVγ5-
specific agonist antibody. Furthermore, cell surface expression of Skint1 is 
necessary for this pathway as it can be inhibited in WT FTOC by providing Skint1-
IgV-specific blocking antibodies (Lewis et al., 2006; Salim et al., 2016). Thus, the 
data are consistent with Skint1 engaging a receptor on DETC progenitors, to drive 
a molecular pathway that can be phenocopied using TCR agonist antibodies.  
Further substantiating the notion of TCR involvement in DETC development, a 
gene expression analysis of Vγ5+ thymocytes in WT versus Skint1 mutant mice 
identified a Skint1-dependent gene expression signature that was indicative of 
strong TCR signalling. This gene expression signature could be also elicited in 
adult γδ thymocytes by TCR agonist antibody stimulation (Turchinovich and 
Hayday, 2011). While these data would be consistent with Skint1 engaging the 
canonical DETC TCR, direct evidence for this has not been shown and it does not 
preclude it acting as a co-stimulator. In either case, the impact of Skint1 provides a 
clear example of how a thymus- and skin-restricted epithelial element can 
selectively elicit TCR-associated pathways to drive the development of a signature 
IEL compartment. 
1.3.7 Canonical DETC have a selective survival advantage in the skin 
Although Skint1 is also expressed by epidermal keratinocytes, it remains to be 
established whether peripheral Skint1 expression is necessary to retain canonical 
DETC in situ. That notwithstanding, there is some evidence to suggest that DETC 
expressing canonical TCRs experience a selective survival advantage in situ. This 
was elegantly demonstrated in a study where TdT expression was forcibly induced 
in neonatal DETC progenitors by replacing its promoter with that for Lck (Aono et 
al., 2000). The approach was successful as both the foetal thymus and newborn 
skin of these mutant mice was enriched for DETC expressing non-canonical TCRs 
with non-germline encoded junctional sequences. However, such cells failed to 
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persist and were largely replaced by canonical DETC by 10 weeks of age. Thus, 
DETC expressing canonical TCRs display a selective survival and/or proliferation 
advantage in situ in neonatal skin.  
In support of this, the epidermis of mice that carry a genetic disruption in the 
TCRVδ1 gene segment (Vδ1-/- mice) remains enriched for Vγ5+ T cells that 
selectively increase in density from post-natal week 1 to week 16. By contrast, no 
such enrichment in Vγ5+ cells is seen in Skint1 mutant mice (Lewis et al., 2006). 
Moreover, Vγ5-/- mice, which also lack canonical DETC, are enriched for cells 
expressing TCRs that are reactive to the 17D1 antibody (Mallick-Wood et al., 
1998). 17D1 binds a conformational epitope present on canonical Vγ5+Vδ1+ TCRs 
and accordingly, does not bind to any T cells in the replacement polyclonal γδ 
epidermal T cell compartment of Skint1 mutant mice. Thus, in the presence of 
functional Skint1, Vγ5-/- and Vδ1-/- mice are each able to generate replacement 
DETC expressing γδ TCRs with features conserved from that of the canonical 
DETC TCR. If Skint1 really is driving the selective peripheral expansion of DETCs 
bearing specific TCRs, one would expect the enrichment in Vγ5+ and 17D1-reactive 
epidermal T cells (in Vδ1-/- and Vγ5-/- mice) to be ablated when these strains are 
crossed with Skint1-mutant mice. 
1.3.8 DETC constitutively engage keratinocytes 
To test whether any TCR signalling occurs at the steady state and during challenge 
in canonical DETC, a recent study has employed intravital imaging and confocal 
microscopy to visualise DETC activation in situ (Chodaczek et al., 2012). During 
the steady state, DETC extend several apically orientated dendrites that are 
anchored to suprabasal keratinocyte tight junctions, forming contacts enriched for 
TCR and phosphorylated intracellular signalling components (e.g. phospho-CD3ζ). 
Consistent with TCR specificity being important in the formation of these contacts, 
such phosphotyrosine-rich aggregates located on projections (PALPs) are not 
observed in rare populations of Vγ5- DETC, or in replacement DETC in TCRδ-/- 
mice (Chodaczek et al., 2012). These data would be consistent with DETC TCR 
constitutively signalling at the steady state in cells specifically expressing the 
canonical DETC TCR. Such signals could promote the selective expansion and/or 
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maintenance of canonical DETC in situ. Furthermore, they may also drive the 
constitutive transcription of IL-13 that has been reported in these cells (Dalessandri 
et al., 2016). In support of this model, conditional deletion of the linker for activated 
T cells (LAT) in TCRδ+ cells specifically reduces the proliferative capacity of DETC 
in neonatal skin and in adult skin following full thickness punch biopsies (B. Zhang 
et al., 2015). 
In addition to promoting their maintenance, constitutive TCR signalling may serve 
to keep DETC in a functionally pre-primed state that enables them to rapidly 
respond to the stress-inducible engagement of NKG2D (Strid et al., 2011; 2008), 
junctional adhesion molecule-like protein (JAML) (Witherden et al., 2010) or CD100 
at their cell surface (Witherden et al., 2012). In the context of constitutive TCR 
signalling, the overt and possibly deleterious activation of DETC in the absence of 
stress may be prevented by their developmental attenuation of TCR 
responsiveness, which has been shown to occur during Skint1-mediated selection 
in the thymus (Wencker et al., 2013). Indeed, altered responsiveness to TCR 
stimulation has also been reported for γδ17 cells, in addition to putative ‘agonist-
selected’ intestinal γδ and TCRβ+CD8αα+ IEL, suggesting it may be an important 
feature in the biology of several innate-like T cell subsets (Malinarich et al., 2010; 
Wencker et al., 2013). 
In summary, Skint1 is an organ-specific determinant of canonical DETC 
composition. Its expression in thymic medullary epithelial cells is critical for the 
selective agonist selection of DETC progenitors and its expression in keratinocytes 
may be required for PALP formation, or for selectively promoting DETC survival in 
situ. The discovery of Skint1 has fuelled the hypothesis that various epithelia 
express tissue-restricted selecting elements that shape the lifelong composition of 
their signature γδ IEL compartments. In support of this, several species that 
express a functional Skint1 orthologue, including rats, cows and cynomolgus 
macaques, possess epidermal or skin-resident γδ T cell compartments with highly 
restricted γδTCR repertoires (Hayday, 2000; Hein and Dudler, 1997; Mohamed et 
al., 2015; Van Rhijn et al., 2007). That notwithstanding, the prospect that Skint 
genes might offer a generalizable mechanism by which tissue-resident γδ T cells 
may be selected and maintained has been widely questioned. This is because 
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neither DETC nor Skint1 is conserved in humans, and because the expression of 
Skint gene family members is predominately restricted to the skin and thymus 
(Boyden et al., 2008; Mohamed et al., 2015). 
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1.4 The Butyrophilins: emerging regulators of γδ  T cells 
Skint genes constitute a subfamily of butyrophilin-like (BTNL/Btnl) genes that are 
closely related to the B7 family of co-stimulators/repressors that are themselves 
thought to have close evolutionary relationships to MHC (Abeler-Dörner et al., 
2012; Afrache et al., 2012; Henry et al., 1999). The butyrophilins (BTN/Btn) derive 
their name (‘butter-loving’) from the prototypic founder BTN1A1/Btn1a1, which is 
highly expressed in epithelial cells of lactating mammary glands; encodes a major 
protein constituent of milk fat globules (MFG); and is critically required for MFG 
secretion (Franke et al., 1981; Jack and Mather, 1990; Ogg et al., 2004). Following 
the discovery of murine Skint1, human BTN3 genes were found to be key 
regulators of the TCR-dependent activation of human circulating Vγ9+Vδ2+ T cells 
(Harly et al., 2012). 
1.4.1 The Butyrophilin gene family 
The extended BTN/Btn gene family contains up to 14 gene groups that are 
believed to have been present in a common Eutherian ancestor (Afrache et al., 
2012). While some groups have been stably conserved across species (e.g. BTN1), 
some groups have been lost (e.g. BTN3 in rodents) and others have undergone 
tandem duplication within specific lineages (e.g. Skint in rodents), consistent with 
rapid evolution and selection (Afrache et al., 2012). Human BTN genes can be sub-
divided into three phylogenetically associated subfamilies, BTN1 (BTN1A1), BTN2 
(BTN2A1, BTN2A2, BTN2A3) and BTN3 (BTN3A1, BTN3A2, BTN3A3). Two of 
these genes are conserved in the mouse including Btn1 (Btn1A1) and Btn2 
(Btn2a2). However, the mouse has many more butyrophilin-like (Btnl) genes, 
including Btnl1, 2, 4, 5, 6, 7, 9 and 10, the closely related Skint1 - 11, erythroblast 
membrane associated protein (Ermap) and myelin oligodendrocyte glycoprotein 
(Mog). Of these, only Btnl2, Btnl9, Mog and Ermap have clear orthologues in 
humans (BTNL2, BTNL9, MOG and ERMAP), whereas SKNTL and BTNL10 are 
predicted to encode pseudogenes. The human genome additionally contains 
BTNL3 and BTNL8, which are not conserved in the mouse (Abeler-Dörner et al., 
2012; Afrache et al., 2012; Rhodes et al., 2016) (Figure 1.7). 
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Most BTN/Btn and BTNL/Btnl genes encode integral membrane proteins with two 
extracellular immunoglobulin (Ig) domains (IgC and IgV) and an intracellular B30.2 
domain (also termed PRY/SPRY) (Rhodes et al., 2016; 2005). The exceptions to 
this are BTN2A3 (likely a pseudogene and/or non-functional) and BTN3A2 which 
lack a B30.2 domain; BTNL2/Btnl2 which encodes four extracellular domains 
(2xIgV and 2xIgC) and lacks the B30.2; and MOG/Mog and ERMAP/Ermap, which 
both contain a single extracellular IgV (although MOG lacks a B30.2) (Rhodes et 
al., 2016) (Figure 1.7). B30.2 (PRY/SPRY) domains are found on ~150 human and 
~700 eukaryotic proteins but their function in immunity is best characterized in 
TRIM proteins, where they appear to have evolved to bind specific endogenous or 
exogenous ligands (Woo et al., 2006). For example, rhesus TRIM5α encodes a 
viral restriction factor that binds human immunodeficiency virus (HIV) capsid via its 
B30.2 domain and targets it for proteasome degradation (Pertel et al., 2011). By 
contrast, the B30.2 domain of TRIM21 serves as a high affinity intracellular Fc 
receptor that binds IgG-opsonised viral particles as they enter the cell cytoplasm. 
This interaction subsequently drives antibody-dependent intracellular neutralisation 
pathways (Rhodes and Trowsdale, 2007). Both of these highly specific protein 
interactions are thought to be enhanced by multimerization of TRIM proteins, which 
enables these molecules to serve as high avidity intracellular innate PRRs (Mische 
et al., 2005). 
As TRIM genes are often located in close proximity to BTN/BTNL gene clusters, it 
is possible that these families share an evolutionary link and that the biological 
activity of BTNs/BTNLs may be similarly regulated by multimerization and/or by 
their engagement of intracellular ligands via B30.2 domains. Indeed, this appears 
to be the case for the prototypic member Btn1a1, where both multimerization 
(Robenek et al., 2006) and intracellular binding of xanthene oxidoreductase (XOR) 
by the B30.2 domain (Jeong et al., 2009) has been proposed to regulate MFG 
secretion from the apical membrane of lactating mammary gland epithelium 
(Franke et al., 1981; Ogg et al., 2004).  





Figure 1.7 Predicted structure and phylogenetic tree of Butyrophilin gene family 
Adapted from: (Abeler-Dörner et al., 2012; Rhodes et al., 2016) 
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1.4.2 BTN3 is a key regulator of human Vγ9+Vδ2+ T cell activation 
Vγ9+Vδ2+ T cells are the most abundant γδ T cell subset in the human circulation 
and display rapid TCR-dependent responsiveness during accumulation of low-
molecular-mass phospho-antigens (pAg) that are intermediary products of 
isoprenoid synthesis (Hayday, 2009; Karunakaran and Herrmann, 2014; Pang et 
al., 2012). Isopentenyl pyrophosphate (IPP) is a key building block for isoprenoids 
that are generated in most eukaryotes via the mevalonate pathway and in various 
plants and microorganisms via the non-mevalonate pathway (Karunakaran and 
Herrmann, 2014). IPP itself is a weak pAg and vastly less potent than its precursor 
in the non-mevalonate pathway, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate 
(HMBPP). The potency of HMBPP is such that infection by HMBPP-producing 
microorganisms (e.g. mycobacterium tuberculosis) can drive extensive clonal 
expansion of Vγ9+Vδ2+ cells, increasing their representation among circulating T 
cells from ~1-5%, to as much as 50% (M. Eberl et al., 2003; Shen et al., 2002).  
IPP accumulates during dysregulation of mevalonate metabolism, which can occur 
during cellular transformation or viral infection and can also occur when IPP-
metabolizing enzymes are pharmacologically inhibited by aminobisphosphonates 
(Gober et al., 2003; J. M. Jameson et al., 2010; Thurnher and Gruenbacher, 2015; 
van Beek et al., 1999). Indeed, aminobisphosphonate-pulsed cells are potent 
activators of Vγ9+Vδ2+ T cells and are often used for functional assays in vitro (H. 
Das et al., 2001). As pAgs are too small to directly crosslink the Vγ9+Vδ2+ TCR, 
activation of these T cells is contingent on cell:cell contact with a human or primate 
‘pAg-presenting cell’ (pAgPC) expressing the three isoforms of BTN3 (BTN3A1, 
BTN3A2, BTN3A3). BTN3 is ubiquitously expressed in human cells and is critical 
for pAg-mediated activation of Vγ9+Vδ2+ T cells (Harly et al., 2012). Hence, short 
hairpin RNA-mediated knock-down of any single BTN3 isomer in a pAgPC 
substantively diminishes its capacity to activate Vγ9+Vδ2+ T cells in vitro (Rhodes et 
al., 2015).  
BTN3A1 is believed to be particularly important for pAg-presentation as its over-
expression (alone) in BTN3A1/3A2/3A3 ‘triple knock-down’ cells (but not that of 
BTN3A2/3A3) is sufficient to fully rescue pAg-presenting capabilities (Harly et al., 
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2012). The Vγ9+Vδ2+ TCR is directly implicated in this pathway as its expression in 
TCR-deficient jurkat T cell lines is sufficient to confer pAg-reactivity (H. Das et al., 
2001). While these data are strongly indicative of BTN3A1 mediating its impact via 
the Vγ9+Vδ2+ TCR, direct binding of BTN3A1 to the TCR has not been reproducibly 
demonstrated and its mechanism of action remains unclear (Rhodes et al., 2015; 
Sandstrom et al., 2014; Vavassori et al., 2013). Recent data suggest that pAgs 
bind to the B30.2 domain of BTN3A1 (Sandstrom et al., 2014), eliciting 
conformational changes to the protein (Sebestyen et al., 2016) that enable its direct 
engagement of the TCR or a co-receptor, or its recruitment of additional factors that 
engage the TCR (Karunakaran and Herrmann, 2014; Riaño et al., 2014). 
Studies of murine Skint1 and human BTN3 have identified two non-orthologous 
members of the same extended gene family that regulate TCR-dependent 
processes in discreet subsets of γδ T cells. While Btn genes are conserved 
amongst placental mammals, closely related gene families have also been 
identified in zebrafish, xenopus and chickens (Afrache et al., 2012; Salomonsen et 
al., 2014). Moreover in chickens, which are particularly abundant in γδ T cells, 
several of these Btn-related BG genes have been shown to display tissue-restricted 
expression (Berndt et al., 2006; Salomonsen et al., 2014). Collectively, these 
studies suggest that butyrophilin and butyrophilin-related gene families are strong 
candidates for evolutionarily conserved regulators of γδ T cell biology and tissue-
specific composition. 
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1.5 Summary and thesis aims 
The mammalian immune system has evolved to mediate rapid responsiveness to 
both microbial and non-microbial environmental challenge. In order to cope with the 
latter, organisms deploy organ-specific innate-like T cells that constitutively monitor 
tissue stress. Such cells can rapidly deploy site-specific effector responses and can 
modulate downstream adaptive immunity, which helps to ensure that the overall 
immune response is appropriate to the context and nature of an environmental 
challenge. Prominent among these cells are the γδ IEL, which in several species 
have been shown to display striking site-specific TCRVγ chain usage. Their 
appropriate anatomical compartmentalization within an organism is critical for 
stress surveillance as its perturbation has profound implications for barrier integrity, 
tumour immunosurveillance and tissue immunopathology. While much is known 
regarding the phenotypic and functional hallmarks of these cells, very little is known 
about how their critical compartmentalisation is established and regulated. 
In an attempt to determine how such compartmentalisation is established, research 
has focussed on characterising the developmental pathways of αβ and γδ IEL. 
Collectively, these studies have provided a prototypic outline for IEL development, 
which involves their developmental agonist selection, followed by their peripheral 
maintenance in discreet epithelia. While providing important information, these 
studies have failed to establish how discreet populations of γδ T cells, defined by 
their TCR Vγ chain usage, establish and maintain their life-long associations with 
specific epithelial tissues.  
In this regard the discovery of Skint1 as an organ-specific regulator of DETC 
composition has provided an important clue. The expression of Skint1 in thymic 
medullary epithelium, where it is necessary for DETC selection, and in suprabasal 
keratinocytes, where it may be necessary for DETC maintenance, suggests that 
discreet epithelia could deploy tissue-specific elements to shape their local γδ IEL 
compartments (Figure 1.8). However, the prospect that Skint genes offer a 
generalizable mechanism by which γδ IEL are selected has been questioned 
because neither DETC nor Skint1 is conserved in humans, and because the Skint 
genes are mostly expressed in the skin and thymus.  
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That notwithstanding, Skint genes are closely related to BTN/Btn/BTNL/Btnl genes 
that are conserved in humans and are emerging as key regulators of γδ TCR-
dependent processes. Specifically, the three isomers of BTN3 are now known to be 
critical for the TCR-dependent activation of human Vγ9+Vδ2+ T cells. As Skint1 and 
BTN3 represent non-orthologous members of the same extended gene family, their 
shared regulation of γδ T cell biology challenges the commonly held notion that 
these immune cells are highly species-specific with few or no conserved features 
(Kazen and Adams, 2011). Furthermore, as BTN/BTNL genes and BTN-related 
genes appear to be conserved across evolution, these studies fuel the hypothesis 
that this extended gene family may contain several subset-specific regulators of γδ 
T cell selection, maintenance and/or activation. To begin testing this hypothesis, 
this thesis will seek to establish whether murine Btnl genes regulate small intestinal 
γδ IEL composition. 





Figure 1.8 Regulation of γδ  IEL composition 
This schematic depicts the hypothesis that will be tested by this thesis: Do 
intestinal Btnl genes regulate the composition of signature small intestinal γδ IEL? 
Adapted from: (Carding and Egan, 2002). 
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1.5.1 Are Btnl1, 4 and 6 determinants of signature intestinal γδ  IEL? 
Within the murine Btn family, the genes most homologous to Skint1 are Btnl1, Btnl4 
and Btnl6 (Abeler-Dörner et al., 2012; Bas et al., 2011). All three of these genes 
are conspicuously expressed in small intestinal enterocytes and are encoded within 
the MHC II locus of chromosome 17. Interestingly, this is a region that has 
previously been associated with regulating intestinal γδIEL composition (Lefrançois 
et al., 1990; Pereira et al., 1997). In vivo, Btnl1 protein is detected on essentially all 
villus enterocytes, where it displays apical perinuclear enrichment and instances of 
juxtaposition with IEL (Bas et al. 2011). Taken together, each of these features 
makes Btnl1, Btnl4 and Btnl6 strong candidates for site-specific regulators of 
signature intestinal γδ IEL composition. 
1.5.2 Specific aims 
The aim of this thesis is to test the hypothesis that organ-specific products of Btnl 
genes serve to establish and maintain the lifelong composition of signature small 
intestinal γδ IEL (Figure 1.8). 
 
To test this hypothesis, my primary objectives are as follows: 
• To characterise the phenotypic maturation of signatory intestinal Vγ7+ IEL in 
WT mice. 
• To identify the developmental time point and anatomical location where Vγ7+ 
IEL acquire their mature cell surface phenotype. 
• To determine the impact of Btnl1 and Btnl4 in this process through a 
comprehensive analysis of Btnl1-/- and Btnl4-/- mice. 
• To investigate the mechanisms by which Btnl genes mediate their impact on 
γδ T cells. 
 




Chapter 2. Materials & Methods 
For full details regarding buffer recipes, cytokines, antibodies, chemicals, materials, 
kits and DNA based reagents, please refer to the appendix. 
2.1 Mice 
All Animal experiments were undertaken in full compliance with UK Home Office 
regulations and under a project license to Prof. Adrian Hayday (80/2480). 
Experiments included 2-36 week-old (as indicated) male and female mice. Wild-
type (WT) C57Bl/6 mice were obtained from Charles River and Harlan. 3 
independently derived embryonic stem (ES) cells for Btnl1-/- (Btnl1tm1(KOMP)Mbp) and 
ES cells for Btnl4-/- (Btnl4tm1(KOMP)Mbp) mice were obtained from the international 
mouse phenotyping consortium (IMPC) (project IDs: CSD67994 and CSD81524). 
WT and Btnl-knockout lines were generated and maintained at The Francis Crick 
Institute's Biological resource facilities. B6.Cg-Foxn1<Nu>/J (NU/NU) mice were 
obtained from the Jackson Laboratory. Nur77.gfp mice were kindly provided by K. 
Hogquist (Moran et al., 2011). Alymphoplasia (aly/aly) mice were previously 
described (Shinkura et al., 1999). For timed pregnancies, mice were mated 
overnight and E0 was considered as the day a vaginal plug was observed. 
2.1.1 Germ-free mice and food antigen-free nutrition 
C57Bl/6 mice maintained on germ-free or on solid-food antigen-free diets were 
bred at the Institute for Medical Microbiology and Hospital Epidemiology, University 
of Marburg, Germany where all experiments were conducted according to the 
German animal protection law. 
Germ-free (GF) mice were kept in plastic isolators (Metall and Plastik, Germany) 
with autoclaved food, bedding and water. Sterility of animals was checked bi-
weekly by culturing faeces in thioglycollate medium under aerobic and anaerobic 
conditions for at least ten days. All handling procedures for GF mice were 
conducted in a laminar flow hood under sterile conditions. All experiments were 
conducted according to the German animal protection law. 




Food antigen-free (FAF) mice were raised on an amino acid-containing diet for up 
to five generations. Pellets of FAF diet (ssniff, S7242-E014/-E714) contained all 
essential vitamins, minerals, trace elements, fat, dextrin, sucrose and free amino 
acids equimolar to the protein content of normal rodent chow (LASQCdietRod16, 
LASvendi). 
2.1.2 Generation of doxycyclin inducible Btnl-1 transgenic (Tg) mice 
Doxycycline (Dox)-inducible Btnl1-Tg mice were generated by injection of Btnl1-/- 
blastocysts with a linearised cassette containing a CMV-promoter regulated by a 
tetracycline response element (TRE) upstream of the Btnl1-ORF. The TRE/CMV 
cassette has been previously described (Oppenheim et al., 2005). R26-rtTA-M2 
(Hochedlinger et al., 2005) or Villin-rtTA-M2 (Roth et al., 2009) mice were bred to 
homozygosity for Btnl1-deficiency and backcrossed onto Btnl-Tg mice for 3 
generations to facilitate global (R26) or local (Villin) induction of Btnl1 transgene 
expression. Doxycycline was administered to the drinking water (1mg/ml Dox, 2% 
sucrose). Ctrl water contained 2% sucrose. Water was changed 3 times a week. 
2.2 Immune cell isolation protocols 
2.2.1 Intestinal intraepithelial lymphocytes 
Intraepithelial lymphocytes (IEL) were isolated from the entire length of the small 
intestine as previously described (Wencker et al., 2013). In brief, small intestinal 
tissue was opened longitudinally and thoroughly washed in ice-cold PBS prior to 
processing. Intestinal tissue was cut into 0.5-1cm long pieces and incubated for 
20min at room temperature on a turning wheel, in 50ml falcon tubes containing 
10ml RPMI:Dithiothreitol (DTT) solution. Tissue suspensions were centrifuged and 
the RPMI:DTT solution was decanted. Tissues were re-suspended in 10ml ‘IEL 
recovery medium’ and vortexed for 4 minutes at maximum speed. Supernatants 
containing cell suspension were harvested through 70µm nylon cell strainers. 
Tissues were then re-suspended in 10ml of fresh IEL recovery medium to repeat 
vortexing and filtration steps. The cell strainers were each washed with 30ml PBS.  




To recover IEL, cells were pelleted and re-suspended in 40% percoll. Samples 
were centrifuged on a 20/40/80% percoll density gradient at 700g for 30min. IEL 
were harvested from the 40% to 80% Percoll interface. 
2.2.2 Isolation of murine thymocytes 
Thymus lobes were dissected and transferred to ice cold PBS. Blood vessels were 
removed under a dissection microscope. Lobes were mechanically disaggregated 
and passed through a 70 µm cell strainer. Cell suspensions were collected for 
staining. 
2.2.3 Isolation of bone marrow cells 
4-6 week old donor mice were sacrificed to harvest femurs and tibias. Bone 
scissors were used to cut the proximal and distal ends of the femur/tibia. Bones 
were flushed with ice cold sterile Hank’s Balanced Salt Solution (HBSS) through a 
27G needle/syringe. Clumps were disaggregated using a 19G needle/syringe, 
passed through a 40µM cell strainer and collected in a 50ml falcon tube. Cells were 
pelleted and re-suspended in 1ml of red blood cell lysis buffer (shaken at room 
temperature for 2 minutes). Cells were washed with HBSS and re-suspended at an 
appropriate concentration. 
2.3 Flow Cytometry 
2.3.1 Antibodies 
Flow cytometry was performed using the following antibodies, coupled to the 
indicated fluorochromes (see Appendix for Cat. Numbers). Fluorophore-
conjugated antibodies for mouse: CD3 APC Cy7 (17A2); CD3 PerCPCy5.5 
(145-2C11); TCRβ Brilliant Violet 421 (H57-597); TCRβ APC (H57-597); CD122 PE 
(TMβ1); CD122 Brilliant Violet 421 (TMβ1); CD122 APC (TMβ1); TIGIT PE 
(GIGD7); CD45RB APC Cy7 (C363-16A); Thy1.2 Brilliant Violet 510 (53-2.1); Lag3 
PerCP-efluor 710 (C9B7W); CD5 PE (53-7.3); CD24 FITC (M1/69); CD24 PECy7 
(M1/69); CD8α PECy7 (53-6.7); CD8α PECy7 (53-6.7); TCR Vδ4 FITC (GL-2); 
TCR Vδ4 PE (GL-2); CD8β PerCpCy5.5 (YTS156.7.7); CD25 PerCpCy5.5 (PC61); 
CD69 PECy7 (H1.2F3); CCR9 PECy7 (CW-1.2); CD44 PECy7 (IM7); TCRVγ7 




(F2.67) was provided by Pablo Pereira (Institut Pasteur, Paris, France); TCRVγ1 
APC (2.11); TCRVγ4 APC (UC3-10A6); TCRδ BV421 (GL3); Ki67 FITC 
(B56/MOPC-21); CD45 Qdot 605 (30-F11); CD5 Brilliant Violet 510 (53-7.3); TCRδ 
PeCy7 (GL3); CD161/NK1.1 Brilliant Violet 650 (PK136); CD4 Brilliant Violet 786 
(GK1.5); CD8α AlexaFluor 700 (53-6.7); CD25 APC (PC61); GITR PE  (DTA-1); 
CD44 FITC (IM7); CD62L PerCP-Cy5.5 (MEL-14); KLRG1 BV421 (2F1); CD11c 
BV786 (HL3); CD11b BV510 (M1/70); F4/80 PerCPCy5.5 (BM8); Ly6G APC (1A8); 
Ly6C AlexaFluor 700 (AL-21); CD103 PE (M290); CD317 Brilliant Violet 650 (927); 
MHCII/IA/IE FITC (2G9); CD86 Pe-Cy7 (GL1); CD3 Brilliant Violet 421 (145-2C11); 
CD19 Brilliant Violet 421 (1D3); CD161/NK1.1 (lin) Brilliant Violet 421 (PK136); 
IgG1 PE (A85-1); B220 (CD45R) AlexaFluor 700 (RA3-6B2); IgM Brilliant Violet 
786 (R6-60.2); IgD PerCPCy5.5 (11-26c.2a); GL-7 AlexaFluor 647 (GL7); CD95 
PECy7 (Jo2); CD138 Brilliant Violet 650 (281-2); CD21/35 FITC (7G6); CD23 
Brilliant Violet 421 (B-ly6). Other antibodies: DYKDDDDK-PE (Flag); 
DYKDDDDK-APC (Flag); HA-DyLight 650; 6x-Histidine-PE; LEAF-Purified Hamster 
IgG Isotype Control (HTK888); LEAF-Purified anti-mouse CD3 (2C11) 
Commercial antibodies were purchased from Biolegend, eBioscience, BD-
Bioscience, Thermo Fisher Scientific or Miltenyi (see appendix). Viability dyes (near 
IR or Blue) were from Invitrogen. All cell surface and intracellular stains were 
performed in 96-well V-bottom plates. 
2.3.2 Production of anti-TCRVγ7 antibody 
F2.67 Hybridoma was cultured in DMEM supplemented with glutamine, 
penicillin/streptomycin, sodium pyruvate, non-essential amino acids, β-mercapto 
ethanol and 5% foetal calf serum (FCS). Anti-TCRVγ7 (F2.67, provided by Pablo 
Pereira [Insitut Pasteur, Paris, France]) was purified from hybridoma supernatant 
using the mouse tissue culture supernatant (TCS) purification system (abcam). 
Purified anti-TCRVγ7 was conjugated to biotin (EZ-Link Sulfo-NHS-LC Biotinylation 
Kit, Thermo Fisher Scientific) or to Alexa-Fluor(AF)647 (labelling kit, Thermo Fisher 
Scientific). 




2.3.3 Viability dye 
Viability dyes were used at a dilution factor of 1:1000 in phosphate buffered saline 
solution (PBS). Cells were stained for 15-20 minutes at 4oC and then washed with 
FACS buffer prior to cell surface staining. Live/Dead Fixable Blue Dead Cell Stain 
Kit (Thermo Fisher) was used for all staining panels apart from spleen and 
mesenteric lymph node immunophenotyping. Zombie NIRTM Fixable Viability Kit 
(Biolegend) was used for spleen and mesenteric lymph node immunophenotyping 
experiments. 
2.3.4 Cell surface stain 
Cells were incubated in 20µl FC block for 15 minutes at 4oC. Antibodies were 
diluted in FACS buffer to produce a 2X concentrated stock solution. 20µl of 2X 
antibody mix was added to each well containing cells suspended in FC block. Cell 
surface stains were performed for 25-30 minutes at 4oC. Samples were either 
analysed on the same day as staining, or fixed for 4mins at room temperature 
(shielded from light) in 4% paraformaldehyde, stored overnight at 4oC and analysed 
the following morning. 
2.3.5 Ki67 intracellular stain 
Ki-67 staining was performed after cell surface stains on cells fixed and 
permeabilzed using the Foxp3 staining buffer kit in accordance with the 
manufacturer’s instructions (eBioscience). In brief, cells were re-suspended in 
Fixation/Permebilization solution and left for 30 minutes at room temperature 
shielded from light. Cells were then washed twice in permeabilization buffer and re-
suspended in 30µl Ki67 antibody mix (1:30 in permeabilization buffer). Cells were 
incubated for 30 minutes at room temperature, washed in permeabilization buffer 
and then washed and re-suspended in FACS buffer for analysis. 
2.3.6 EdU Click-iT assay 
EdU incorporation was assessed by flow cytometry 3 hours post-intraperitoneal 
injection (50mg/kg) (Click-iT EdU AF647 Assay Kit, Invitrogen). EdU Click-iT 




reaction was performed according to manufacturer’s instructions in 96-well V-
bottom plates in 70µl reaction mix.  
All flow cytometry data analysis performed on FlowJo (Version 9.9). 
2.3.7 Spleen and mesenteric lymph node immunophenotyping 
Comprehensive immunophenotyping of mesenteric lymph node (MLN) and splenic 
immune cells in Btnl1-/-, Btnl1+/- and C57Bl/6 mice, was performed using a platform 
developed by the Wellcome trust Infection and Immunity Immunophenotyping (3i) 
consortium (www.immunophenotyping.org). Briefly, spleen and MLN were digested 
in collagenase (1mg/ml)/DNAse (0.1mg/ml) in 2% foetal calf serum (FCS) 
phosphate buffered saline (PBS +Ca/Mg) for 20 minutes at 37oC. Samples were 
filtered through 30µm cell strainers, and shaken for 2 minutes at room temperature 
in red blood cell (RBC) lysis buffer (SIGMA). Samples were washed in PBS, 
centrifuged and plated on 96-well V-Bottom plates for staining. All stains were 
performed at 4oC for 20 minutes. Full details regarding the phenotyping panels and 
gating strategy are included (see Appendix). Samples were acquired on a BD LSR 
Fortessa X-20 equipped with 405nm (40mW), 488nm (50mW), 561nm (50mW) and 
640nm (100mW) lasers. 
2.4 Quantitative-RT-PCR, transfection and lentiviral 
transduction. 
2.4.1 MODE-K transfectants/transductants 
MODE-K cell transductants were generated and kindly provided by Dr Vantourout  
for this study. Briefly, the self-inactivating lentiviral vector pCSIGPW (SFFV 
promoter – Multiple Cloning Site [MCS] – IRES-GFP – CMV promoter – 
PuromycinR) was constructed by replacing the PuromycinR/mIR cassette from the 
pAPM vector (Pertel et al., 2011) by a custom EcoRI-XhoI-PmeI-NotI-BamHI-XbaI-
MluI MCS. The IRES-GFP cassette was cloned by PCR from the pIRES2-eGFP 
vector (Clonetech) using the BamHI/XbaI sites. The CMV promoter was cloned by 
PCR from the pCDNA3.1+ vector (Thermo Fischer Scientific) using the MluI/ClaI 
sites. The Puromycin resistance gene was cloned by PCR from the pGIPZ vector 
(Dharmacon) using the ClaI/AgeI sites. The pCSIGHW variant was generated by 




exchanging the puromycin resistance gene with a hygromycin B resistance gene, 
which was cloned by PCR from the pLHCX vector (Clontech). 
cDNAs were (sub-)cloned into pCSIGPW or variant vectors. Btnl1, Btnl4 and Btnl6 
were previously described (Bas et al., 2011).  
Transfections were carried out in HEK293T cells using PEI (3:1 PEI:DNA ratio, 
Polysciences). Btnl/BTNL expression was checked 48h post-transfection. Lentiviral 
particles were produced in HEK293T cells by co-transfection of pCSIGPW or 
pCSIGHW either empty (empty vector; EV) or containing Btnl cDNA, pCMVΔR8.91 
(HIV-1 tat/rev/gag/pol) (Zufferey et al., 1997), and pHIT/G (MLV env) (Fouchier et 
al., 1997). Transduced cells were treated with puromycin and hygromycin 48h post-
transduction for 7 days, sorted on the basis of GFP expression and used for 
functional assays. 
2.4.2 Quantitative RT–PCR. 
For whole tissue analysis, the small intestine was divided into 3 segments 
(proximal 1/3, medial 1/3 and distal 1/3) and a 0.5cm piece of whole small intestine 
was taken from the middle of each. Tissue was either frozen in RNAlater or directly 
lysed in RLT lysis buffer (supplemented with β mercaptoethanol [1:100]), in 2ml 
eppendorf tubes in a tissue lyser (Qiagen; with metal beads). RNA was purified 
using the Qiagen RNeasy kit, according to manufacturer’s instructions. Cellular 
samples were flow stored into 400µl of IEL recovery medium in 1.5ml eppendorf 
tubes (4oC). Sorted cells were pelleted, and lysed in RLT lysis buffer 
(supplemented with β mercaptoethanol [1:100]) prior to RNA purification (Qiagen 
RNeasy kit).  
cDNA was synthesized using Superscript-II (Invitrogen) and analysed using Power-
Sybr-green assay (Invitrogen) using a ViiA7 Real-time PCR machine (Applied 
Biosystems). 
2.4.3 qRT-PCR primers 
Btnl1 For:  5'-TGACCAGGAGAAATCGAAGG-3' 
Btnl1 Rev:  5'-CACCGAGCAGGACCAATAGT-3' 




Btnl4 For:  5'- CATTCTCCTCAGAGACCCACACTA-3' 
Btnl4 Rev:  5'- GAGAGGCCTGAGGGAAGAA-3' 
Bntl6 For:  5'-GCACCTCTCTGGTGAAGGAG-3' 
Btnl6 Rev:  5'-ACCGTCTTCTGGACCTTTGA-3' 
β-Actin For:  5'-CAGCTTCTTTGCAGCTCCTT-3' 
β-Αctin Rev:  5'-CACGATGGAGGGGAATACAG-3' 
Sox13 For:  5’-CTCCAGGCCTTCCCAGAC-3’ 
Sox13 Rev:  5’-CATGGACTTCCAGCGAGAAC-3’ 
Rorγc For:  5’-GGTGACCAGCTACCAGAGGA-3’ 
Rorγc Rev: 5’-CCACATACTGAATGGCCTCA-3’ 
Tbp For: 5’-GGGGAGCTGTGATGTGAAGT-3’ 
Tbp Rev: 5’-CCAGGAAATAATTCTGGCTCA-3’ 
CycloFor: 5’- CAAATGCTGGACCAAACACAA-3’ 
Cyclo Rev: 5’- CCATCCAGCCATTCAGTCTTG-3’ 
2.5 Southern Blotting 
2.5.1 Genomic DNA extraction 
Genomic DNA was extracted from tail tissue. Tissue was incubated overnight 
(shaking at 56oC) in 360µl tail buffer + 15µl Proteinase K (10mg/ml stock). 125µl 
5M NaCl was added to precipitate debris, which was pelleted before harvesting the 
supernatant. Supernatant was transferred to a tube containing 250µl isopropanol. 
Samples were centrifuged, isopropanol decanted and pellets were re-suspended in 
500µl 70% ethanol. Samples were centrifuged, ethanol decanted and pellets were 
air dried for ~1hr at room temperature. DNA was eluted in milliQ H2O. 
2.5.2 DNA digestion, electrophoresis and Southern blotting 
10-20µg genomic DNA was digested with the indicated restriction enzymes (AseI, 
EcoRI or Kpnl) under conditions recommended by manufacturer’s instructions 
(New England Biolabs). Digested DNA was ethanol precipitated, mixed with 
bromophenol blue loading buffer and ran on 0.8% agarose gel (constant voltage: 
40V overnight). Agarose gel was incubated at room temperature with depurination 
buffer for (10mins with gentle agitation); then with denaturation buffer (30mins with 




gentle agitation); then with neutralisation buffer (30mins with gentle agitation); then 
rinsed with milli-Q water. 
DNA was blotted overnight by capillary action onto a nitrocellulose membrane in 
20X SSC buffer. Nitrocellulose blotted DNA was cross-linked by ultra-violet (UV) 
radiation, then dried for 1 hour at room temperature. 
2.5.3 Probe generation 
Digoxigenin (DIG)-labelled DNA probes were generated by PCR of genomic DNA 
using the following primers: 
Btnl1 For: 5'-ACTGGCTTCCTCAGAGTCAT-3' 
Btnl1 Rev: 5'-CAGTAGTGAATGGCCCCTGA-3' 
Btnl4 For: 5'-GACCAACGCTTCCCTACCTC-3' 
Btnl4 Rev: 5'-GCCTTGGGTCCAACAAGACA-3' 
Btnl1-Ex3-F2: 5'- GGTTTTCTGTGAAGGGACCA -3' 
Btnl1-Ex4-R2: 5'- GGTCTGCAACTCAGAGGAGG -3' 
PCR amplification was performed using REDTaq polymerase (Sigma) and DIG-
labeled deoxynucleotide solution mix (Roche) 
2.5.4 Probe hybridization/detection 
All steps were performed according to manufacturer’s instructions (Roche). Blots 
were hybridized in DIG-Easy-hyb buffer overnight at 65oC; washed for 2x 5 minutes 
at room temperature in 2xSSC/0.1%SDS; washed for 2x 15 minutes in 
0.1xSSC/0.1%SDS; and then rinsed in PCR grade water. Blocking was performed 
using DIG-blocking reagent for 30mins at room temperature. Detection antibody 
was diluted 1:10,000 in DIG-blocking reagent and incubated with the blot for 
30mins at room temperature. Blots were then washed for 2x 15 minutes in wash 
buffer, equilibrated for 5 minutes in detection buffer and developed using the DIG-
Luminescence Detection Kit.  




2.6 MODE-K co-culture and IEL stimulation assays 
2.6.1 IEL Stimulation 
96-well U-bottom plates were coated overnight at 4oC with 50µl PBS containing 
10µg/ml LEAF-purified anti-mouse CD3ε or Hamster IgG Isotype Control (Biolgend). 
Wells were washed once with PBS 1X and IEL were seeded at a density of 105/well 
in complete RPMI (see Appendix). IEL were stimulated overnight (16-18hrs) at 
37oC and 10% CO2.  
2.6.2 IEL:MODE-K co-cultures 
MODE-K transductants were maintained in ‘MODE-K culture medium’ at 37oC/5% 
CO2. Co-cultures were performed at 37oC/10% CO2 in ‘complete RPMI’ (see 
Appendix). 
105 MODE-K cells were seeded onto each well of a 48-well plate 24hrs prior to co-
culture experiments (Day -1). At Day 0, ‘MODE-K culture medium’ was replaced 
with ‘complete RPMI’ and 105 unsorted or (where indicated) positively FACS-sorted 
(CD45+Vγ7+) IEL were seeded onto MODE-K monolayers. Cells were co-cultured 
for 4 hours, 6 hours or 16-18 (overnight) hours (as indicated) prior to harvesting for 
analysis. 
For transwell assays, 2x105 MODE-K cells were seeded onto 24-well transwell 
plates (3µm pore size - Corning) 24h prior to the addition of 3x105 IEL, either in 
direct contact (below), sequestered from (above), or split 50:50 with MODE-K cells 
(above and below the transwell). Cells were harvested after 16-18 hours of co-
culture. 
2.7 Bone Marrow Chimeras and Adoptive IEL Transfers 
2.7.1 Bone marrow chimeras 
10-12 week-old recipient mice were irradiated with 2 doses of 480 Rad, 3-4 hours 
apart, 24 hours prior to tail vein intravenous (IV) injection with 5-10x106 donor bone 
marrow cells. Analysis was performed 4-12 weeks later (as indicated). 




2.7.2 Adoptive IEL transfer 
IEL harvested from 4 week-old WT mice were column-purified using CD45 
microbeads (MACS Miltenyi biotec) and IV-injected into 6 week-old TCRδ-/- and 
TCRδ -/-.Btnl1-/- recipients. Analysis was performed 2-3 weeks later. 
2.8 Microscopy 
2.8.1 Gut whole mount staining 
Thesis presents 4 maximum intensity projection images kindly provided by Dr Hart. 
2.8.1.1 Day 1 – Fixation and primary stain 
Proximal 1/3 of small intestine was harvested and flushed with ice cold PBS. Fat 
was removed and tissue was cut longitudinally. Using a scalpel, 2x 2-3mm wide 
sections of gut wall were harvested and incubated in Zamboni’s fixative for 2hrs at 
room temperature (gentle agitation). Samples were washed 5 times for 5 minutes 
with washing buffer (gentle agitation) and then blocked for 1 hour (with gentle 
agitation) at room temperature with normal goat serum (Block A). Primary stain: 
αCD3 (17A2-unconjugated) in Block A overnight at 4oC with gentle agitation. See 
appendix for buffer/fixative details. 
2.8.1.2 Day 2 – Secondary stain 
Samples were washed 4 times for 5 minutes with washing buffer (gentle agitation), 
before incubating with ‘Block B’ for 3hrs at room temperature (gentle agitation). 
After blocking, samples were incubated with conjugated antibodies (TCRβ-BV421, 
Vγ7-AF647, Vδ4-FITC, Goat anti-Rat IgG Alexa Fluor 555) diluted in ‘Block B’ 
overnight at 4oC (gentle agitation). See appendix for buffer details. 
2.8.1.3 Day 3 – Mounting and image acquisition 
Samples were washed 4 times for 5 minutes in washing buffer (gentle agitation) at 
room temperature. Then they were mounted as whole tissues in vectashield for 
confocal analysis. Z-Sections were acquired on a confocal-LSM-710 microscope 




(Zeiss) and processed and analysed using Imaris Software (Bitplane Scientific 
Solutions). See appendix for buffer details. 
2.8.1.4 Imaris Image analysis 
3D image analysis on z-stacks was carried out using Imaris (Bitplane). The 
surfaces tool was used to identify CD3+ cells. Voxels outside of these structures 
were set to zero in each of the channels to create masks. 
2.8.2 Histology 
Thesis presents histology data acquired in collaboration with the Francis Crick 
Institute Experimental Histopathology Core Facility. 
2.8.2.1 BrdU incorporation in intestinal epithelium 
Mice were injected intraperitoneally with BrdU (50mg/kg; Sigma) 3 hours prior to 
sacrifice. Intestinal tissue was harvested, flushed with ice cold PBS, cut 
longitudinally and fixed as a gut roll. BrdU incorporation was assessed by 
immunohistochemistry in paraffin-embedded histological sections of the gut roll. 
2.8.2.2 RNAscope 
RNAscope analysis was performed on paraffin-embedded sections using probes 
and kits obtained from Advanced Cell Diagnostics Inc. using the RNAscope 2.0 HD 
Reagent Kit-BROWN. Reference sequences are as follows: 
Btnl1.NM_001111094.1 (576-1723); Btnl4 NM030746.1 (560-968); 
Btnl6.NM_030747.1 (245-1552). 
2.9 RNA sequencing 
RNA sequencing was performed in collaboration with the Francis Crick Institute 
Advanced Sequencing Core Facility. Vγ7+CD122hi and Vγ7+CD122lo IEL were flow 
sorted from pooled D14-17 pups directly into RLT plus micro buffer (supplemented 
with 1:100 β mercaptoethanol). RNA was prepared using the RNA-Micro-plus kit 
(Qiagen). cDNA libraries were generated using the KAPA Stranded RNA-seq Kit 
with RiboErase (HMR) (KAPA BIOSYSTEMS). Paired-end sequencing was 




performed on a HiSeq 2500 (illumina) using rapid run chemistry (read length: 
100bp). 
2.9.1 Bioinformatics analysis of RNA sequencing 
101 base-pair paired-end reads were aligned and quantified using RSEM (v1.2.11) 
(B. Li and Dewey, 2011) with Bowtie2. Reads were aligned to a transcriptome 
constructed from the mm10 mouse genome and a UCSC knownGene gtf file. A 
mean alignment rate of 57.4 million fragments per sample was observed. Using the 
gene level quantification, only detected genes (mean TPM value across all samples 
> 1; 13,313 genes) were selected. Differential expression between the CD122hi and 
CD122lo Vγ7+ IEL groups using DESeq2 (M. I. Love et al., 2014) was identified by 
taking into account the paired structure within the replicate groups. Using an FDR 
of 0.01 2664 phenotype dependent gene expression effects were identified. 
2.10 Quantification and Statistical Analysis 
2.10.1 Cell enumeration 
Total thymocyte and IEL yields were analysed on an electronic cell counter (CASY 
counter; INNOVATIS), which determined live lymphocyte events by cell diameter 
and electrical conductivity. Subset counts in thesis (e.g. total enumeration of Vγ7+ 
IEL) were calculated as: Total lymphocyte yield x (Vγ7+ [%live events] / 100). 
2.10.2  Statistics 
Unless stated otherwise, bar/spider charts display mean ±SD and p values were 
derived from unpaired two tailed t-tests, assuming equivalent SD (ns p>0.05). 
 




Chapter 3. Signature Small Intestinal Intraepithelial 
γδ  T cells 
3.1 Introduction 
Signature Vγ5+ DETC carry a mature cell surface phenotype characterised by high 
levels of cell surface TCR, CD45RB and CD122 and low levels of CD24 and 
CD62L (Lewis et al., 2006; Sumaria et al., 2011). Their thymic progenitors acquire 
this signature phenotype during their developmental interactions with Skint1-
expressing thymic medullary epithelial cells (Lewis et al., 2006). Hence, mice that 
carry a loss-of-function mutation in Skint1 lack canonical DETC because their 
progenitors experience developmental defects in the thymus, fail to attain 
phenotypic and functional maturity and fail to home to the skin (Barbee et al., 2011; 
Boyden et al., 2008; Lewis et al., 2006). 
The developmental up-regulation of CD122 that occurs during Skint1-mediated 
DETC selection is also associated with agonist selection of developing thymocytes 
(Baldwin et al., 2004; Hanke et al., 1994). Agonist selection describes positive 
selection of thymocytes that engage their TCR ligand in the thymus, experience 
strong TCR signalling but do not undergo clonal deletion. Examples of such 
‘agonist-selected’ cells include iNKT cells and TCRβ+CD8αα+ intestinal IEL 
(Hogquist and S. C. Jameson, 2014). Although there is no direct evidence of Skint1 
engaging the DETC TCR, phenotypic maturation of DETC progenitors in the 
thymus of Skint1-mutant mice can be rescued in vitro by supplementing FTOC with 
agonist antibodies specific for the Vγ5+ TCR (Lewis et al., 2006). Moreover, Skint1-
mediated selection has been shown to induce a gene expression signature in 
DETC progenitors associated with strong TCR signalling (Turchinovich and 
Hayday, 2011). This expression signature includes up-regulation of Tbx21, Egr3, 
Tnfrsf9 and down-regulation of Rorc, and Sox13 and can be phenocopied in adult 
γδ thymocytes by direct TCR stimulation in vitro (Turchinovich and Hayday, 2011). 
Therefore, it is considered that Skint1 regulates the developmental agonist 
selection of DETC progenitors. 




TCRβ+CD8αα+ IEL comprise a subset of self-reactive ‘agonist-selected’ intestinal 
αβ IEL that are not restricted by classical MHC (Cheroutre et al., 2011; Oh-hora et 
al., 2013; Rocha et al., 1991). Thymic agonist selection of TCRβ+CD8αα+ IEL 
progenitors is also associated with up-regulation of CD122 and T-bet, which in the 
small intestine phenotypically differentiates TCRβ+CD8αα+ IEL from MHC-restricted 
TCRβ+CD8αβ+ or CD4+ IEL subsets (Klose et al., 2014; McDonald et al., 2014; 
Pennington et al., 2003). While TCRβ+CD8αα+ IEL appear to be phenotypically and 
functionally distinct from TCRβ+CD8αβ+ and CD4+ IEL, they share many features 
with bulk γδ IEL. For example, most γδ and TCRβ+CD8αα+ IEL share a similar cell 
surface phenotype, including their expression of CD122 and the CD8αα 
homodimer, a negative regulator of TCR signalling (Cheroutre and Lambolez, 
2008). Both populations also express Lag3, while lacking CD5 and Thy1, and 
contain sub-populations of cells that express various members of the Ly49 family of 
inhibitory NK receptors (Denning et al., 2007; Klose et al., 2014). Moreover, γδ IEL 
and TCRβ+CD8αα+ IEL share expression of several genes, including inducible 
cAMP early repressor of transcription (ICER), regulator of G protein signalling 2 
(Rgs2) and FcεRIγ, many of which are shared by DETC but not by TCRβ+CD8αβ+ 
IEL (Denning et al., 2007; Pennington et al., 2003). Thus, by various phenotypic 
metrics DETC, intestinal γδ IEL and intestinal TCRβ+CD8αα+ IEL share more in 
common with each other than with populations of intestinal MHC-restricted αβ IEL. 
Given that DETC and TCRβ+CD8αα+ IEL acquire various features of their mature 
phenotype during an agonist selection process in the thymus. We hypothesized 
that γδ IEL development may be similarly defined by an agonist-selection-type 
process regulated by a Skint1-like gene. To study this, we first sought to 
characterise the phenotypic profile of signature small intestinal γδ IEL, identify the 
developmental time point at which it is acquired and where possible, identify 
parallels with Skint1-selected DETC selection or agonist-selected TCRβ+CD8αα+ 
IEL. 




3.2 Phenotypic profile of signature γδ  IEL 
3.2.1 Vγ7+ IEL are signature intestinal γδ  IEL  
Previous studies have shown that most small intestinal γδ T cells colonise the gut 
shortly after birth (Lefrançois and Olson, 1994; Torow et al., 2015) and that Vγ7+ T 
cells predominate among small intestinal γδ IEL (Kawaguchi et al., 1993). To verify 
this, we determined γδ IEL composition in adult mice by flow cytometry of freshly 
recovered cells. Consistent with with previous reports (Chennupati et al., 2010; 
Kawaguchi et al., 1993; Pereira et al., 1997), Vγ7+ cells were the predominant 
intestinal γδ IEL subset comprising ~60% of the compartment. Vγ1+ cells comprised 
~25% and the remaining ~15% mostly expressed Vγ4 (Figure 3.1A; data not 
shown). 
Most αβ IEL were positive for CD8α, which was expressed as a CD8αα homodimer 
by ~50% and as a CD8αβ heterodimer by ~40%. The remaining 10% of αβ IEL 
either expressed CD8αα alongside CD8αβ (~5%), or were CD8α- and mostly CD4+ 
(~5%) (Figure 3.1A; data not shown). Furthermore, a small but variable proportion 
of cells co-expressed CD4 with CD8αα, as has been also been reported in the 
literature (data not shown) (Y. Huang et al., 2011; Mucida et al., 2013; Reis et al., 
2013; 2014). 
DETC are among the first T cells to emerge from the embryonic thymus and 
populate the neonatal epidermis (Aono et al., 2000; Ramond et al., 2013). To 
assess when Vγ7+ IEL first populated the small intestinal epithelium, we recovered 
IEL from 2 to 3-week old suckling mouse pups and analysed γδ IEL composition by 
flow cytometry. Between 2 to 3 weeks of age, the representation of Vγ7+ T cells 
increased from ~40% to >60% of γδ IEL (Figure 3.1B). By week 3, these cells had 
become the predominant γδ IEL subset and were maintained as such for at least 9 
months thereafter. Hence, it was concluded that Vγ7+ IEL were the signature small 
intestinal γδ IEL and that these cells became the predominant intestinal γδ IEL 
subset by 3 weeks of age. 




3.2.2 Vγ7+ IEL carry an agonist-selected cell surface phenotype 
As discussed, Skint1-mediated selection of DETC progenitors is associated with 
the acquisition of a mature CD122HICD45RBHITCRHI cell surface phenotype and 
down-regulation of Sox13 and Rorc. To establish whether signature small intestinal 
Vγ7+ IEL carried a similar ‘agonist-selected’ phenotype, freshly recovered IEL from 
3-5 week old weanling mice were analysed. From day 21 to 40 (D21-40), Vγ7+ cells 
expressed uniformly high levels of CD122, the IL-2R/IL-15Rβ sub-unit; and of 
TIGIT, an inhibitory co-receptor. By contrast, Vγ7- (CD3+TCRβ-) IEL were largely 
negative for cell surface expression of both markers (Figure 3.2A). Vγ7+ IEL also 
expressed the highest levels of cell surface TCR (by anti-CD3 antibody) relative to 
αβ and to Vγ7- γδ IEL and expressed ~4-fold lower levels of Sox13 and Rorc 
relative to Vγ7- cells (Figure 3.2B). Thus, amongst small intestinal γδ IEL, Vγ7+ 
cells from 21 to 40 day-old mice selectively adopted a mature agonist selected 
phenotype reminiscent of Skint1-selected DETC. 
By contrast to the differences in cell surface expression of TCR, CD122 and TIGIT, 
Vγ7+ IEL were almost indistinguishable from Vγ7- cells with regards to their 
expression of CD44, CD45RB, and CCR9 (Figure 3.2C). To identify additional 
features that may differentiate putative ‘selected’ Vγ7+ IEL from Vγ7- IEL, we sought 
to assess the extent to which these distinct T cell populations phenocopied the 
reported ‘agonist-selected’ phenotype of TCRβ+CD8αα+ IEL. As mentioned 
previously TCRβ+CD8αα+ IEL cells are defined by their expression of the CD8αα 
homodimer, CD69 and Lag3, and are largely negative for CD5 and Thy1 (Denning 
et al., 2007; Gangadharan et al., 2006; Ma et al., 2009; McDonald et al., 2014). 
Whereas almost 100% of Vγ7+ IEL expressed the CD8αα homodimer, only ~70% 
of Vγ7- IEL were CD8αα+ (Figure 3.2D). Furthermore, while Vγ7+ IEL uniformly 
expressed high levels of CD69 and Lag3, and were mostly (~90%) negative for 
CD5 and Thy1; a significantly greater proportion of Vγ7- IEL were negative for Lag3 
(~50%), expressed lower levels of CD69 and were positive for CD5 and Thy1 (30-
40%) (Figure 3.2D). These results indicate that Vγ7+ IEL more closely phenocopy 
‘agonist-selected’ TCRβ+CD8αα+ IEL than Vγ7- IEL.  




Taken together, these data demonstrate that intestinal Vγ7+ IEL selectively 
phenocopy Vγ5+ DETC and TCRβ+CD8αα+ IEL in that they carry a cell surface 
phenotype (CD122HI, TCRHI, TIGITHI, CD8αα+, CD69HI, Lag3HI, CD5LO, Thy1LO), 
consistent with a prior agonist selection.  





Figure 3.1 Composition of small intestinal IEL 
A) Gating strategy for small intestinal Vγ7+ IEL in 12 week(W)-old C57Bl/6 mice 
(n≥12). B) Representation of Vγ7+ IEL over time (W20-36 è n=5; other time points 
è n≥12). Panel (A) includes data representative of ≥3 experiments. Panel (B) 
includes data pooled from >20 independent experiments. 





Figure 3.2 Phenotype of small intestinal γδ  IEL in 21-40 day-old mice 
A) Cell surface phenotypes of Vγ7+, Vγ7- (CD3+TCRβ-Vγ7-) and αβ IEL from 21-40 
day-old mice (n≥8). B) Gene expression by qRT-PCR in Vγ7+ vs. Vγ7- γδ IEL (n=3). 
C-D) Cell surface phenotypes of Vγ7+ and Vγ7- (CD3+TCRβ-Vγ7-) IEL from 21-40 
day-old mice (n≥8). Data are representative of 1 (B), or ≥3 independent 
experiments (A,C,D). Data in panel (B) provided by Dr Jandke. 




3.3 Intestinal selection of Vγ7+ IEL 
3.3.1 Neonatal small intestine harbours putative Vγ7+ IEL precursors  
Having defined the phenotype of signature Vγ7+ IEL in mice at D21-40 
(CD122HITCRHILag3HICD5-Thy1-CD8αα+) (Figure 3.2), these cell surface markers 
were used to identify the time point and anatomical location in which Vγ7+ IEL attain 
phenotypic maturity. Interestingly, a number of studies have suggested that 
intestinal γδ IEL develop or mature extra-thymically (Lambolez et al., 2002; 
Lefrançois and Olson, 1994; Naito et al., 2008; Saito et al., 1998; K. Suzuki et al., 
2000). In support of this hypothesis, significant numbers of intestinal γδ IEL, but not 
DETC or αβ IEL, develop in athymic NU/NU mice (Almeida et al., 2015; Guy-Grand 
et al., 1991; Nonaka et al., 2005). Furthermore, it has been shown that enterocyte-
specific transgenic expression of IL-7 in IL-7-/- mice is sufficient to restore intestinal 
γδ IEL development in the absence of thymic output (Laky et al., 2000). Hence, 
small intestinal microenvironments appear to have a unique capacity to support 
extrathymic development and/or differentiation of Vγ7+ IEL. 
To test whether extrathymic maturation takes place in euthymic C57Bl/6 mice, the 
cell surface phenotype of Vγ7+ IEL from 14 to 17 day-old mice was analysed by 
flow cytometry. We chose these specific time points because earlier time points 
were associated with T cell yields that were too small to analyse. Furthermore, 
previous data (Figure 3.1B) suggested that Vγ7+ IEL are a minority of γδ IEL at this 
stage and thus may contain a greater representation of recently infiltrated Vγ7+ T 
cells. In support of an extrathymic intestinal pathway of differentiation, the analysis 
identified an enrichment of Vγ7+ IEL carrying an ‘immature’ CD122LO cell surface 
phenotype between post-natal days (D)14 to 17, relative to weanling mice (D21-40) 
(Figure 3.3A).  
These putative precursor cells could also be distinguished from Vγ7+ IEL at D21-40 
by low levels of cell surface TCR (by anti-CD3), CD122 and TIGIT, lack of 
expression of Lag3 and CD8α, and increased expression of Thy1 and CD5 (Figure 
3.3A). Furthermore, a small proportion of Vγ7+ IEL at D14-17 expressed CD24 
(heat stable antigen), whereas CD24 expression was not seen after D21 (Figure 




3.3A). Thus, the data suggest that ‘immature’ Vγ7+ IEL could constitute a precursor 
to signature CD122HITCRHI Vγ7+ IEL that predominate amongst intestinal γδ IEL 
from D21 (Figure 3.1B, 3.2). 
To define the composite cell surface phenotype of a putative Vγ7+ IEL precursor 
cell in D14-17 mice, we found that ‘immature’ cells could be segregated from 
‘mature’ counterparts according to CD122LO(MFI<200)Thy1+, and CD122HI(MFI>500)Thy1- 
status, respectively (Figure 3.3B). Applying this gating strategy to a comparative 
analysis of D14 versus D28 Vγ7+ IEL, ~40% of Vγ7+ IEL were classed as ‘immature’ 
at D14, compared to ~10% of Vγ7+ IEL at D28. Combining this gating strategy with 
stringent phenotypic analysis of CD5, CD24, CD8α and Lag3 expression (Figure 
3.3A), the phenotype of ‘mature’ Vγ7+ IEL (CD122HIThy1-CD8α+Lag3+CD24-CD5-) 
showed no overlap with putative ‘immature’ precursors (CD122LOThy1+CD8α-Lag3-
CD24+CD5+) (n≥7; p<0.0001 for statistical analysis of each marker individually) 
(Figure 3.3B). Likewise, high expression of cell surface TCR and TIGIT also 
segregated with ‘mature’ CD122HI Vγ7+ IEL and not with ‘immature’ CD122LO 
counterparts (Figure 3.3C). Thus, Vγ7+ IEL at D14-17 were enriched for putative 
‘immature’ precursor cells that carried a cell surface phenotype similar to Vγ7- γδ 
ΙΕL in weanling (W3-6) mice (Figure 3.2A, D) and to non-selected DETC 
progenitors in Skint1-mutant mice (CD122LO, TCRLO, CD24+) (Lewis et al., 2006). 
3.3.2 No evidence for intrathymic maturation of Vγ7+ thymocytes 
Having characterised a putative Vγ7+ precursor population in neonatal small 
intestinal epithelium, we next sought to determine whether any component of the 
Vγ7+ IEL phenotype is acquired by Vγ7+ thymocytes. To test this, we used flow 
cytometric analysis to study Vγ7+ thymocytes across 4 developmental time points 
(D1-D7; D14-D18; W3-W5; W5-W8) to compare their cell surface phenotype to that 
of signature Vγ7+ IEL (Figure 3.2). Importantly, these time points span the first 8 
weeks of life, encompassing peak thymus activity in C57Bl/6 mice (Hsu et al., 
2003). Across all 4 time-points Vγ7+ thymocytes were a rare population, totalling 
~10,000 cells at D1-7, ~30,000 cells at D14-D18, ~40,000 cells at W3-W5, and 
~20,000 cells at W5-W8 (Figure 3.4A). During W3-W5, Vγ7+ thymocytes carried an 
‘immature’ cell surface phenotype characterised by low CD45RB expression, high 




CD5 expression and greater Thy1 expression relative to Vγ7+ IEL harvested from 
the same mouse (Figure 3.4B). The ‘immature’ cell surface phenotype of Vγ7+ 
thymocytes was replicated across the 4 time points analysed (Figure 3.4C). Vγ7+ 
thymocytes were also CD8α- and expressed significantly lower CD122 levels and 
TCR (by anti-CD3), relative to Vγ7+ IEL from the same mouse (Figure 3.4D). 
Hence, there was no evidence for intra-thymic maturation of Vγ7+ thymocytes, 
which instead appeared to more closely phenocopy putative intestinal precursors of 
Vγ7+ IEL as they carried an ‘immature’ TCRLO, CD122LO, Thy1+, CD5+, CD8α- cell 
surface phenotype. 




Figure 3.3 Phenotype of small intestinal Vγ7+ IEL in neonatal mice 
A) Cell surface phenotypes of Vγ7+ IEL at postnatal day (D)14-17 vs. D21-40 (n≥7). 
B) Upper: Cell surface phenotype of Vγ7+ IEL at D14 vs. D28 (Median fluorescence 
intensity [MFI] corresponds to CD122). Lower: Cell surface phenotypes of 
CD122HIThy1-Vγ7+ vs. CD122LOThy1+Vγ7+ IEL at D14-17 (n≥7). C) Cell surface 
TIGIT expression at D14-17 in Vγ7+CD122HI vs. Vγ7+CD122LO IEL (n≥7). Data are 
representative of ≥3 (A,B-upper,C) experiments. Panel (B-lower) includes data 



























































































































Figure 3.4 Phenotype of Vγ7+ thymocytes 
A) Quantification of Vγ7+ thymocytes assayed by flow cytometry. B) Cell surface 
phenotypes of Vγ7+ IEL and thymocytes (n=5). C) Cell surface phenotypes of Vγ7+ 
thymocytes at indicated time points. D) Cell surface phenotypes of Vγ7+ IEL and 
thymocytes (n=5). Data are representative of ≥2 (B,D) independent experiments. 
Panels include data pooled from >3 (C) or >6 (A) independent experiments. 




3.3.3 Vγ7+ IEL develop independently of the thymus or most peripheral 
lymphoid organs 
Given that there was no evidence for intrathymic maturation of Vγ7+ thymocytes, 
we sought to assess whether Vγ7+ IEL could attain phenotypic maturity via 
extrathymic pathways in athymic NU/NU mice. To do this, we analysed γδ IEL 
composition and CD122 expression by flow cytometry of freshly recovered Vγ7+ IEL. 
While adult (W8-13) NU/NU mice were depleted in αβ IEL (<10% of CD3+ IEL), 
they retained a substantive compartment of γδ IEL that comprised >90% of all CD3+ 
cells (Figure 3.5A). Absolute numbers of Vγ7+ IEL in adult NU/NU mice were 
roughly ~3 fold lower than age-matched euthymic controls (~1.5M versus ~0.5M 
cells; data not shown). However, the representation of Vγ7+ IEL amongst γδ IEL in 
NU/NU mice (~80%) was comparable, if not slightly enriched relative to euthymic 
controls (~70%). To better assess γδ IEL composition in NU/NU mice, GL2 analysis 
was included. GL2 antibody specifically engages the TCRVδ4+ chain and ~20% of 
γδ IEL in euthymic and NU/NU mice were Vγ7+GL2+ (Figure 3.5A). Furthermore, 
Vγ7+ IEL in NU/NU mice were uniformly CD122HI, indicative of phenotypic maturity. 
Thus, we concluded that despite a reduction in absolute cell count, the 
development and maturation of Vγ7+ and Vγ7+GL2+ IEL was unaffected by thymus-
deficiency. 
A recent study suggested that Vγ7+ IEL require priming in PP or MLN before 
homing to the epithelium (Guy-Grand et al., 2013). To test this we analysed γδ IEL 
composition and CD122 expression in alymphoplasia (aly/aly) mice. aly/aly mice 
carry a partially penetrant loss-of-function point mutation in NF-κb-inducing kinase 
(Nik). As Nik is upstream of NF-κb activation in TNFSFR signal transduction, its 
loss of function impairs LTβR signalling during lymphoid tissue organogenesis and 
thus gives rise to mice that lack all lymph nodes, Peyer’s patches and isolated 
lymphoid follicles (Fütterer et al., 1998; Shinkura et al., 1999). By contrast to 
athymic mice, aly/aly mice that had been surgically confirmed to lack peripheral 
and mesenteric lymph nodes, displayed comparable absolute numbers of Vγ7+ 
(~2M) and Vγ7+GL2+ (~200,000) cells relative to age-matched controls (Figure 
3.5B). Their γδ IEL compartments were enriched for Vγ7+ IEL (~80%) and they 




displayed a similar proportion of Vγ7+GL2+ cells (~10%). Furthermore, Vγ7+ IEL 
were uniformly CD122HI suggesting they did not depend on priming in peripheral 
lymphoid organs for development (Figure 3.5B). Indeed, these findings further 
substantiate a report that found normal γδ IEL composition in aly/aly mice that were 
simultaneously athymic (Nonaka et al., 2005). 
3.3.4 Vγ7+ IEL can develop independently of the microbiome and of dietary 
protein antigen 
Given that Vγ7+ IEL could mature normally in NU/NU and aly/aly mice, we 
considered intestinal factors that may drive their local maturation. Strong 
candidates included antigens derived from the microbiome and/or diet. To test the 
effects of such factors, we analysed IEL composition and cell surface phenotype by 
flow cytometry of cells recovered from adult (W9-13) C57Bl/6 mice raised in total 
germ-free (GF) conditions, on a protein-antigen free diet (FAF) or on a protein-
antigen free diet in germ-free conditions (GF/FAF). These ‘antigen-free’ mice were 
compared to C57Bl/6 controls raised in conventional specific pathogen-free 
conditions (SPF). Whereas γδ IEL made up ~50% of CD3+ cells in SPF mice, their 
representation increased to ~60% in GF mice and ~75% in FAF and GF/FAF mice 
(Figure 3.6). Hence, αβ T cell but not γδ T cell recruitment to the small intestinal 
epithelium appeared to be partially dependent on the microbiome and greatly 
dependent on food-derived antigens, consistent with previous reports (Bandeira et 
al., 1990).  
The decrease in αβ IEL representation in GF/FAF mice was predominantly 
attributed to loss of TCRβ+CD8αβ+ cells which decreased from ~350,000 cells in 
SPF mice to ~150,000 in GF and ~100,000 in FAF and GF/FAF (Figure 3.6). 
TCRβ+CD8α- IEL were also reduced in number, but these were a minor proportion 
to begin with (data not shown). By contrast, the representation of Vγ7+ IEL 
remained unchanged in GF, FAF and GF/FAF relative to SPF mice, making up 
~60% of all γδ IEL irrespective of the antigen-exposure status of the mouse. 
Consequently, their mean absolute cell number increased slightly from ~400,000 
cells in SPF mice, to ~500,000 cells in GF and FAF/GF mice and ~650,000 cells in 
FAF mice, possibly compensating for αβ IEL depletion that occurred under these 




conditions (Figure 3.6). On analysis of CD122 expression, we found that Vγ7+ IEL 
from GF, FAF and GF/FAF mice were uniformly CD122HI, indicating that they had 
attained phenotypic maturity in the absence of these exogenous local antigens. 
Hence, Vγ7+ IEL development and maturation was not dependent on a thymus, 
priming in peripheral lymphoid organs, or antigens derived from dietary proteins 
and the microbiome. 






Figure 3.5 Analysis of Vγ7+ IEL in NU/NU and aly/aly mice 
A) Left: IEL composition in W8-14 wild type (WT) vs. NU/NU mice. The GL2 
antibody detects the TRDV2-2-encoded Vδ4 chain. Right: Cell surface CD122 
expression on NU/NU Vγ7+ IEL (n≥12). B) γδ IEL composition (left), cell count 
(middle) and cell surface CD122 expression (right) in W8-12 WT vs. alymphoid 
(aly/aly) mice. Panel (A) presents data representative of ≥3 independent 
experiments. Panel (B) presents data pooled from 2 independent experiments. 





Figure 3.6 IEL development in germ-free and food antigen-free mice 
IEL composition (upper), cell count (lower left), and CD122 expression (lower right) 
in SPF, germ-free (GF), food antigen-free (FAF), or GF-FAF C57Bl/6 mice at W9-
13 (n≥4). Data are representative of 1 (GF-FAF) or 2 (SPF, GF, FAF) independent 
experiment(s). 




3.3.5 Putative maturation checkpoint of Vγ7+ IEL associated with significant 
changes in gene expression profile  
Having established that Vγ7+ IEL can develop independently of the thymus, 
peripheral lymphoid organs, the microbiome and diet-derived protein antigens, we 
considered that these cells’ development and maturation may be driven by a 
germline-encoded factor similar to Skint1. Skint1-mediated selection of DETC 
progenitors is associated with their acquisition of a gene expression signature, 
which was characterised by a genome-wide expression analysis of Vγ5+ foetal 
thymocytes in WT versus Skint1-mutant mice (Turchinovich and Hayday, 2011). 
Similar analyses have since been performed to compare the gene expression 
profile of ‘immature’ CD24HI to ‘mature’ CD24LO Vγ1+, Vγ4+ and Vγ1+Vδ6+ 
thymocytes (Narayan et al., 2012). However, the paucity of ‘mature’ Vγ7+ 
thymocytes at any point during the first 8 weeks of life (Figure 3.4A-D) has hitherto 
prohibited any comparable analysis of their intrathymic development (Narayan et 
al., 2012). As our analysis of small intestinal Vγ7+ IEL at D14-17 had identified both 
immature and mature Vγ7+ IEL (Figure 3.3B), we proceeded to compare their gene 
expression profiles. To do this, RNA was purified from flow-sorted CD122HIVγ7+ IEL 
and CD122LOVγ7+ IEL that had been isolated from pooled D14-D17 mice on four 
separate occasions and subject to RNA sequencing (Figure 3.7A) (GEO accession 
number: GSE85422).  
Altogether, 2664 genes showed statistically significant up- or down-regulation 
between CD122HI and CD122LO Vγ7+ IEL. Consistent with their distinct cell surface 
phenotypes, many of these differentially regulated genes were identified as 
encoding cell surface proteins (Figure 3.7A-GO Term: Cell Surface). Furthermore, 
there was full concordance between gene expression profile and the cell surface 
phenotypes that we had defined in ‘mature’ and ‘immature Vγ7+ IEL (Figure 3.3B). 
Thus, we concluded that our purification strategy had been successful and that the 
data were representative of the two populations of interest. 
To define the extent to which peripheral Vγ7+ IEL maturation phenocopied Skint1-
mediated DETC selection, we compared our gene list to genes that had previously 
been shown to be up- or down-regulated across the Skint1-mediated selection 




checkpoint (Turchinovich and Hayday, 2011) (Figure 3.7B). Many genes that were 
up- (e.g. Tnfrsf9 [4-1BB/CD137], Xcl1 [lymphotactin]) or down-regulated (e.g. 
Sox13, Sox4, Bcl11b) in CD122HI versus CD122LO Vγ7+ cells, were similarly up- or 
down-regulated across the Skint1-selection checkpoint of DETC progenitors 
(Figure 3.7B). Of note, Rorc and Tbx21 did not meet the stringent statistical cut off 
applied during our re-analysis of the Skint1-selection microarray dataset (hence, 
neither are included in Figure 3.7B). However, it was shown by qRT-PCR that 
Tbx21 is up-regulated and Rorc is down-regulated during Skint1-mediated 
selection (Turchinovich and Hayday, 2011) and likewise, both genes were similarly 
up- and down-regulated in CD122HI versus CD122LO Vγ7+ IEL. Hence, both the 
Skint1-selection checkpoint of DETC progenitors and the putative peripheral 
maturation checkpoint of Vγ7+ IEL in D14-17 mice were associated with up-
regulation of Tbx21, Tnfrsf9, Xcl1 and Tbx21 and down-regulation of Sox13, Sox4, 
Rorc and Bcl11b. 
Deep gene ontology analysis revealed a striking enrichment of cell cycle genes in 
CD122HI relative to CD122LO Vγ7+ cells, which suggested these cells might be 
selectively expanding in situ (Figure 3.7A). Indeed, selective expansion at this 
early time point (D14-17) could explain the increase in abundance of Vγ7+ IEL from 
postnatal W2 to W3 (Figure 3.1B). To verify that this increase in abundance was 
not an artefact of variation in IEL recovery between suckling pups and weaned 
mice, we employed confocal microscopy to assess γδ IEL composition in proximal 
small intestinal whole mounts at D17 relative to D21. Confocal analysis revealed an 
~4-fold enrichment of Vγ7+ IEL at D21 relative to D17 in the proximal gut (p=0.002) 
(Figure 3.8A). Thus, we concluded that the peripheral maturation of Vγ7+ IEL might 
be accompanied by their selective expansion, enabling them to achieve 
representational predominance amongst small intestinal γδ IEL by postnatal D21. 
3.3.6 Vγ7+ IEL selectively expand in situ 
To test our hypothesis that Vγ7+ IEL selectively cycled in situ in the neonatal gut, 
IEL were isolated at various time points and analysed for Ki67 expression by flow 
cytometry. Ki67 expression identifies all non-quiescent cells outside of G0 in the cell 
cycle. Consistent with Vγ7+ IEL undergoing selective cycling in situ, as many as 2-




fold more Vγ7+ cells stained positive for Ki67 relative to Vγ7- IEL at every time point 
between D14 and W5-7 (Figure 3.8B). From D14-16 to D21-24, the proportion of 
Vγ7+ IEL expressing Ki67 increased from ~50% to almost 100%, which correlated 
with the increase in representation of ‘mature’ CD122HIThy1- cells at each of these 
time points (~60% and ~90%, respectively) (Figure 3.8B; 3.3B). By contrast ~25% 
of Vγ7- γδ IEL were Ki67+ between D14-16, ~60% were Ki67+ at D19, and <50% of 
Vγ7- cells were Ki67+ from D21-24 to W5-7. By W5-7 Ki67 expression in the Vγ7+ 
compartment had significantly declined and approached the levels of expression 
seen in Vγ7- IEL. In mice over 11 weeks old, IEL were mostly quiescent and Ki67 
expression was virtually indistinguishable between the 2 compartments (Figure 
3.8B). These data suggest that Vγ7+ IEL selectively cycle in neonatal mice, from at 
least D14 to W5-7, after which the intestinal γδ IEL compartment as a whole is 
largely quiescent. 
Because Ki67 is a broad marker of non-quiescence and may not necessarily 
correlate with cell division, we also compared DNA synthesis in Vγ7+ IEL to Vγ7- 
IEL by incorporation of the thymidine analogue 5-ethynyl-2 deoxyuridine (EdU), 
during a 3hr pulse in vivo at D28. Whereas ~10% of Vγ7+ IEL incorporated EdU, 
only ~4% of Vγ7- IEL were EdU+ (p<0.0001) (Figure 3.8C). Furthermore, the rate of 
EdU incorporation in Vγ7+ IEL was comparable to rapidly cycling CD8αβ+ 
thymocytes, ~10% of which also incorporated EdU over a 3hr pulse (Figure 3.8C). 
Taken together, these data provide compelling evidence that the small intestinal 
epithelium accommodates the selective expansion of signature Vγ7+ IEL between 
D14 and W5-7. 





Figure 3.7 Gene expression analysis of neonatal small intestinal Vγ7+ IEL 
A) Heat map of genes differentially regulated (log-2-FoldChange) between 
Vγ7+CD122hi and Vγ7+CD122lo IEL sorted from post-natal day (D)14-17 mouse 
pups. Data generated by total RNA sequencing (‘cell cycle’ & ‘cell surface’ GO 
terms annotated). Fold changes are scaled to median expression values across the 
samples. B) Heat map of genes differentially regulated between Vγ7+CD122HI and 
Vγ7+CD122LO IEL from D14-D17 mice and between Skint1-selected and non-
selected Vγ5+ DETC progenitors (n=4). Data are representative of 1 experiment. 






Figure 3.8 Cell cycle analysis of small intestinal γδ  IEL 
A) IEL composition assessed by confocal microscopy of proximal small intestinal 
whole mounts from post-natal day (D)17 (left) and D21 (middle) mice (n=3). Right: 
Quantification corresponding to confocal images. B) Ki67 expression in Vγ7+ vs. 
Vγ7- IEL directly ex vivo (D19èn=4; all othersèn=8-27). C) EdU incorporation 
during 3hr pulse in vivo in Vγ7+ and Vγ7- (CD3+TCRβ-Vγ7-) IEL and CD8αβ+ 
thymocytes from 4 week-old mice assessed by flow cytometry. Panel (A) is 
representative of 1 experiment. Some panels include data pooled from 3 (C) or >20 
(B) independent experiments. Data in panel (A) provided by Dr Hart. 





Our studies have demonstrated that the small intestinal epithelium harbours 
signature Vγ7+ IEL that selectively expand in situ as the neonatal mouse develops 
into an adult. Having characterised the mature composition and cell surface 
phenotype of signature Vγ7+ IEL, we were able to show that this immune 
compartment develops in the absence of a thymus and peripheral lymph nodes, 
isolated lymphoid follicles and Peyer’s patches. Their development was also not 
dependent on exogenous antigens derived from the microbiome or dietary protein.  
Consistent with previous reports (Narayan et al., 2012), our studies have found no 
evidence for intra-thymic maturation of Vγ7+ thymocytes. However, they do provide 
some evidence to support an extra-thymic intestinal pathway of development for 
these cells. Phenotypically ‘immature’ Vγ7+ IEL were enriched for in the small 
intestinal epithelium of 14 to 17 day old animals. These putative precursors were 
characterized by their CD122LOTCRLOThy1+ status, which was reminiscent of pre-
selection DETC in Skint1-mutant mice. Furthermore, several genes that were found 
to be up- or down-regulated in ‘mature’ CD122HI versus ‘immature’ CD122LO Vγ7+ 
IEL, were similarly up- or down-regulated by Skint1-mediated selection in DETC 
progenitors. While these data are consistent with CD122LO Vγ7+ IEL being ‘pre-
selection precursors’ of their CD122HI counterparts, our study did not include a 
lineage-tracing analysis to conclusively demonstrate a true precursor-product 
relationship. Hence, we conclude that CD122LO Vγ7+ IEL potentially represents an 
extra-thymic pre-selected precursor of CD122HI Vγ7+ IEL.  
Having defined the phenotypic hallmarks of Vγ7+ IEL and time frame over which it 
was universally acquired in the small intestinal epithelium, we proceeded to study 
the endogenous Skint1-like factors that may regulate these cells’ development or 
maturation.  




Chapter 4. Btnl genes in Vγ7+ IEL development 
4.1 Introduction 
In seeking endogenous Skint1-like molecules that may regulate the development 
and composition of signature small intestinal γδ IEL, we turned our attention to the 
extended BTN/Btn gene family, to which Skint genes are closely related (Abeler-
Dörner et al., 2012; Afrache et al., 2012). Outside of the Skint family, Btnl1, Btnl4 
and Btnl6 display the greatest homology to Skint1 (Bas et al., 2011). As with most 
butyrophilin(-like) genes, Btnl1, Btnl4 and Btnl6 encode type I membrane proteins 
with 2 extracellular Ig domains, a single transmembrane region and an intracellular 
B30.2 (PRY/SPRY) domain (see Chapter 1) (Rhodes et al., 2016). As Skint1 has 
three transmembrane regions and lacks a B30.2 domain, its homology to Btnl1, 
Btnl4, and Btnl6 is concentrated in its extracellular Ig domains (IgC and IgV), which 
features a strikingly similar amino acid sequence (Figure 1.7) (Bas et al., 2011). 
Btnl1, Btnl4 and Btnl6 are exclusively highly expressed in small intestinal 
enterocytes and are each encoded within the MHC class II locus, in a region of the 
genome that has previously been associated with regulating the variation in γδ IEL 
composition across genetically distinct inbred mouse strains (Lefrançois et al., 
1990; Pereira et al., 1997). In vivo, Btnl1 protein forms heteromeric complexes with 
Btnl6 and reportedly displays a perinuclear staining pattern, which occasionally co-
colocalizes with CD3+ IEL (Bas et al., 2011; Lebrero-Fernández et al., 2016). In 
vitro, over-expressed Btnl1 has been shown to regulate the effector response of 
intestinal epithelial cell lines during their incubation with IFNγ-rich supernatants of 
activated intestinal IEL (Bas et al., 2011). Given their selective expression in small 
intestinal enterocytes and striking similarity to Skint1, Btnl1, Btnl4 and Btnl6 are 
strong candidates for organ-specific regulators of signature small intestinal γδ ΙΕL 
development. In support of this, it was recently shown that murine intestinal 
epithelial cell lines co-expressing Btnl1 and Btnl6 could selectively stimulate Vγ7+ T 
cells in vitro (Lebrero-Fernández et al., 2016). 
Having characterized a putative extrathymic pathway for the maturation and 
expansion of Vγ7+ IEL (see Chapter 3), we hypothesized that it could be regulated 
by Btnl1, Btnl4 and/or Btnl6. However, as there is very little known regarding the 




function of Btnl1, Btnl4 and Btnl6 in the biological context of small intestinal 
physiology, we started by analysing the ontogeny of Btnl expression in small 
intestinal enterocytes.  
To investigate the role of Btnl1 and Btnl4 in detail and to test our hypothesis that 
intestinal Btnl genes may regulate the peripheral maturation of signature intestinal 
Vγ7+ IEL we obtained Btnl1 and Btnl4 knockout mice and tested the impact of 
Btnl1- and Btnl4-deficiency in vivo on the composition of γδ IEL and systemic 
immune cell populations. 
4.2 Ontogeny of intestinal Btnl gene expression  
4.2.1 Intestinal Btnl1, Btnl4 and Btnl6 expression is detectable from post-
natal day 7 
To analyse the onset of Btnl1, Btnl4 and Btnl6 expression in the murine gut, qRT-
PCR was performed on RNA purified from small intestinal tissue harvested at 12 
time points  between E15 and post-natal D37 (E15, D6, 7, 13, 14, 16, 17, 18, 21, 
25, 28, 37). Proximal small intestinal tissue was selectively harvested for this assay 
because this is the region of the small intestine that has the greatest density of γδ 
IEL (H. Suzuki et al., 2002; Tamura et al., 2003). Btnl1, Btnl4 and Btnl6 were all 
detectable before, during and after post-natal W2-3 (Figure 4.1A). Btnl4 was first 
detected at E15, Btnl1 and Btnl6 became detectable by post-natal D6. Btnl1 
expression additionally increased by ~2-fold at D13 and expression of the three 
Btnl genes continued into adulthood (Figure 4.1A) (Bas et al., 2011; Lebrero-
Fernández et al., 2016). Thus, the expression of the three Btnl genes was 
detectable within and beyond the developmental window of postnatal D14 to D21, 
which would be in agreement with their hypothezised role in regulating Vγ7+ IEL 
maturation and expansion (Figure 3.1B; 3.3 3.7; 3.8). 
4.2.2 Btnl1 expression is concentrated in post-mitotic villus enterocytes in 
the proximal 2/3 of the small intestine 
To assess where in villus microanatomy Btnl1 message is expressed, analysis by 
RNAscope was performed on paraffin-embedded histological sections of small 
intestinal tissue. Proximal gut tissue was harvested from adult (W8-W10) mice that 




had received a 3 hour pulse with bromodeoxyuridine (BrdU) (see Materials and 
methods), a thymidine analogue that incorporates into cells in S phase. Btnl1 
expression was detected in small intestinal epithelium, where it was concentrated 
in post-mitotic differentiated villus enterocytes and poorly detectable in rapidly 
dividing BrdU+ crypt cells and the lamina propria (Figure 4.1B). The enrichment of 
Btnl1 in post-mitotic villus enterocytes was detectable from post-natal D7 and 
showed no significant difference in its distribution when compared to small 
intestinal sections from D25 or adult (W8-10) mice (Figure 4.1B,C). Thus, the 
expression and anatomical distribution of Btnl1 was established early in post-natal 
small intestine and was maintained as such into adulthood. 
Previous studies have shown that γδ IEL density is greatest in the proximal small 
intestine and greatly decreases towards the ileum and colon (H. Suzuki et al., 
2002; 2000; Tamura et al., 2003).  To test whether the macroanatomical 
distribution of Btnl1 expression along the length of the gut correlated with γδ IEL 
density, RNAscope analysis was performed on paraffin embedded gut sections 
taken from the proximal, medial and distal 1/3 of the small intestine and from the 
colon (Figure 4.1C). Histological analysis showed that Btnl1 was poorly expressed 
in colon enterocytes relative to small intestinal enterocytes (Figure 4.1D). This was 
further substantiated by qRT-PCR, which identified a ≤2-fold and ≤10-fold 
enrichment of Btnl1 in the proximal 2/3 of the small intestine relative to the distal 
1/3 and colon, respectively (Figure 4.1E). In summary, Btnl1 expression correlated 
with the reported gradient of γδ IEL as it was highly expressed in the proximal 2/3 of 
the small intestine and poorly expressed in the distal portion. Both the anatomical 
distribution of Btnl1 expression and the temporal onset of Btnl1, Btnl4 and Btnl6 
expression would accommodate their potential role in regulating Vγ7+ IEL 
development. 





Figure 4.1 Intestinal expression of Btnl genes 
A) Analysis of Btnl1, Btnl4 and Btnl6 expression in proximal small intestine by qRT-
PCR. B) Top: Histological analysis (H&E, left), Btnl1 expression (RNAScope, right) 
and BrdU incorporation vivo (bottom) 3hrs after intraperitoneal injection, in paraffin-
embedded sections of proximal small intestine (n≥3). C-D) RNAscope analysis of 
Btnl1 expression (n≥3). E) Analysis of Btnl1 expression by qRT-PCR (n=3). Data 
are representative of 1 (B) or ≥2 (C,D,E) independent experiments. Panel (A) 
includes data pooled from 2 independent experiments. qRT-PCR data provided by 
Dr Jandke (A) and Dr Cipolat (E). 




4.3 Validation of Btnl1-/- and Btnl4-/- mice 
To test the impact of Btnl1 and Btnl4 on the development of intestinal IEL, we 
obtained three independently generated strains of Btnl1-/- mice (CSD67994) and 
one of Btnl4-/- (CSD81524), that were each generated by targeted mutagenesis of 
embryonic stem (ES) cells by the International Knockout Mouse Consortium 
(IKMC) (Figure 4.2A). Btnl1-/- mice lack exons 3 and 4 of the Btnl1 gene, which 
encode the extracellular IgV and IgC domains, respectively. Btnl4-/- mice lack exons 
2-9, which encode most of the extracellular, transmembrane and intracellular 
domains of the peptide. Exons from both genes were targeted by homologous 
recombination and replaced by a cassette encoding a LacZ reporter construct and 
a neomycin resistance gene, which was used to select for targeted ES cells 
(Figure 4.2A).  
4.3.1 Btnl1 and Btnl4 alleles were successfully targeted in Btnl1-/- and Btnl4-/- 
mice 
Gene knockouts were confirmed by Southern blotting of genomic DNA purified from 
Btnl1+/- ES cells and tail tissue of C57Bl/6 (WT), Btnl1-/-, Btnl4-/-, and Btnl4+/- mice. 
DNA was digested with AseI for Btnl1 analysis or KpnI for Btnl4 analysis. 
Digoxigenin (DIG)-labelled DNA probes were generated to target an intronic region 
5’ to the Btnl1 gene and 3’ to the Btnl4 gene (Figure 4.2A). As predicted from 
sequence information, WT Btnl1 migrated at 7.095Kb, whereas targeted Btnl1 
migrated at 17.9Kb. WT Btnl4 migrated at 7.8Kb, whereas targeted Btnl4 migrated 
at 3.7Kb (Figure 4.2B). Successful targetting of Btnl1 was further validated by 
additional Southern blots, probing for the intronic sequence 3’ to the Btnl1 gene 
and for insertion of the LacZ cassette (data not shown).  
To verify that Btnl1 and Btnl4 expression was ablated in Btnl1-/- and Btnl4-/- mice, 
RNAscope analysis was performed on paraffin-embedded small intestinal tissue 
sections taken from WT, Btnl1-/- and Btnl4-/- mice. Btnl1, Btnl4 and Btnl6 all 
displayed similar enrichment in post-mitotic villus enterocytes in WT tissue (Figure 
4.3A). No Btnl1 and Btnl4 expression was detected in Btnl1-/- and Btnl4-/- tissue 
respectively. By contrast non-targetted genes (e.g. Btnl6) were consistently 
detected in Btnl1-/- and Btnl4-/- mice. These data demonstrate that RNAscope 




probes are both sensitive and specific to their respective targets. Further analysis 
of gene expression in Btnl1-/- mice found no detectable thymic expression (by qRT-
PCR) of Btnl1 and additionally demonstrated that thymic Btnl1 expression in WT 
mice was >107-fold lower than that detected in small intestinal tissue (Figure 4.3B). 
Taken together, these data confirm that Btnl1-/- and Btnl4-/- mice do indeed lack 
expression of Btnl1 and Btnl4, respectively. 





Figure 4.2 Btnl1-/- and Btnl4-/- mice 
A) Organisation of WT and targeted loci for Btnl1 and Btnl4. Grey: untranslated 
region; green: translated region; orange: targeting cassette. Knockout ES cell 
clones were obtained from the Knockout Mouse Project Repository (KOMP) IKMC-
ID 67994 (Btnl1) and 81524 (Btnl4). B) DNA analysis by southern blot for targeting 
of alleles in Btnl1-/- (left) and Btnl4-/- (right) mice. Genomic DNA was digested using 
the indicated restriction enzymes (red arrowheads). Probes were generated to bind 
sequences upstream of Btnl1 and downstream of Btnl4 (blue bars: See materials 
and methods). Panel (B) is representative of 1 (right) or 2 (left) independent 
experiments. Data in panel (B-right) provided by Dr Jandke. 






Figure 4.3 Btnl expression in Btnl1-/- and Btnl4-/- mice 
A) Histological analysis of Btnl1, Btnl4 and Btnl6 expression by RNAscope (n≥3). 
B) Analysis of Btnl1 expression by qRT-PCR. Panel (A) is representative of 1 
experiment. Data in panel (B) provided by Dr Roberts. 




4.4 Impact of Btnl genes on IEL development in vivo 
4.4.1 Btnl1 but not Btnl4 is critical for the development of signature 
intestinal Vγ7+ IEL 
To determine the impact of Btnl1 on intestinal Vγ7+ IEL development, IEL 
composition was assayed by flow cytometry of cells freshly recovered from the 
small intestine of adult (W6-15) WT versus Btnl1-/- mice. In three independently 
generated Btnl1-/- mouse strains, there was a ~3-fold reduction in the 
representation of Vγ7+ IEL and an ≤8-fold reduction in that of Vγ7+GL2+ IEL 
amongst γδ IEL relative to WT and Btnl1+/- mice (Figure 4.4). This decrease in the 
representation of Vγ7+ IEL translated into a ~90% reduction in absolute numbers of 
Vγ7+ and Vγ7+GL2+ IEL in Btnl1-/- relative to WT mice (p<0.0001) (Figure 4.4). Loss 
of Vγ7+ IEL was mostly compensated for by an expansion of innate-like 
TCRβ+CD8αα+ IEL (~1Million [M] cells in WT versus ~2M cells in Btnl1-/-, p<0.0001) 
and a smaller increase in Vγ7- γδ IEL (0.9M in WT versus 1.6M in Btnl1-/-, 
p=0.0012), which included both Vγ1+ and Vγ4+ IEL (Figure 4.5A). By contrast, 
there was no significant change in the absolute numbers of MHC-restricted 
TCRβ+CD8αβ+ and TCRβ+CD8α- (mostly CD4+) IEL (Figure 4.4). To exclude the 
formal possibility that Btnl1 deficiency selectively impacted upon the recovery of 
Vγ7+ IEL from the small intestinal epithelium, analysis of IEL composition by 
confocal microscopy was performed on whole mounts of proximal small intestinal 
tissue. Corroborating the data acquired by flow cytometry, Btnl1-/- mice displayed 
almost total depletion of Vγ7+ IEL, which was associated with an expanded TCRβ+ 
IEL compartment (Figure 4.5B). Thus, Btnl1 expression was critical for the normal 
development of signature Vγ7+ IEL. 
By contrast to the profound and selective impact of Btnl1 on Vγ7+ IEL development, 
flow cytometry of small intestinal IEL recovered from adult (W12) Btnl4-/- mice 
revealed no significant differences in the representation of Vγ7+ or Vγ7+GL2+ IEL 
relative to age-matched WT controls (Figure 4.6A). Furthermore, there was no 
significant difference in the absolute cell numbers of Vγ7+, Vγ7+GL2+, Vγ7-, 
TCRβ+CD8αα+ and TCRβ+CD8αβ+ recovered from the small intestine of Btnl4-/- 




relative to WT mice. Hence, Btnl1 but not Btnl4 was required for the development 
of signature intestinal Vγ7+ IEL. 
4.4.2 Btnl1 is critical for the athymic development of signature intestinal 
Vγ7+ IEL 
As Btnl1 is strongly expressed specifically in small intestinal villus epithelium, we 
considered that the impact of Btnl1 is mediated extra-thymically and within the 
small intestine (Figure 4.3A,B). To test the contribution of Btnl1 to bona fide 
extrathymic Vγ7+ IEL development, Btnl1-/- mice were crossed with athymic NU/NU 
mice and the IEL composition was analysed by flow cytometry of cells freshly 
recovered from the small intestine. NU/NU.Btnl1-/- mice displayed a ~3-fold and 
≤10-fold reduction in the representation of Vγ7+ and Vγ7+GL2+ IEL amongst γδ IEL, 
respectively, relative to age matched NU/NU controls (Figure 4.6B). As was shown 
for euthymic Btnl1-/- mice (Figure 4.4), this depletion in Vγ7+ IEL equated to a 
>90% reduction in the overall number of Vγ7+ and Vγ7+GL2+ cells recovered from 
the small intestine of NU/NU.Btnl1-/- relative to NU/NU mice (Figure 4.6B). Given 
these data, we concluded that although NU/NU mice harbour 3-4-fold fewer 
intestinal γδ IEL relative to euthymic mice (Guy-Grand et al., 1991), the Vγ7+ IEL 
that do develop are similarly dependent on Btnl1. Moreover, as NU/NU mice lack 
most αβ IEL, these data refute the possibility that Btnl1 deficiency drives expansion 
of TCRβ+CD8αα+ IEL, rather than depletion of Vγ7+ IEL. In summary, Btnl1 was 
critical for the development of Vγ7+ IEL in euthymic and athymic mice. 






Figure 4.4 IEL composition in Btnl1-/- mice 
Upper: Representative dot plots from 3 independently derived Btnl1-/- lines and 
associated controls (n≥6). Lower: Enumeration of IEL subsets in W6-15 WT vs. 
Btnl1-/- mice by flow cytometry. Lower panel includes data pooled from 6 
independent experiments.  




                
 
Figure 4.5 IEL composition in Btnl1-/- mice 
A) TCRVγ1 and TCRVγ4 chain usage amongst small intestinal γδ IEL in WT vs. 
Btnl1-/- mice (n=8-16) B) Representative maximum intensity projections from 
confocal analysis of IEL composition in proximal small intestinal whole-mounts from 
adult WT vs. Btnl1-/- mice. (n=3). Data are representative of 1 (B), or >4 (A) 
independent experiments. Data in panel (B) provided by Dr Hart. 





Figure 4.6 IEL composition in Btnl1-/- and Btnl4-/-, NU/NU and NU/NU.Btnl1-/- mice 
A) γδ IEL composition (left) and absolute numbers (right) of γδ and αβ IEL subsets 
in W12 WT vs. Btnl4-/- mice. B) γδ IEL composition (upper) and absolute numbers 
(lower) of Vγ7+ and Vγ7+GL2+ IEL in W10-12 NU/NU vs. NU/NU.Btnl1-/- mice. 
Panels (A) and (B) each include data pooled from 2 independent experiments. 
Data in panel (A) provided by Dr Jandke. 
 




4.5 The specificity of Btnl1 for Vγ7+ IEL 
4.5.1 Btnl1 has no impact on systemic immune cell composition 
The impact of the Skint1 mutation is highly specific to signature Vγ5+ DETC and 
has no reported consequences for systemic immune composition (Barbee et al., 
2011; Boyden et al., 2008; Lewis et al., 2006; Turchinovich and Hayday, 2011). To 
test the specificity of Btnl1 for Vγ7+ IEL, a comprehensive multi-parametric flow 
cytometry analysis of immune cell composition was performed in cells freshly 
isolated from the  mesenteric lymph nodes and spleen of Btnl1-/-, Btnl1+/- and WT 
adult (W10-W11) mice. The analysis was designed and performed by the Infection 
and Immunity Immunophenotyping (3i) consortium and included a complete 
analysis of mesenteric lymph node (MLN) T cell composition and splenic T cell, B 
cell and myeloid cell composition (see materials and methods). There was no 
significant difference in splenic T cell, B cell and myeloid cell or MLN T cell 
composition between WT, Btnl1+/- and Btnl1-/- mice (Figure 4.7; 4.8). Furthermore, 
flow cytometric analysis of TCRVγ chain usage within splenic and MLN γδ T cell 
compartments revealed no significant difference in the representation of Vγ1+ 
(~50%), Vγ4+ (~25%), Vγ7+ (<10%) and Vγ1/4/6- triple negative (~10%) γδ T cells 
between adult (W10-11) WT, Btnl1+/- and Btnl1-/- mice (Figure 4.9). Therefore we 
concluded that Btnl1 had no detectable impact on the composition of these 
systemic immune compartments. 
4.5.2 Btnl1 has no impact on the development of Vγ7+ thymocytes 
To check whether Btnl1 has an impact on Vγ7+ thymocyte development, flow 
cytometric analysis was employed to quantify and phenotype Vγ7+ thymocytes from 
WT, Btnl1+/- and Btnl1-/- mice at postnatal D4-5, D14-15 and W5-W8. There was no 
significant difference in the absolute numbers of Vγ7+ or Vγ7+GL2+ thymocytes in 
Btnl1-/- mice relative to WT mice at D14-15 and W5-8, or relative to Btnl+/- mice at 
D4-5 (Figure 4.10A). Furthermore, there was no detectable difference in cell 
surface phenotype in Vγ7+ thymocytes from Btnl1-/- mice relative to WT mice at 
D14-15 and W5-8, or relative to Btnl+/- mice at D4-5 (Figure 4.10B). Indeed, as 
previously shown (Figure 3.4A-D), Vγ7+ and Vγ7+GL2+ thymocytes were mostly 




CD122- or CD122LO, CD45RBLO, CD5+, CD24+, CD69- and Thy1+ (Figure 4.10B). 
Hence, Vγ7+ thymocytes retained an ‘immature’ cell surface phenotype irrespective 
of Btnl1 expression over the first 8 weeks of life, during which thymus activity is at 
its peak in C57Bl/6 mice (Hsu et al., 2003). There was therefore no evidence that 
Btnl1 had any impact outside of the small intestinal signature Vγ7+ IEL 
compartment. 





Figure 4.7 Mesenteric lymph node immune composition in WT, Btnl1+/- and Btnl1-/- 
mice 
Mesenteric lymph node T cell composition assayed by multi-parametric flow 
cytometry in W10-11 adult mice. Data are presented as Log10(% indicated subset). 
Radar plot presents mean values (n=8). Data are representative of 1 experiment 
performed in collaboration with Dr Laing and 3i team. 





Figure 4.8 Splenic immune compartments in WT, Btnl1+/- and Btnl1-/- mice 
Splenic T cell, B cell and myeloid cell composition assayed by multi-parametric flow 
cytometry in W10-11 adult mice. Data are presented as Log10(% indicated subset). 
Radar plot presents mean values (n=8). Data are representative of 1 experiment 
performed in collaboration with Dr Laing and 3i team. 





Figure 4.9 Splenic/Mesenteric lymph node γδ  T cell composition in WT, Btnl1+/- 
and Btnl1-/- mice 
Splenic and mesenteric lymph node γδ T cell composition assayed by multi-
parametric flow cytometry in W10-11 adult mice (n=8). Data are representative of 1 
experiment. 





Figure 4.10 Vγ7+ thymocytes in Btnl1-/- mice 
A) Enumeration of Vγ7+ and Vγ7+GL2+ thymocytes from WT, Btnl1+/- and Btnl1-/- 
mice at indicated time points. B) Cell surface phenotypes of Vγ7+ and Vγ7+GL2+ 
thymocytes from WT, Btnl1+/- and Btnl1-/- mice at indicated time points (n≥6). 
Panels (A) and (B) include data pooled from ≥3 independent experiments.  





In agreement with previous reports, we have shown that Btnl1, Btnl4 and Btnl6 are 
strongly expressed in the small intestinal epithelium (Bas et al., 2011), and that 
their expression is more specifically within post-mitotic, differentiated villus 
enterocytes. Given that Btnl1- but not Btnl4-deficiency was associated with a 
striking depletion in signature small intestinal Vγ7+ IEL, we conclude that Btnl1 but 
not Btnl4 is critically required for the development of Vγ7+ IEL.  
Btnl1-/- mice displayed no overt difference in the composition of their systemic T cell, 
B cell and myeloid cell compartments relative to WT controls. Furthermore, thymic 
Btnl1 expression is almost negligible and accordingly, its deficiency had no effect 
on the development of Vγ7+ thymocytes. Hence, the impacts of Btnl1 appear to be 
mediated extrathymically and are specific to signature intestinal Vγ7+ IEL. 
Consistent with this, bona fide extrathymic development of Vγ7+ IEL was impaired 
in NU/NU.Btnl1-/- relative to NU/NU mice. In summary, we conclude that Btnl1 is 
critical for an extrathymic component of signature intestinal Vγ7+ IEL development. 
We next proceeded to investigate the impact of intestinal Btnl1 on the extrathymic 
development of signature Vγ7+ IEL, which we further sought to characterise. 




Chapter 5. Impact of Btnl1 on extrathymic Vγ7+ IEL 
maturation 
5.1 Introduction 
We previously demonstrated that at postnatal D14-D17, Vγ7+ IEL in WT mice were 
enriched for cells that carried an ‘immature’ TCRLOCD122LOCD24+ cell surface 
phenotype, reminiscent of pre-selection DETC progenitors in Skint1-mutant mice 
(Figure 3.3A-C). Furthermore, relative to ‘mature’ CD122HI Vγ7+ IEL, putative 
CD122LOVγ7+ ‘immature’ precursors expressed greater levels of Bcl11b, Sox13 and 
Sox4 and lower levels of Tnfrsf9, Xcl1 and Tbx21 (Figure 3.7), suggesting Vγ7+ IEL 
may peripherally transition through a similar developmental checkpoint to DETC 
progenitors in the thymus.  
Having shown that Btnl1 was a critical determinant for the development of 
signature small intestinal Vγ7+ IEL (Figure 4.4; 4.5A-B), we next sought to 
determine how its impact was mediated. Given that Btnl1 is exclusively highly 
expressed in small intestinal epithelium (Figure 4.1A-E) (Bas et al., 2011), and that 
its deficiency was not associated with a thymic, splenic or MLN immune phenotype 
(Figure 4.7; 4.8; 4.9; 4.10A-B), we hypothesized that Btnl1 regulated the 
peripheral selection of Vγ7+ IEL in trans from small intestinal villus enterocytes. 
Within this model, we also considered that selective interactions with Btnl1-
expressing enterocytes could be driving the selective expansion of signature Vγ7+ 
IEL in situ, in the small intestine of neonatal and weanling mice (Figure 3.8A-C).  
To test this, we phenotypically characterized the ‘residual’ Vγ7+ IEL found in Btnl1-/- 
mice; we assessed whether haematopoietic expression of Btnl1 was necessary for 
Vγ7+ IEL development; and we established an inducible Btnl1 transgenic mouse 
model to assess the impact or re-introducing Btnl1 into Btnl1-/- mice. 




5.2 Phenotypic status of ‘residual’ Vγ7+ IEL in Btnl1-/- mice 
5.2.1 Btnl1-/- mice are enriched for putative CD122LO Vγ7+ IEL precursors that 
fail to selectively expand in situ 
To test whether residual Vγ7+ IEL in Btnl1-/- mice carried a pre-selection 
CD122LOTCRLOTIGITLO phenotype (Figure 3.3A) (Lewis et al., 2006), flow 
cytometric analysis was performed on IEL freshly isolated from postnatal D21 to 
D35 Btnl1-/- mice. By contrast to age-matched WT controls, a greater proportion of 
Vγ7+ and Vγ7+GL2+ IEL in Btnl1-/- mice carried a CD122LOTIGITLO phenotype, 
although TCR (by anti-CD3) expression was comparable (Figure 5.1A). 
Furthermore, ‘residual’ Vγ7+ IEL from D35 Btnl1-/- mice phenocopied their WT 
counterparts in D14 mice (Figure 3.3B), as ~50% of the population carried the 
‘immature’ CD122LOThy1+ phenotype (Figure 5.1B). Indeed, ‘Immature’ cells were 
also enriched for putative CD8α-Lag3-CD5+CD24+ precursors, which was virtually 
undetectable in the CD122HIThy1- Vγ7+ compartment (Figure 5.1B). While Vγ7+ IEL 
in Btnl1-/- mice showed no overall difference in cell surface TCR expression to age-
matched WT counterparts (n≥4; p<0.003 for statistical analysis of each marker 
individually) (Figure 5.1A), high versus low TCR expression did segregate with 
CD122HITIGITHI and CD122LOTIGITLO Vγ7+ cells, respectively (Figure 5.1C). Thus, 
it was concluded that 21-35 day-old Btnl1-/- mice were enriched for the putative 
CD122LOThy1+CD8α-Lag3-CD5+CD24+ Vγ7+ IEL precursors that had previously 
been identified in 14-17 day old WT mice (Figure 3.3A-C).  
To investigate whether Vγ7+ IEL failed to undergo selective expansion in the 
absence of Btnl1, EdU incorporation in 28 day-old mice was assayed by flow 
cytometry of IEL recovered after a 3hr EdU pulse in vivo. While ~10% of Vγ7+ and 
Vγ7+GL2+ IEL in WT mice incorporated EdU over this time frame, ~6% of Vγ7+ and 
~5% of Vγ7+GL2+ IEL in Btnl1-/- mice were found to do so (p<0.0001) (Figure 5.2A). 
Furthermore, EdU incorporation in Btnl1-/- ‘residual’ Vγ7+ IEL failed to phenocopy 
rapidly dividing CD8αβ+ thymocytes, ~10% of which were EdU+, and instead more 
closely resembled Vγ7- IEL, ~4% of which were EdU+ (Figure 5.2A). Hence, the 
depletion of Vγ7+ IEL in Btnl1-/- mice may be at least partly due to a failure in 
selectively expanding this compartment in situ. Consistent with this, a significantly 




smaller proportion of Vγ7+ IEL expressed Ki67 at post-natal D14-16 (p<001), D21-
24 (p<0.0001), D25-31 (p<0.0001) and W5-7 (p=0.0001) (Figure 5.2B). From W11-
16, most >90% of Vγ7+ IEL were quiescent in both WT and Btnl1-/- mice and there 
was no significant difference in Ki67 expression. Taken together, these data 
suggest that selective interactions with Btnl1-expressing small intestinal 
enterocytes may drive phenotypic maturation and expansion of Vγ7+ IEL, such that 
by D21 they form the predominant and signature intestinal γδ IEL compartment. 





Figure 5.1 'Residual' Vγ7+ IEL in Btnl1-/- mice 
A) Surface phenotypes of Vγ7+ and Vγ7+GL2+ IEL from W3-5 Btnl1-/- mice (n≥8) B) 
Upper: Thy1 and CD122 expression by Vγ7+ IEL from D35 Btnl1-/- mice (n=8); 
Lower: Surface phenotypes of CD122HIThy1- vs. CD122LOThy1+ Vγ7+ IEL from W4-
6 Btnl1-/- mice (n≥4). C) CD3 and TIGIT expression in CD122HI vs. CD122LO Vγ7+ 
IEL (shown in figure 4.10A) from Btnl1-/- mice (n≥8). Data are representative of ≥3 
experiments. Panel (B) includes data pooled from ≥3 experiments. 




                 
 
Figure 5.2 Post-natal expansion of Vγ7+ IEL in Btnl1-/- mice 
A) EdU incorporation during 3hr pulse in vivo in γδ IEL and CD8αβ thymocytes from 
W4 WT vs. Btnl1-/- mice (Vγ7- gated from CD3+TCRβ- cells) (n≥9). B) Ki67+ 
expression in Vγ7+ IEL freshly isolated from WT vs. Btnl1-/- mice (D14èn≥4; All 
other time pointsèn=8-27). Panels include data pooled from 3 (A) or >8 (B) 
independent experiments. 




5.2.2 Btnl1 acts in trans from small intestinal enterocytes 
To test our hypothesis that enterocyte Btnl1 expression confers a selective 
advantage to Vγ7+ IEL in trans, we established conditions (see materials and 
methods) by which adult (W5-W6) bone marrow could reconstitute signature Vγ7+ 
and Vγ7+GL2+ IEL compartments in irradiated adult (W8-W10) TCRδ-/- recipients. 
Analysis of IEL composition was performed by flow cytometry of freshly recovered 
cells. Following bone marrow transfer, it took 5-6 weeks for Vγ7+ IEL to reliably 
reconstitute to a level at which they were the predominating (60-70%) γδ ΙΕL subset. 
However, it took ≥10 weeks for the reconstituted γδ IEL compartment to attain a 
40% representation amongst total CD3+ IEL (Figure 5.3A). Using these conditions, 
it was shown that WT and Btnl1-/- bone marrow were equally capable at 
reconstituting signature CD122HI Vγ7+ IEL Figure 5.3B). Hence, haematopoietic 
expression of Btnl1 was dispensable for the reconstitution and phenotypic 
maturation of donor bone marrow-derived Vγ7+ IEL. 
To determine whether host Btnl1 expression was required for Vγ7+ IEL 
reconstitution, Btnl1-sufficient CD45.1+ bone marrow was transferred into irradiated 
CD45.2+ congenic WT or Btnl1-/- hosts. Analysis of IEL composition was performed 
4-5 weeks post bone marrow transfer. Although overall reconstitution of intestinal 
IEL in ‘T cell sufficient’ WT and Btnl1-/- hosts was less effective that that observed 
in TCRδ-/- mice (Figure 5.3A,B), ~40% of the reconstituted CD45.1+CD3+TCRβ- 
IEL were Vγ7+ in WT hosts, whereas only ~17% were Vγ7+ in Btnl1-/- hosts (Figure 
5.4A). Moreover, the reconstituted Vγ7+ and Vγ7+GL2+ IEL compartment was 
mostly CD122HI in WT hosts and CD122LO in Btnl1-/- hosts (Figure 5.4A). Hence, 
both the efficiency of Vγ7+ IEL reconstitution and the capacity to support Vγ7+ IEL 
maturation was highly dependent on host Btnl1 expression. Complementing these 
findings, CD45+ IEL purified from 21 to 35 day-old mice could reconstitute the 
intestinal Vγ7+ IEL compartment of recipient TCRδ-/- mice, albeit very inefficiently. 
However, this too was greatly impaired in TCRδ-/-.Btnl1-/- recipients (Figure 5.4B). 
Taken together, these data support the notion that enterocyte-expressed Btnl1 acts 
in trans to promote the selective phenotypic maturation and expansion of signature 
Vγ7+ IEL precursors as they arrive in the gut epithelium. 





Figure 5.3 Reconstitution of signature Vγ7+ IEL from adult donor bone marrow 
A) Intestinal IEL composition assayed by flow cytometry in irradiated TCRδ-/- hosts 
at indicated time-points after reconstitution with adult (W5-6) WT bone marrow 
(n≥3). B) γδ IEL composition and cell surface phenotype in irradiated TCRδ-/- hosts 
8-10 weeks after reconstitution with WT vs. Btnl1-/- bone marrow (n≥7). Data are 
representative of 1 (A) or 3 (B) independent experiments. 





Figure 5.4 Reconstitution of Vγ7+ IEL in Btnl1-/- mice 
A) CD45.1+ γδ IEL composition and cell surface phenotype in irradiated CD45.2+ 
WT vs. Btnl1-/- hosts 4-5 weeks after reconstitution with adult (W5-6) CD45.1+ bone 
marrow (n=7). B) γδ IEL composition 2-3 weeks after adoptive transfer of (CD45+) 
IEL column-purified from weanling (W4-5) mice into W6 WT.TCRδ-/- vs. Btnl1-/-
.TCRδ-/- hosts. (n=6). Panels (A) and (B) are each representative of 2 independent 
experiments. 




5.3 Transgenic rescue of Vγ7+ IEL deficiency in Btnl1-/- mice 
5.3.1 Generation of an inducible Btnl1 transgenic mouse 
Having established that Btnl1 acts in trans to regulate the intestinal maturation and 
expansion of Vγ7+ IEL, we considered whether re-introduction of Btnl1 expression 
would be sufficient to rescue maturation and/or expansion of ‘residual’ Vγ7+ IEL in 
Btnl1-/- mice. We thus generated Btnl1-/- mice transgenic (Tg) for Btnl1 under the 
control of a doxycycline (Dox)-inducible promoter, an approach previously used to 
generate Dox-inducible Rae-1-Tg mice (Oppenheim et al., 2005; Strid et al., 2008). 
Briefly, Btnl1-/- blastocysts were injected with a linearized cassette containing the 
Btnl1-open reading frame (ORF) downstream of a tetracycline-responsive element 
(TRE) controlling a minimal cytomegalovirus (CMV) promoter (Figure 5.5A). 
Successful insertion of the Btnl1-transgene in Btnl1-/- pups was confirmed by 
Southern blotting of genomic DNA purified from tail tissue and digested with EcoRI. 
As predicted by the genomic and transgene sequences, WT Btnl1 migrated at 
7.3kB and the Btnl1 transgene migrated at 2.3kB (Figure 5.5A,B). 
To induce Btnl1 expression, Btnl1-Tg+ mice were crossed with Btnl1-/- mice 
expressing the reverse tetracycline trans-activator (rtTA-M2) regulated by the 
ubiquitous Rosa26 promoter (R26.rtTA) (Hochedlinger et al., 2005); or by the 
enterocyte-specific Villin promoter (Villin.rtTA) (Roth et al., 2009). Bi-transgenic 
(BiTg) Btnl1-/- offspring generated from these crosses inherited both the Btnl1-Tg 
and the reverse tetracycline transactivator (rt-TA) and could inducibly express Btnl1 
globally (R26.rtTA) or locally (Villin.rtTA) in response Dox treatment (Figure 5.6). 
As previously reported, supplementation of drinking water with low-dose (1mg/ml) 
Dox had minimal impact on gut health (Roth et al., 2009). Dox water is bitter in 
taste, so to incentivise its consumption we supplemented it with 2% sucrose and 
accordingly, treated BiTg negative controls with 2% sucrose alone (ctrl water). To 
control for any non-specific effects of Dox, single transgenic (SiTg) mice that had 
only inherited the Btnl1-Tg (SiTg) were also Dox-treated. 





Figure 5.5 Generation of a Dox-inducible Btnl1 transgenic mouse 
A) Upper: Schematic representation of the WT Btnl1 locus. Lower: TRE-Btnl1 
transgene construct. The linearized TRE/CMV cassette has been previously 
described (Oppenheim et al., 2005). Grey: unstranslated region; green: translated 
region; orange: upstream-tetracycline response element/CMV promoter and 
downstream-β-globulin/polyA tail. B) DNA analysis by Southern blot to detect 
transgene insertion. Genomic DNA was digested with EcoR1 as indicated 
(arrowheads) and a probe (blue bar) targeting the indicated region (Exon3/4 
boundary in ORF) was generated to detect the WT and targeted allele. Panel (B) is 
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Figure 5.6 Schematic of Btnl1 induction in Bi-transgenic mice 
Doxycycline treatment specifically induces Btnl1 transcription in mice that are Bi-
transgenic for the Reverse Tetracycline (Tet) Transactivator (rtTA2-M2) and Btnl1. 
R26.rtTA+ BiTg mice inducibly express Btnl1 globally. Villin.rtTA+ BiTg mice 
inducibly express Btnl1 locally in enterocytes. Schematic adapted from: (Strid et 
al., 2008).  




5.3.2 Global Btnl1 induction elicits selective stimulation and phenotypic 
rescue of Vγ7+ IEL  
To verify the Dox-dependency of Btnl1 induction in BiTg mice, Btnl1 expression 
was assayed by qRT-PCR in adult (W7-13) BiTg, SiTg and Btnl1-/- mice after two 
weeks of Dox treatment. Dox-treated mice were compared to untreated WT and 
ctrl-water-treated BiTg mice. Consistent with the mouse genotypes, Dox-dependent 
Btnl1 expression was detected in BiTg but not in SiTg or Btnl1-/- mice (Figure 5.7A). 
Although the magnitude of Btnl1 expression in BiTg mice was ~5-fold lower than in 
WT mice, its induction was highly dependent on Dox-treatment, with little to no 
leaky expression in littermate controls (Figure 5.7A). Thus, BiTg mice provided a 
well-controlled system to study the impact of de novo Btnl1 expression in Btnl1-/- 
mice. 
To examine the impact of such global Btnl1 induction, adult (W7-13) BiTg and 
littermate controls were treated with Dox or Ctrl water for 1-2 weeks before IEL 
composition and phenotype analysis. Dox-treated BiTg mice displayed no 
significant differences in the frequency and absolute cell numbers of signature Vγ7+ 
and Vγ7GL2+ cells relative to littermate controls (Figure 5.7B). Hence, Btnl1 
expression over this time frame did not rescue the signature Vγ7+ IEL compartment. 
However, the proportion of CD122HI cells within the Vγ7+ IEL compartment 
increased from <50% in ctrl-treated BiTg and Dox-treated SiTg to >70% in Dox-
treated BiTg mice (Figure 5.8A). Furthermore, most CD122HI cells were 
additionally Ki67+, indicating that they had been selectively stimulated out of 
quiescence. The proportion of CD122+Ki67+ cells amongst Vγ7+ IEL was up to 4-
fold higher in Dox-treated BiTg mice (>40%) than in ctrl-treated BiTg (<10%) and 
Dox-treated SiTg (<10%) mice (Figure 5.8A). Such stimulation was specific to the 
Vγ7+ IEL compartment, as ~50% of Vγ7+ IEL in BiTg mice were Ki67+ following 
Dox-treatment, relative to <20% of TCRβ+ and Vγ7- γδ IEL. Indeed, TCRβ+ and Vγ7- 
γδ IEL displayed no Dox-dependent changes in Ki67 expression (Figure 5.8B). In 
summary, global Btnl1 induction in adult BiTg mice partially phenocopied Vγ7+ IEL 
maturation in neonatal mice, as it selectively elicited up-regulation of CD122 and 
Ki67 expression but failed to achieve numerical expansion of this signature IEL 
compartment. 




              
Figure 5.7 IEL composition in Doxycycline-treated adult Bi-transgenic mice 
A-B) 7-13 week old Btnl1-/- SiTg and BiTg mice were treated with Dox-water 
(1mg/ml Dox; 2% sucrose) or Ctrl-water (2% sucrose) for 1-2 weeks. A) Btnl1 
expression by qRT-PCR vs. untreated WT mouse. B) γδ IEL composition (Left) and 
absolute cell numbers (Right) assessed by flow cytometry (sugarèn=3-5; 
restèn=4-14). Panels include data representative of 2 (A) or ≥3 (B-left) 
independent experiments. Panel (B-right) presents data pooled from ≥3 
independent experiments.  




        
Figure 5.8 IEL phenotype in Doxycycline-treated adult Bi-transgenic mice 
(A-B) 7-13 week old adult Btnl1-/- SiTg and BiTg mice were treated with Dox-water 
(1mg/ml Dox; 2% sucrose) or Ctrl-water (2% sucrose) for 1-2 weeks and analysed 
by flow cytometry. (A) CD122 and Ki67 expression in Vγ7+ IEL. (B) Ki67 expression 
in IEL subsets (sugarèn=5; SiTgèn=14; BiTgèn=9). Panels include data that are 
representative of (A) and pooled (B) from ≥3 independent experiments 




5.3.3 Villin-specific Btnl1 induction elicits selective stimulation and 
phenotypic rescue of Vγ7+ IEL  
Having demonstrated that global Btnl1 induction could achieve selective phenotypic 
changes in Vγ7+ IEL in vivo, we next tested whether local villin-specific Btnl1 
expression could achieve similar results (Figure 5.6). The villin promoter is active 
in enterocytes along the length of the small and large intestine, in the proximal 
tubules of the kidney and in a small population of cells in the stomach wall (Roth et 
al., 2009). To compare this system with our previous experiments, we treated adult 
(W7-W13) BiTg mice and littermate controls with Dox or Ctrl water for 1-2 weeks 
before analysis. 
Vγ7+ IEL recovered from Dox-treated BiTg mice were uniformly Lag3+ and mostly 
CD22HIThy1LO, whereas those recovered from ctrl-treated BiTg littermates were 
mostly CD122LO and a greater proportion were Lag3- and Thy1+. Hence, villin-
specific Btnl1 expression was sufficient to elicit selective phenotypic changes in 
Vγ7+ IEL (Figure 5.9A). In agreement with our previous findings, CD122HI Vγ7+ IEL 
from BiTg mice selectively up-regulated Ki67 in response to Dox-treatment, 
indicating they had been stimulated out of quiescence (Figure 5.9B). Thus, ~40% 
of Vγ7+ IEL from Dox-treated BiTg mice expressed both CD122 and Ki67 whereas 
<10% of Vγ7+ IEL from ctrl-treated BiTg and Dox-treated SiTg mice were found to 
do so. Such stimulation was specific to the Vγ7+ IEL compartment, ~40% of which 
expressed Ki67 in Dox-treated BiTg mice compared to ~10% of TCRβ+ and Vγ7- γδ 
IEL. While there were no Dox-dependent changes in Ki67 expression amongst 
TCRβ+ or Vγ7- γδ IEL, there was a Dox-independent 10-20% increase in Ki67 
expression in some ctrl-treated BiTg mice (Figure 5.9B). Given these data, we 
concluded that villin-specific Btnl1 induction was sufficient to drive phenotypic 
rescue of Vγ7+ IEL in trans. 
In spite of the Dox-dependent increase in Ki67 expression seen in Vγ7+ IEL from 
BiTg mice, 1-2 weeks Dox-treatment had no impact on the representation of Vγ7+ 
or of Vγ7+GL2+ IEL amongst γδ IEL (data not shown). To test whether a longer 
period of Dox treatment could rescue the Vγ7+ IEL compartment, we Dox treated 7-
13 week-old BiTg mice alongside Dox-treated SiTg and ctrl-treated BiTg littermates 




for a 3-4 week period. However, there was no significant increase in the 
representation or absolute cell counts of Vγ7+ or Vγ7+GL2+ IEL in Dox-treated BiTg 
relative to ctrl-treated BiTg and Dox-treated SiTg mice (Figure 5.10). Hence, while 
villin-specific Btnl1 induction in adult mice (W7-13) was sufficient to achieve 
selective phenotypic rescue and stimulate Vγ7+ IEL in vivo, it did not numerically 
rescue this signature IEL compartment. We therefore concluded that Btnl1 
expression could elicit phenotypic transition of CD122LOThy1+ Vγ7+ IEL into 
CD122HIThy1- IEL while not promoting detectable expansion. 





Figure 5.9 IEL phenotypes following villin-specific induction of Btnl1 in Bi-
transgenic adults 
(A-B) 7-13 week old adult Btnl1-/- SiTg and BiTg mice were treated with Dox-water 
(1mg/ml Dox; 2% sucrose) or Ctrl-water (2% sucrose) for 1-2 weeks and analysed 
by flow cytometry. (A) Cell surface phenotypes of Vγ7+ IEL in Ctrl- vs. Dox-treated 
Btnl1-/- BiTg mice (n≥5). (B) Left: CD122 and Ki67 expression in Vγ7+ IEL. Right: 
Ki67 expression (n≥5). Panel (A) is representative of ≥2 independent experiments. 
Panel (B) contains data pooled from ≥3 independent experiments. 




                
Figure 5.10 γδ  IEL composition following villin-specific induction of Btnl1 in Bi-
transgenic adults 
7-13 week old adult Btnl1-/- SiTg and BiTg mice were treated with Dox-water 
(1mg/ml Dox; 2% sucrose) or Ctrl-water (2% sucrose) for 3-4 weeks and analysed 
by flow cytometry. γδ IEL composition (Left) and absolute cell counts (Right) (Ctrl 
waterèn=3; Dox waterèn≥6). Left panel presents data pooled from 3 independent 
experiments. Statistical significance determined using Holm-Sidak method. 




5.3.4 Neonatal Villin-specific Btnl1 induction is sufficient to elicit both 
phenotypic and numerical rescue of Vγ7+ IEL 
As Btnl1 induction in adult mice failed to rescue the expansion of signature Vγ7+ 
IEL, we sought to analyse the impact of villin-specific Btnl1 induction in BiTg pups, 
where its expression would overlap with the temporal window in which Vγ7+ 
achieve representational dominance amongst γδ IEL (Figure 3.1B; 3.6A). To do 
this, we commenced Dox-treatment of nursing females at post-natal D7 or of 
weanling litters at D21. Analysis was performed by flow cytometry of IEL recovered 
from Dox-treated mice when they reached 5-6 weeks of age. All animals were 
blindly treated with Dox and genotyping was performed retrospectively. 
Villin-specific Btnl1 induction in BiTg pups elicited an increase in the representation 
of Vγ7+ IEL from ~20% to ~50% of γδ IEL (p<0.0001), and an increase in the 
representation of Vγ7+GL2+ IEL from <5% to ~10% (p<0.0001), relative to littermate 
controls (Figure 5.11A). Moreover, this representational increase was 
accompanied by significant phenotypic changes. Dox-treated BiTg mice 
phenocopied untreated 28-35 day-old WT mice as >95% of Vγ7+ IEL were CD8α+, 
Lag3+, CD24- and CD5-, ~90% were Thy1- and >75% were CD122+. By contrast 
Dox-treated SiTg mice phenocopied Dox-treated Btnl1-/- mice as ~75% expressed 
CD8α; ~60% expressed lag3; ~50-60% expressed CD122; ~40% expressed Thy1; 
~15% expressed CD24; and ~20% expressed CD5 (Figure 5.11B). Taken together, 
these data show that re-introducing Btnl1 expression in gut epithelium is sufficient 
to drive both expansion and phenotypic maturation of Vγ7+ IEL in trans in neonatal 
(D7-21) but not adult (>W7) BiTg mice.  





Figure 5.11 Villin-specific induction of Btnl1 transgene in Bi-transgenic pups 
(A-B) 7-21 day-old Btnl1-/- mixed-transgenic litters were blindly treated with Dox-
water (1mg/ml Dox; 2% sucrose) for 2-5 weeks and analysed by flow cytometry. 
Genotyping was performed retrospectively. (A) γδ IEL composition (B) Surface 
phenotypes of W4-5 C57Bl/6 mice vs. Dox-treated mixed transgenic litters 
(SiTgèn=4; Restèn≥6). Radar plot displays mean values. Panels (A, B) present 
data pooled from ≥3 experiments. 





Our studies show that Btnl1 mediates its selective impacts upon Vγ7+ IEL in trans 
from the small intestinal epithelium. Btnl1-deficient enterocytes are thus incapable 
of supporting the phenotypic maturation and expansion of signature small intestinal 
Vγ7+ IEL as they infiltrate the neonatal gut. Consequently, Btnl1-/- deficient animals 
carry a much-depleted Vγ7+ IEL compartment, enriched for cells expressing an 
‘immature’ CD122LOThy1+Lag3-CD5+CD24+ cell surface phenotype. This ‘immature’ 
phenotype is reminiscent of pre-selection DETC in Skint1-mutant mice (Lewis et 
al., 2006) and of putative Vγ7+ IEL precursors that are enriched for in WT mice at 
D14 (Figure 3.3A-C). Therefore, it is possible that Btnl1-/- mice harbour a small 
compartment of putative ‘immature’ Vγ7+ IEL precursors into their adulthood.  
Consistent with this, acute induction of Btnl1 expression in the small intestinal 
epithelium of adult (W7+) Btnl1-/- mice was sufficient to selectively elicit phenotypic 
change in the majority of ‘residual’ Vγ7+. That such phenotypic changes in adult 
BiTg mice took place in the absence of detectable expansion supports the notion 
that Btnl1 elicits a true phenotypic transition. However, it is not definitive proof of a 
precursor-product relationship. Whereas Btnl1 induction in adults was associated 
with phenotypic change alone, its induction in BiTg pups (D7-D21) was associated 
with both expansion and phenotypic maturation. Given this, we conclude that 
enterocyte-expressed Btnl1 elicits extrathymic phenotypic maturation and 
numerical expansion of Vγ7+ IEL but that these effects are highly separable, with 
numerical expansion being confined to a developmental window within the first 5 
post-natal weeks. 
Having established that transgenic expression of Btnl1 can elicit gain-of-function 
effects and rescue extrathymic Vγ7+ IEL maturation ± expansion, we proceeded to 
investigate whether Btnl1 can elicit similar gain-of-function effects in vitro. 




Chapter 6. The Mechanism of Btnl1 Activity 
6.1 Introduction 
The specificity of enterocyte-expressed Btnl1 for Vγ7+ IEL could imply that this 
molecule acts via a TCR-dependent pathway. Indeed, there is a strong precedent 
for BTN family members to regulate γδTCR-dependent or -associated processes, 
with BTN3 regulating human Vγ9Vδ2+ T cell activation and Skint1 regulating murine 
DETC selection (Barbee et al., 2011; Boyden et al., 2008; Harly et al., 2012; 
Sandstrom et al., 2014; Turchinovich and Hayday, 2011). To further explore 
whether Btnl1 may exert its impact on Vγ7+ IEL via a TCR-associated pathway, it 
was necessary to establish a system in which Btnl1 could elicit gain-of-function 
effects on Vγ7+ IEL in vitro. 
A recent study demonstrated that primary small intestinal enterocytes constitutively 
harbour Btnl1 in complex with Btnl6 (Lebrero-Fernández et al., 2016). Furthermore, 
the same study reported that Btnl1 expressed together with Btnl6 in MODE-K cells 
(Vidal et al., 1993) could preferentially elicit cell division in Vγ7+ IEL that had 
previously undergone a 2 week expansion protocol in vitro (Lebrero-Fernández et 
al., 2016). The expansion protocol employed by this study has also been used by 
other studies of intestinal IEL biology (Bas et al., 2011; Swamy et al., 2015) and 
involves 48hrs of direct TCR stimulation in the presence of IL-2, IL-3, IL-4 and IL-15, 
followed by 12 days of culture in media supplemented with IL-2 alone. Given that 
such stimulation carries the potential to alter the composition and/or 
responsiveness of cultured T cells, it is not clear to what extent ‘expanded’ IEL are 
representative of IEL in vivo. To avoid this potential confounding issue in our 
studies we tested gain of function effects of MODE-K.Btnl transductants on 
intestinal IEL directly ex vivo in the absence of prior or concomitant TCR 
stimulation.  
MODE-K cells are derived from proximal small intestinal epithelial cells of 2-week 
old germ-free mice that were cultured in vitro and immortalized by retroviral 
transduction of the large T gene of SV40 (Vidal et al., 1993). These cells express 
negligible levels of Btnl1, Btnl4 and Btnl6 and are insensitive to contact-mediated 
inhibition but do retain some features that are characteristic of intestinal epithelial 




cells (Bas et al., 2011). For example, MODE-K cells adhere to plastic and form 
elongated cellular structures with stubby cytoplasmic protrusions that resemble 
microvilli (Vidal et al., 1993). MODE-K cells also retain expression of villin and 
cytokeratin 18, that are expressed in intestinal enterocytes and in glandular 
epithelial cells of the digestive tract, respectively (Vidal et al., 1993). As MODE-K 
cells retain some features of intestinal epithelium while lacking Btnl1, Btnl4 and 
Btnl6 expression, they provide a highly appropriate platform for Btnl gene gain-of-
function assays.  
Our previous studies have shown that enterocyte expression of Btnl1 selectively 
elicits a number of phenotypic changes in Vγ7+ IEL in vivo (see Chapter 5). 
Prominent amongst these are the up-regulation of CD122 and down-regulation of 
CD24, both of which also occur during Skint1-mediated DETC selection (in the 
thymus) and during thymic agonist selection of αβ thymocytes (Hanke et al., 1994; 
Lewis et al., 2006; McDonald et al., 2014; Narayan et al., 2012; Oh-hora et al., 
2013). In vitro, the only systems in which Skint1-mediated selection of DETC 
progenitors has been rescued are FTOC and re-aggregate thymic organ cultures 
(RTOC) (Barbee et al., 2011; Turchinovich and Hayday, 2011). While murine bone 
marrow stroma-derived OP9 cells expressing delta-like 1 (OP9-DL1) can support 
the development of many αβ and γδ T cell lineages, OP9-DL1 cells transduced with 
Skint1 have historically not been able to rescue Skint1-mediated selection outside 
of a RTOC (Barbee et al., 2011). Hence, it was likely that MODE-K.Btnl 
transductants would not be able to recapitulate the phenotypic changes (e.g. 
CD122 up-regulation) associated with Btnl1-mediated selection in vivo. We 
therefore had to broaden our repertoire of read-outs for gain-of-function effects. 
One read-out employed by Lebrero-Fernandez, et al., (2016) was up-regulation of 
the IL2-receptor-α (IL2Rα) sub-unit (CD25), which is a robustly characterized 
consequence of TCR-mediated T cell activation but not of TCR-mediated agonist 
selection (Depper et al., 1984; Hanke et al., 1994; Kim and Leonard, 2002). Up-
regulation of CD25 is detectable within ~6hrs of TCR engagement and has been 
shown to occur during TCR agonist antibody stimulation of DETC in a LAT-
dependent manner (B. Zhang et al., 2015). TCR-driven up-regulation of CD25 is 
also thought to be an important event at the beginning of the 14-day intestinal IEL 
expansion protocol as it enhances IEL responsiveness to IL-2 cytokine in vitro (Bas 




et al., 2011; Lebrero-Fernández et al., 2016; Swamy et al., 2015). As intestinal IEL 
do not express CD25 directly ex vivo (Denning et al., 2007), its up-regulation in a 
gain-of-function assay would be a sensitive read-out associated with TCR-
mediated T cell activation. Additional read outs that may accompany up-regulation 
of CD25 include down-regulation of the TCR and down-regulation of CD122, which 
is selectively shuttled for proteasomal degradation during cytokine-driven IL-2 
receptor internalisation (Hémar et al., 1995; Kim and Leonard, 2002; Yu and Malek, 
2000).  
Given BTN3 is known to regulate the antigen-driven TCR-dependent activation of 
Vγ9Vδ2+ T cells (Harly et al., 2012; Rhodes et al., 2015; Sandstrom et al., 2014), 
we investigated whether Btnl1 expressed by MODE-K cells could similarly regulate 
the activation of signature Vγ7+ IEL. All gain-of-function assays were performed in 
the presence of IL-2, IL-3, IL-4 and IL-15 to maximise IEL viability during culture. 
Our gain-of-function read-outs included expression of CD25, CD122 and cell 
surface TCR (by anti-CD3). 
6.2 Regulation of cell surface of Btnl1, Btnl4 and Btnl6 
expression in MODE-K cells 
Skint1 protein is poorly detectable at the cell surface, even when over-expressed in 
Human Embryonic Kidney (HEK)-293T cells (Barbee et al., 2011). Btnl6 is also 
poorly expressed at the cell surface of MODE-K cell transductants but can traffic to 
the cell membrane when in complex with Btnl1 (Lebrero-Fernández et al., 2016). 
To investigate the intracellular trafficking of Btnl1, MODE-K cells were transfected 
with of N-terminally tagged Btnl cDNA (FLAG-Btnl1, HIS-Btnl4 and HA-Btnl6) 
individually, or in pairs. By flow cytometric analysis, Btnl1 cell surface expression 
was found to be greatly enhanced by co-expression of Btnl6 or Btnl4 (MFI 
increased from 333 to >1300). Likewise, cell surface Btnl6 expression was 
dependent on co-expressed Btnl1 (MFI increased from <200 to >1500), whereas 
there was no evidence of collaboration between Btnl6 and Btnl4 (Figure 6.1). Thus, 
the cell surface trafficking of a given Btnl molecule appeared to be tightly regulated, 
if not dependent upon co-expression of a specific, closely related Btnl isoform.  




Given that Btnl4-/- mice displayed no detectable IEL phenotype (Figure 4.5A) and 
that Btnl1 and Btnl6 were previously shown to stimulate IEL in vitro and form 
heterodimers in vivo (Lebrero-Fernández et al., 2016), we tested the impact of 
Btnl1 and/or Btnl6 expressed in stably transduced MODE-K cells following 
overnight co-culture with intestinal IEL. 






Figure 6.1 Cell surface Btnl expression in transfected MODE-K cells 
Cell surface expression of FLAG-Btnl1, HIS-Btnl4 or FLAG-Btnl6 co-transfected in 
MODE-K cells. Constructs contained a tagged-Btnl linked to a GFP reported via an 
internal ribosome entry site (IRES). Histogram overlays show the expression of 
each BTNL after gating on GFP+ cells (numbers in brackets indicate geometric 
mean fluorescence intensity, gMFI). Cell lines were produced and analysed by Dr 
Vantourout. 




6.3 The impact of MODE-K cells co-expressing Btnl1 and Btnl6 
on intestinal IEL  
6.3.1 Co-expression of Btnl1 and Btnl6 renders MODE-K cells capable of 
stimulating Vγ7+ IEL 
Overnight co-culture with MODE-K cells transduced with empty vectors (MODE-
K.EV), Btnl1 (MODE-K.L1) or Btnl6 (MODE-K.L6) was associated with CD25 up-
regulation in a small proportion (≤8%) of all IEL. However, MODE-K cells co-
expressing Btnl1 and Btnl6 (MODE-K.L1+6), elicited a significant up-regulation of 
CD25 specifically in 15-30% of signature Vγ7+ IEL (Figure 6.2). Relative to co-
culture with MODE-K.EV, co-culture with MODE-K.L1+6 but not MODE-K.L1 or 
MODE-K.L6 was associated with a 2-8-fold increase in the proportion of Vγ7+ cells 
expressing CD25 (p<0.0001). By contrast, there was no MODE-K.L1+6-dependent 
increase in CD25 expression amongst TCRβ+ or Vγ7- γδ IEL and there was no 
variation in its induction amongst IEL that had been co-cultured with MODE-K.EV 
relative to MODE-K.L1 or MODE-K.L6 (Figure 6.2). Concomitant expression of 
Btnl1 and Btnl6 therefore rendered MODE-K cells capable of selectively stimulating 
signature intestinal Vγ7+ IEL in vitro. Given the lack of variation in the impact of 
MODE-K.EV relative to MODE-K.L1 or MODE-K.L6, our follow up studies 
exclusively employed MODE-K.EV as negative controls.  
CD25 up-regulation downstream of TCR engagement can be detected within 6 
hours (Depper et al., 1984; Kim and Leonard, 2002; Reinherz et al., 1982) and is 
often associated with down-regulation of the TCR (José et al., 2000) and CD122 
(Hémar et al., 1995; Yu and Malek, 2000). To test whether MODE-K.L1+6 could 
elicit these changes in Vγ7+ cells, we analysed CD25 expression by flow cytometry 
after 4 and 6 hours of co-culture with MODE-K.L1+6. We also assessed cell 
surface TCR (by anti-CD3) and CD122 expression in Vγ7+ IEL following overnight 
co-culture with MODE-K.L1+6. CD25 expression was detectable on ~5.5% and 
~2% of Vγ7+ IEL following 6 hours of co-culture with MODE-K.L1+6 and MODE-
K.EV, respectively (p<0.0001) (Figure 6.3A). Furthermore, cells that up-regulated 
CD25 were found to down-regulate TCR (detected by anti-CD3) and CD122 




expression (Fignre 6.3B, C). Hence, the impact of MODE-K.L1+6 on Vγ7+ IEL 
evoked both the kinetics and the phenotypic consequences of TCR stimulation.  






Figure 6.2 Primary intestinal IEL co-cultured with MODE-K transductants 
Upper: Primary small intestinal IEL from week (W)3-6 mice cultured overnight with 
MODE-K cells transduced with constructs expressing either an empty vector (EV), 
Btnl1 (L1), Btnl6 (L6) or Btnl1+6 (L1+6) analysed by flow cytometry for CD25 
expression (n=21). Lower: Fold change in %CD25+ cells in the indicated IEL 
subsets following overnight co-culture with the indicated MODE-K transducants, 
normalised to %CD25+ cells following co-culture with MODE-K EV. (n=21). Data 
are representative of ≥5 independent experiments 





Figure 6.3 Vγ7+ IEL stimulation during co-culture with MODE-K transductants 
A) Primary small intestinal IEL from W3-4 mice cultured for the indicated times with 
MODE-K cells transduced with constructs expressing an empty vector (EV) vs. 
Btnl1+Btnl6 (L1+6) (n=7). B) CD3 expression in Vγ7+CD25+ vs. Vγ7+CD25- IEL 
following overnight co-culture with MODE-K.L1+6 (n=21). C) CD122 vs. CD25 
expression on Vγ7+ cells from W3-5 mice following overnight co-culture with the 
indicated MODE-K transductants (n=21). Panels (B,C) are representative of ≥5 
independent experiments. Panel (A) includes data pooled from 2 independent 
experiments 




6.3.2 Cell-to-cell proximity with MODE-K.L1+6-cells is necessary and 
sufficient to elicit Vγ7+ IEL stimulation  
As previously discussed (see Chapter 1), cell-to-cell contact with a BTN3-
expressing pAgPC is both necessary and sufficient to elicit TCR-dependent 
activation of human Vγ9+Vδ2+ T cells (Karunakaran and Herrmann, 2014). To test 
whether MODE-K.L1+6 were sufficient to elicit CD25 up-regulation on Vγ7+ IEL, in 
the absence of any other cell subset, we performed overnight co-cultures using 
Vγ7+ IEL that had previously been positively sorted by flow cytometry. While 
positive sorting of TCRVγ7+ cells was associated with increased background 
induction of CD25 during co-culture with MODE-K.EV (6-7%), this did not obscure 
the >2-fold increase in CD25-expressing Vγ7+ IEL following co-culture with MODE-
K.L1+6 (Figure 6.4A). Hence, the MODE-K.L1+6-driven stimulation of Vγ7+ IEL did 
not depend on any other cell-types. 
To test whether Vγ7+ IEL stimulation was contingent on their proximity to MODE-K 
transductants, we compared CD25 expression on IEL cultured in direct contact with 
the MODE-K monolayer, or sequestered in a suspended trans-well. Consistent with 
cell-to-cell proximity being important, <5% of Vγ7+ IEL up-regulated CD25 when 
sequestered from MODE-K.EV and this did not change during sequestered co-
culture with MODE-K.L1+6 (Figure 6.4B, black bars). While CD25 expression 
could be rescued by culturing IEL in direct contact with the monolayer (Figure 6.4B, 
red and yellow bars), it could not be rescued in sequestered IEL by additionally 
including IEL beneath the trans-well in contact with the MODE-K.L1+6 monolayer 
(Figure 6.4B, yellow and blue bars). Thus, we concluded that Vγ7+ IEL stimulation 
was contingent on their cell-to-cell proximity to MODE-K.L1+6 cells and that soluble 
mediators produced by MODE-K.L1+6, or by CD25+Vγ7+ cells were insufficient to 
trans-activate sequestered T cells. In summary, cell-to-cell contact with MODE-
K.L1+6 was both sufficient and necessary to elicit Vγ7+ IEL stimulation. 
6.3.3 Co-culture with MODE-K.L1+6 elicits weak T cell activation 
MODE-K.L1+6-dependent stimulation of Vγ7+ IEL in vitro induced down-regulation 
of cell surface TCR, CD122 and up-regulation of CD25. This phenotype is more 




associated with T cell ‘activation’, rather than agonist selection, particularly as the 
latter induces up-regulation of CD122. To check for other consequences of putative 
IEL activation, we assayed 48hr co-culture supernatants for 36 cytokines in a 
luminex assay. Co-cultures that included γδ IEL (isolated from WT and TCRβ-/- 
mice) displayed MODE-K.L1+6-dependent increases in IFNγ (~2-fold; p≤0.04), GM-
CSF (1.2 to 1.5-fold; p≤0.002), and CCL4 (~1.3-fold; p≤0.02), three typical effector 
molecules of intestinal IEL (Figure 6.5) (Hayday et al., 2001; Malinarich et al., 
2010; Shires et al., 2001). By contrast, MODE-K.L1+6-dependent increases in 
cytokine production were not observed in co-cultures lacking γδ IEL (from TCRδ-/- 
mice), although these were associated with greater background levels of IFNγ 
production irrespective of co-culture condition. Hence, ≤150pg/ml IFNγ was 
detected following co-culture of TCRδ-/- with MODE-K.EV, relative to <50pg/ml, 
which was detected following co-culture of WT or TCRβ-/- IEL. We therefore 
concluded that weak γδ IEL activation may be occurring in vitro during co-culture 
with MODE-K.L1+6. 
Taken together, these data attest to a specific cell-cell interaction taking place 
between Vγ7+ IEL and MODE-K cells in vitro. This interaction was dependent on 
MODE-K expression of Btnl1+Btnl6 and may have elicited weak T cell activation, 
possibly via a TCR-dependent pathway. 




         
Figure 6.4 Contact dependency during IEL:MODE-K co-culture 
A) CD25 expression in positively FACS-sorted Vγ7+ IEL from W3-5 mice cultured 
overnight with MODE-K cells expressing EV vs. L1+6 (n=4). Upper: Purity of 
positively sorted Vγ7+ IEL. Lower: CD25 expression after overnight co-culture with 
indicated MODE-K transductant. B) Mean CD25 expression in Vγ7+ IEL from W3-5 
mice following the indicated overnight trans-well culture conditions 
(blue/blackèsegregated; red/yellowèin contact) (n=3). Panels are each 
representative of ≥2 independent experiments. Data in panel (B) provided by Dr 
Roberts. 




                    
 
Figure 6.5 Cytokine production over 48 hours of IEL:MODE-K co-culture 
IEL were isolated from 4 week-old mice of the indicated genotypes and co-cultured 
with the indicated MODE-K transductants for 48hrs. Supernatants were harvested 
and analysed by luminex assay for the presence of 36 cytokines, chemokines and 
growth factors (n=3). Data are representative of 1 experiment. 




6.4 Molecular impact of co-culture with MODE-K.L1+6  
6.4.1 Co-culture with MODE-K.L1+6 induces transcription at the Nr4a1 gene 
locus amongst CD25+Vγ7+ IEL 
Expression of Nr4a1 (Nur77) marks one of the earliest transcriptional events 
downstream of TCR engagement in peripheral T cells and in thymocytes (Osborne 
et al., 1994; Winoto and Littman, 2002). This transcription factor is a member of the 
steroid-thyroid hormone receptor superfamily and is believed to be important for 
thymic negative selection (Winoto and Littman, 2002; Zhou et al., 1996), although 
mice deficient for Nur77 alone display no obvious defects in this process (S. L. Lee 
et al., 1995). Whereas the non-redundant functions of Nur77 in T cells and 
thymocytes are poorly defined, its transcriptional regulation is relatively well 
characterized and strongly associated with TCR-dependent calcium signalling 
(Feske et al., 2001; Winoto and Littman, 2002). Unlike CD69, the up-regulation of 
Nur77 is not induced by inflammatory stimuli and is thus considered to be a more 
specific read-out for TCR-associated intracellular signalling pathways. Because of 
this, the Nur77.gfp mouse that encodes a GFP reporter at the Nr4a1 gene locus 
has been widely adopted to study developmental TCR signalling in iNKT cells and 
TCRβ+CD8αα+ IEL (Hogquist and S. C. Jameson, 2014; McDonald et al., 2014; 
Moran et al., 2011).  
To test whether co-culture with MODE-K.L1+6 induced transcription at the Nr4a1 
gene locus, flow cytometric analysis was performed on primary IEL that had been 
recovered from W3-5 Nur77.gfp mice and cultured overnight on monolayers of 
MODE-K.EV or MODE-K.L1+6. Directly ex vivo, ~20% of TCRβ+, ~36% of Vγ7- and 
~28% of Vγ7+ IEL expressed detectable levels of GFP. Irrespective of whether IEL 
were cultured with MODE-K.EV versus MODE-K.L1+6, GFP expression decreased 
to ~7% of TCRβ+ and <25% of Vγ7- γδ IEL (Figure 6.6A). By contrast, while co-
culture with MODE-K.EV saw GFP expression amongst Vγ7+ IEL drop from ~28% 
to <10%, co-culture with MODE-K.L1+6 was associated with an increase in GFP 
expression, such that ~34% of Vγ7+ IEL were GFP+ (Figure 6.6A). Thus, the 
selective interactions taking place between MODE-K.L1+6 and Vγ7+ IEL in vitro 




were sufficient to sustain and enhance transcription at the TCR-associated 
immediate early Nr4a1 gene locus. 
GFP expression was detectable in ~100% of Vγ7+CD25+ cells following co-culture 
with MODE-K.L1+6 but only ≤50% of Vγ7+ IEL that up-regulated CD25 during co-
culture with MODE-K.EV. Moreover, ≤50% of ‘background’ CD25-expression 
amongst TCRβ+ and Vγ7- γδ IEL was associated with concomitant GFP-expression, 
irrespective of co-culture condition (Figure 6.6A). These data suggested that the 
induction of CD25 amongst Vγ7+ IEL that had been stimulated by MODE-K.L1+6 
was uniquely driven via a TCR-associated pathway that elicited transcription at the 
Nr4a1 gene locus. In support of this notion, CD122-CD25+GFP+ cells were 
observed in ~7.5% of Vγ7+ IEL that had been cultured with MODE-K.L1+6 cells, 
relative to only ~1% of Vγ7+ IEL that had been cultured with MODE-K.EV (Figure 
6.6B). We therefore concluded that CD25 up-regulation amongst Vγ7+ IEL co-
cultured with MODE-K.L1+6 was uniquely linked to a TCR-associated pathway, 
whereas background CD25 induction was not. 





Figure 6.6 IEL from Nur77.gfp mice co-cultured with MODE-K transductants 
A) GFP and CD25 expression in small intestinal IEL isolated from W3-5 Nur77.gfp 
mice ex vivo or following overnight co-culture with MODE-K expressing EV vs. L1-6 
(n=8). B) %Vγ7+ cells from Nur77.gfp versus WT mice that were simultaneously 
CD25+ GFP+ CD122- following overnight co-culture with the indicated MODE-K 
transductants. Panels (A) are representative of and include data pooled (B) from 2 
independent experiments. 
 




6.4.2 Stimulation with TCR agonist antibody elicits CD25 up-regulation in 
intestinal IEL 
To verify whether direct TCR cross-linking could elicit CD25 expression amongst 
intestinal IEL recovered from W3-6 mice, freshly recovered cells were stimulated 
overnight on plate-bound anti-CD3 (10µg/ml) and analysed by flow cytometry. 
While TCR-stimulation elicited CD25 expression in ~10% of Vγ7+ IEL, this effect 
was smaller than that seen for TCRβ+ IEL (~20% CD25+) and Vγ7- IEL (~40% 
CD25+) (Figure 6.7A). Furthermore, it was also smaller than the ~20% of Vγ7+ IEL 
that up-regulated CD25 in response to co-culture with MODE-K.L1+6 (Figure 6.7B). 
By contrast, ‘residual’ Vγ7+ IEL from Btnl1-/- mice displayed greatly enhanced 
responsiveness to TCR stimulation with ~30% of cells up-regulating CD25 (Figure 
5.7B). Consistent with their capacity to respond to the acute up-regulation of Btnl1 
in vivo (See chapter 5), residual Vγ7+ from Btnl1-/- mice could also respond to 
MODE-K.L1+6 in vitro. However, by contrast to their enhanced responsiveness to 
direct TCR cross-linking, their up-regulation of CD25 following co-culture with 
MODE-K.L1+6 was comparable to that seen in Vγ7+ cells from WT mice, with ~20% 
of cells up-regulating CD25 (Figure 5.7B). Thus, although anti-CD3 stimulation 
could elicit CD25 up-regulation in all IEL subsets, the responsiveness of Vγ7+ IEL to 
direct TCR cross-linking was attenuated in cells that had previously encountered 
Btnl1 in vivo. By contrast, prior exposure to Btnl1 in vivo had no effect on the 
responsiveness of Vγ7+ IEL to co-culture with MODE-K.L1+6. 
To test whether TCR-associated signalling components were required for MODE-
K.L1+6-driven stimulation, co-cultures were supplemented with PP2, an inhibitor of 
Src-family kinases (SFK) or its negative control, PP3. SFKs act proximally to TCR 
triggering and are responsible for phosphorylating ITAM domains on the 
cytoplasmic tails of CD3. When such phosphorylation is inhibited, the TCR complex 
is unable to recruit intracellular Syk-family kinases and TCR signal cannot be 
propagated (P. E. Love and Hayes, 2010; Smith-Garvin et al., 2009). Consistent 
with SFK activity being critical for Vγ7+ IEL stimulation, supplementation of the co-
culture with PP2 but not PP3 reduced the proportion of Vγ7+ IEL up-regulating 
CD25 during co-culture with MODE-K.L1+6 by ~90% (Figure 6.8). By contrast, 




PP2 had no effect on background induction of CD25 during co-culture with MODE-
K.EV. Taken together, these data support the hypothesis that MODE-K can elicit 
Btnl1+Btnl6-dependent stimulation of Vγ7+ IEL via a TCR-associated molecular 
pathway. Furthermore, they suggest that background CD25 expression is 
independent of SFK and thus occurs independently of TCR signalling. 




                          
 
Figure 6.7 Direct TCR stimulation of 10 intestinal IEL and IEL co-cultured with 
MODE-K transductants 
A) CD25 expression in primary IEL from WT W3-6 mice treated overnight with 
plate-bound αCD3 (10mg/ml) or IgG isotype control (n≥12). B) Mean CD25 
expression on Vγ7+ IEL from W3-5 WT vs Btnl1-/- mice following the indicated 
overnight culture conditions (n=7; IgG/αCD3 at 10µg/ml plate-bound). Panels (A,B) 
include data pooled from ≥3 independent experiments. 




           
 
Figure 6.8 IEL:MODE-K co-cultures in the presence of signalling inhibitors 
CD25 expression in primary Vγ7+ IEL from W4 mice treated with PP2, PP3 or 
vehicle and co-cultured overnight with the indicated MODE-K transductants. Values 
above graphs correspond to the concentration of PP2 or PP3 that was used. 
Upper: Representative plots following co-culture. Lower: two different 
concentrations of PP2/PP3. Data are representative of 1 experiment. Data provided 
by Dr Roberts. 
 





These studies have demonstrated that MODE-K cells expressing Btnl1 together 
with Btnl6 are sufficient to elicit selective stimulation of co-localised Vγ7+ IEL, giving 
rise to several of the same consequences as TCR-mediated T cell activation. 
These consequences include up-regulation of CD25, enhanced transcription at the 
Nr4a1 gene locus and down-regulation of the TCR (by anti-CD3) and of CD122. 
Consistent with its putative induction downstream of TCR signal, the up-regulation 
of CD25 was highly sensitive to SFK inhibition by PP2. By contrast, background 
induction of CD25 during co-culture with MODE-K.EV was not sensitive to PP2-
mediated inhibition and was also not strongly associated with active transcription at 
the Nr4a1 gene locus. We therefore conclude that MODE-K.L1+6 cells are able to 
selectively activate a TCR-associated response-pathway in intestinal Vγ7+ IEL. 
Our studies have also shown that selective interactions with Btnl1-expressing 
enterocytes in vivo may attenuate the responsiveness of Vγ7+ IEL to direct TCR 
stimulation ex vivo. Thus, relative to Vγ7+ IEL from WT mice, a greater proportion of 
‘residual’ Vγ7+ IEL from Btnl1-/- mice up-regulated CD25 in response to direct TCR 
cross-linking. By contrast, the responsiveness of Vγ7+ IEL from WT and Btnl1-/- 
mice to stimulation by MODE-K.L1+6 was not significantly different. The 
comparable responsiveness of Vγ7+ IEL from WT and Btnl1-/- mice to MODE-
K.L1+6-mediated stimulation in vitro is consistent with their capacity to respond to 
Btnl1 in vivo (see chapter 5) and further supports the notion that CD122LO Vγ7+ IEL 
in Btnl1-/- mice are precursors to signature CD122HI Vγ7+ IEL in WT mice.  
Given these collective observations, we conclude that MODE-K.L1+6 can elicit 
selective stimulation of Vγ7+ IEL, via the engagement of cell surface receptors, 
which may include the Vγ7+ TCR. 




Chapter 7. Discussion 
Up to this point, the discovery of Skint1 had provided a singular insight into how 
organ-specific products of epithelial cell differentiation may actively regulate γδ IEL 
composition (Barbee et al., 2011; Lewis et al., 2006). However, as Skint genes are 
mostly expressed in the skin and thymus, and neither Skint nor DETC are 
conserved in humans, the generality of this pathway was unclear (Boyden et al., 
2008). The aim of this thesis was to determine whether Skint1-mediated regulation 
of DETC composition is exceptional, or whether it represents a generalizable 
mechanism by which epithelia regulate the composition of local intraepithelial γδ T 
cell compartments. 
To investigate this, we characterized the phenotypic maturation of signature small 
intestinal Vγ7+ IEL and found evidence to suggest that this occurred via an 
extrathymic pathway. This pathway exhibited key parallels with Skint1-mediated 
DETC selection and was found to be dependent on enterocyte-expressed Btnl1, a 
gene that is closely related to Skint1 (see Chapter 1). Consistent with the 
extrathymic nature of this pathway, the impact of Btnl1 was mediated within the gut 
and its transgenic expression in small intestinal enterocytes was sufficient to 
rescue phenotypic transition and expansion of Vγ7+ IEL in vivo. To study the 
mechanism through which Btnl1 acts, we developed a gain-of-function system in 
vitro and showed that Btnl1 can co-operate with Btnl6 to stimulate Vγ7+ IEL via a 
TCR-associated pathway. In summary, our studies firmly establish that Skint1-
mediated DETC selection is one example of a general mechanism employed by 
epithelia to establish and maintain the signature γδ IEL composition. Furthermore, 
they provide additional evidence to support the notion that Btnl molecules influence 
IEL composition through the selective activation of TCR-associated signalling 
pathways. 
7.1 Hallmarks of signature small intestinal γδ  ΙΕL 
Consistent with their status as the signature small intestinal γδ IEL subset, Vγ7+ IEL 
selectively displayed a mature cell surface phenotype that resembled both Skint1-
selected DETC and/or agonist-selected TCRβ+CD8αα+ IEL (Table 7.1). This 




included uniformly high expression of CD122, TCR, TIGIT, CD69 and Lag3; their 
expression of the CD8αα+ homodimer; and their lack of cell surface Thy1 and CD5. 
 
Table 1 Surface phenotypes of DETC and intestinal IEL subsets 
Expression levels presented as high (+++); moderate (++); low (+); mostly negative 
+/-); and negative (-). Data for Vγ7+ and Vγ7- IEL are presented in thesis results 
chapters. Data for TCRβ+CD8αα+/CD8αβ+ IEL and DETC are compiled from our 
unpublished data and are corroborated by several studies (Denning et al., 2007; 
Gangadharan et al., 2006; Klose et al., 2014; Lewis et al., 2006; Mayans et al., 
2014; McDonald et al., 2014; Payer et al., 1991; 1995; 1994; Pennington et al., 
2003; 2006; Sumaria et al., 2011; Turchinovich and Hayday, 2011). 
 
IEL subset CD122 TIGIT TCR CD8αα  Lag3 CD5 Thy1 CD69 
Vγ7+  +++ +++ +++ +++ +++ - +/- +++ 
DETC +++ +++ +++ - +++ - ++ +++ 
TCRβ+CD8αα+  +++ +++ + +++ +++ - +/- +++ 
Vγ7- 
(CD3+TCRβ-) 
+/- +/- ++ ++ +/- +/- +/- ++ 
TCRβ+CD8αβ+  +/- +/- + +/- +/- +++ +++ ++ 




7.1.1 Dependency on IL-15 signalling 
Of these phenotypic markers, CD122 (IL-2/-15Rβ) is one of the most critical 
components of DETC and intestinal IEL biology. High expression of CD122 by 
DETC, TCRβ+CD8αα+ and Vγ7+ ΙΕL confers sensitivity to IL-15, which is 
constitutively produced by epithelial cells and is critically required for their long-term 
maintenance (De Creus et al., 2002; Kawai et al., 1998; Lai et al., 2008; Lodolce et 
al., 1998; Ma et al., 2009; Schluns et al., 2004). By contrast, intestinal Vγ1+ and 
TCRβ+CD8αβ+ TRM IEL express low levels of CD122, and accordingly, are not 
dependent on IL-15-signalling for their reconstitution in bone marrow chimeras 
(Schenkel et al., 2016; Schluns et al., 2004; Sheridan et al., 2014). Thus, a 
dependency on IL-15 signalling differentiates signature IEL compartments, 
including DETC, Vγ7+ and TCRβ+CD8αα+ IEL from other populations of co-
localised intestinal or dermal γδ or αβ T cells.  
The developmental up-regulation of CD122 is classically associated with agonist 
selection and has been shown to occur in αβ or γδ thymocytes following agonist 
ligand engagement (Hanke et al., 1994; Jensen et al., 2008; McDonald et al., 2014; 
Muñoz-Ruiz et al., 2016; Oh-hora et al., 2013). Indeed, intraperitoneal injection of 
TCR agonist antibody in adult mice has recently been shown to elicit a significant 
increase in representation of CD122HINK1.1+ γδ thymocytes (Muñoz-Ruiz et al., 
2016). Moreover, DETC up-regulate CD122 along with their TCR during Skint1-
mediated selection, which is thought to involve a TCR-associated pathway (Lewis 
et al., 2006; Turchinovich and Hayday, 2011). Assuming the level of CD122 
expression correlates with sensitivity to IL-15, selective up-regulation of CD122 
amongst Btnl- or agonst-selected IEL subsets could confer a selective survival 
advantage to these cells, enabling them to preferentially thrive in their respective 
epithelial microenvironments. 
7.1.2 Inhibitory co-receptors 
Signature Vγ7+ IEL were also characterized by their constitutively high expression 
of several co-inhibitory receptors including the CD8αα homodimer, Lag3 and TIGIT, 
all of which have been shown to be up-regulated on αβ T cells during antigen 




dependent activation (Y. Huang et al., 2011; Joller et al., 2011; Mucida et al., 2013; 
Reis et al., 2014; 2013; Triebel et al., 1990). Lag3 and TIGIT are additionally up-
regulated during thymic agonist selection and are highly expressed in the periphery 
by agonist-selected CD4+ regulatory T cells (C.-T. Huang et al., 2004; Joller et al., 
2014; Oh-hora et al., 2013). The precise mechanisms by which these co-inhibitory 
receptors attenuate T cell activation are not fully understood but their ligands are 
often expressed in the small intestinal epithelium, either at the steady state or 
during inflammation.  
CD8αα binds mouse thymus leukaemia antigen (TLA), a non-classical MHC class I 
molecule, which is constitutively expressed by thymic epithelium and intestinal 
epithelium and can be induced on activated APCs (Y. Huang et al., 2011; 
Leishman et al., 2001). The CD8αα homodimer is believed to repress T cell 
activation and has been shown to promote T cell survival in the context strong TCR 
signaling (Cheroutre and Lambolez, 2008; Gangadharan et al., 2006; Y. Huang et 
al., 2011; Madakamutil et al., 2004). TIGIT is a member of the Ig superfamily and 
may regulate T cell activation intrinsically by recruiting phosphatases to its 
cytoplasmic immunoreceptor tyrosine-based inhibitory (ITIM) motif (Anderson et al., 
2016). TIGIT competes with DNAM-1, a positive co-stimulator of lymphocyte 
activation, for the engagement of poliovirus receptor (PVR), which is expressed in 
the gastro-intestinal tract (Anderson et al., 2016; Chan et al., 2014; Uhlen et al., 
2015). Lag3 is structurally similar to CD4 and has been shown to engage both 
MHC class II or LSECtin (CLEC4G), although it is not yet clear which of these 
interactions are responsible for its repressor function in vivo (Huard et al., 1995; Xu 
et al., 2014). Nonetheless, MHC class II expression can be induced on small 
intestinal epithelial cells by IFNγ signaling, whereas LSEctin is highly expressed in 
the hepatobilliary system and in melanoma but is relatively understudied in the 
small intestine (Büning et al., 2005; Xu et al., 2014). Thus, it is possible that all 
these co-inhibitory receptors are constitutively and/or inducibly engaged to increase 
the threshold for IEL activation. 
High activation thresholds may be critical to maintain the ‘activated-yet-resting’ 
state of intestinal IEL that are thought to harbour considerable cytolytic potential 
(Fahrer et al., 2001; Shires et al., 2001). Intestinal γδ IEL constitutively express high 
levels of granzyme (Gzm)A and GzmB, which can induce apoptosis upon entry into 




target cells (Beresford et al., 1999); and FasL, which induces apoptosis of target 
cells upon engagement of Fas (Fahrer et al., 2001; Nagata and Golstein, 1995; 
Shires et al., 2001). Given that agonist-selected IEL are thought to be self-reactive, 
constitutive inhibition may be critical to prevent their inappropriate activation in the 
absence of overt challenge (Cheroutre et al., 2011; Hayday et al., 2001; Rocha et 
al., 1991). Moreover, as many of these inhibitory co-receptors are also shared by 
DETC but not by other tissue-resident γδ or αβ T cell subsets, they may represent a 
generalizable form of T cell regulation employed by the intraepithelial gatekeepers 
of the lymphoid-stress surveillance response.  
7.1.3 Extrathymic maturation 
Whereas DETC progenitors acquire their mature cell surface phenotype across a 
Skint1-dependent checkpoint in the embryonic thymus (Lewis et al., 2006; 
Turchinovich and Hayday, 2011), our studies found no evidence for intra-thymic 
maturation of Vγ7+ or Vγ7+GL2+ cells during the first 8 post-natal weeks. Instead, 
we identified a putative developmental checkpoint for these signature T cells in the 
small intestinal epithelium between postnatal D14 and D21. This checkpoint was 
associated with significant phenotypic change and selective expansion of Vγ7+ IEL, 
such that their representation amongst γδ IEL increased by 1.5- to 4-fold during this 
time. Furthermore, transition through this checkpoint occurred independently of the 
thymus, most secondary lymphoid organs, the microbiome and diet-derived protein, 
evoking Skint1-mediated DETC selection and MHC-mediated selection of αβ T 
cells in the thymus.  
A notable difference between our data regarding the extra-thymic maturation of 
Vγ7+ IEL and the intra-thymic maturation of DETC is that we were not able to 
demonstrate a time point at which 100% of Vγ7+ IEL carried an immature cell 
surface phenotype. Instead, we found that at D14-D17, Vγ7+ IEL displayed a bi-
modal distribution in cell surface phenotype, with an enrichment in ‘immature’ 
CD122loThy1+ putative precursor cells. Although post-natal D14 was the earliest 
time-point at which these cells could be reliably recovered in sufficient numbers for 
flow cytometric analysis, it is likely that Vγ7+ begin their infiltration of the small 
intestinal epithelium at an earlier time point (Kuo et al., 2001), which would allow a 




significant proportion of cells to have attained phenotypically maturity 
(CD122hiThy1-) by the time of our analysis.  
Our phenotypic profiling of putative Vγ7+ precursor cells demonstrated that they 
carried a TCRLOTIGITLOLag3-CD24+CD5+CD8α- cell surface phenotype that was 
reminiscent of pre-selection DETC and of Vγ7+ thymocytes and importantly, did not 
overlap with the phenotype of their ‘mature’ Vγ7+ IEL counterparts (see table 1) 
(Lewis et al., 2006; Turchinovich and Hayday, 2011). The expression of CD24 on 
putative intestinal precursor cells was particularly surprising, as it is conventionally 
associated with γδ and αβ thymocyte maturation (Narayan et al., 2012). Thus, by 
multiple phenotypic criteria, the putative precursor population we have 
characterised evokes a pre-selection DETC or ‘immature’ γδ thymocyte population. 
Consistent with this, several genes that are up- or down-regulated across the 
Skint1 selection checkpoint were similarly up- or down-regulated in ‘mature’ 
CD122HI Vγ7+ IEL relative to ‘immature’ CD122LOVγ7+ IEL. Up-regulated genes 
included Tbx21 (T-bet), which is known to be critical for the development of γδ and 
αβ CD8αα+ IEL (Klose et al., 2014; Kwong and Lazarevic, 2014); Xcl1, which is 
highly expressed by intestinal IEL and is produced by DETC (Boismenu et al., 
1996; Lei and Takahama, 2012; Shires et al., 2001); and Tnfrsf9 (4-1bb), which is a 
positive co-stimulatory receptor for T cell activation that is known to be up-
regulated during TCR engagement (S. J. Lee et al., 2013). Down-regulated genes 
include Bcl11b, Sox13, Sox4 and Rorc, all of which play important roles during γδ 
thymocyte differentiation (Gray et al., 2013; Kang and Malhotra, 2015; Kueh et al., 
2016; Malhotra et al., 2013; Turchinovich and Hayday, 2011); and are particularly 
important for the development of IL-17 producing γδ T cells (Figure 1.5) (Gray et 
al., 2013; Malhotra et al., 2013; Turchinovich and Pennington, 2011). This 
comparative gene expression analysis is the first of its kind for Vγ7+ cells, as 
previous studies have been unable to identify ‘mature’ and ‘immature’ counterparts 
co-localised within the same organ (e.g. the thymus) (Narayan et al., 2012). As 
both Skint1-mediated DETC selection, and intestinal Vγ7+ IEL maturation were 
associated with similar changes in gene expression, these data suggested similar 
intracellular pathways were being activated across the two developmental 
checkpoints. 




While our data are consistent with a model in which CD122loThy1hi Vγ7+ IEL mature 
into their CD122hiThy1lo counterparts, our work has not confirmed that a true 
precursor-product relationship exists between these two populations. To address 
this, future studies should seek to adopt lineage-tracing methods to map out the 
development pathway of these cells. An initial approach could be to adoptively 
transfer cell trace violet-loaded γδ thymocytes, which uniformly display an 
‘immature’ cell surface phenotype, into an adult lympho-depleted host. By labelling 
these cells, one could track their infiltration into the gut and correlate cycles of cell 
division with changes in the expression of CD122 and Thy1. 
7.2 The biological impact of Btnl1 in vivo 
Consistent with our hypothesis, our analysis of Btnl1- and Btnl4-deficient mice has 
demonstrated that Btnl1 but not Btnl4 is a critical determinant for signature Vγ7+ IEL. 
Btnl1-/- mice displayed a ~90% depletion of signature small intestinal Vγ7+ IEL. The 
lymphodepletion associated with Btnl1-deficiency was highly specific to the Vγ7+ 
IEL compartment as Btnl1-/- mice displayed no depletion in other intestinal γδ IEL 
(e.g. Vγ1+ and Vγ4+), and likewise displayed no alterations in systemic T cell, B cell 
and myeloid cell composition. Moreover, Btnl1-deficiency had no impact on the 
abundance or cell surface phenotype of Vγ7+ thymocytes. Thus, Btnl1 is a critical 
extrathymic regulator of intestinal γδ IEL composition. These data further 
substantiate previous reports showing Btnl1, Btnl4 and Btnl6 to be exclusively 
highly expressed in small intestinal enterocytes (Bas et al., 2011). Furthermore, 
they extend the paradigm of Skint1-mediated DETC selection to other epithelial 
tissues, suggesting it represents a generalizable mechanism of regulating γδ IEL 
composition.  
In the absence of Btnl1, Vγ7+ IEL failed to uniformly acquire their mature cell 
surface phenotype and failed to selectively expand in situ. Hence, the severely 
depleted ‘residual’ Vγ7+ IEL compartment of Btnl1-/- mice was enriched for cells 
carrying an ‘immature’ CD122LOTIGITLOThy1+CD8α-Lag3-CD24+CD5+ cell surface 
phenotype reminiscent of Vγ7+ thymocytes; ‘immature’ Vγ7+ IEL from D14-D17 WT 
mice; and pre-selected DETC-progenitors (Lewis et al., 2006). ‘Residual’ Vγ7+ IEL 
also displayed a significantly reduced rate of thymidine analogue incorporation at 




D28 and a smaller proportion of cells expressed Ki67 at every time point analysed 
between D14 to W7. Given that haematopoietic expression of Btnl1 was 
dispensable for Vγ7+ IEL development, we concluded that enterocyte-expressed 
Btnl1 acted in trans to drive the extrathymic maturation and expansion of Vγ7+ IEL. 
Thus, the depletion in Vγ7+ IEL from Btnl1-/- mice was at least partly caused by a 
failure of Btnl1-deficient enterocytes to support the neonatal maturation and 
expansion of this signature intestinal immune compartment.  
7.2.1 Some Vγ7+ IEL in Btnl1-/- mice attain ‘mature’ CD122HI status 
A key difference between the impact of Btnl1 and Skint1 on signature IEL 
compartments is that Skint1-mediated selection initially takes place in the thymus, 
whereas Btnl1-mediated selection takes place peripherally in the small intestinal 
epithelium (Lewis et al., 2006; Turchinovich and Hayday, 2011). Consequently, 
DETC progenitors in Skint1-mutant mice display developmental defects in the 
thymus and fail to home to the skin, whereas putative Vγ7+ IEL precursors in Btnl1-/- 
mice infiltrate the small intestinal epithelium but fail to mature and expand in situ 
(Barbee et al., 2011; Boyden et al., 2008; Jin et al., 2010). Although Vγ7+ IEL are 
highly depleted in the absence of Btnl1, our data do show that a proportion of Vγ7+ 
IEL in Btnl1-/- mice are able to attain a CD122HIThy1LO cell surface phenotype, 
reminiscent of their ‘mature’ counterparts in WT mice (see Chapter 5). Assuming 
Vγ7+ IEL in WT mice universally acquire their mature cell surface phenotype in the 
gut, the up-regulation of CD122 in Btnl1-deficient animals must be occurring via an 
alternative pathway and there are various possibilities in this regard. 
Firstly, in the absence of Btnl1, it is possible that Btnl4 and/or Btnl6 could elicit 
some degree of phenotypic maturation in a proportion Vγ7+ IEL in vivo. Alternatively, 
it is possible that a proportion of ‘residual’ Vγ7+ IEL are still able to engage other 
cell surface molecules on enterocytes that are sufficient to induce their maturation. 
For example, ~1% of mouse γδ T cells including Vγ7+ IEL can engage non-classical 
MHC class Ib molecules (T10/T22) via their TCRδ CDR3 (Adams et al., 2008; 
2005; Chien and Konigshofer, 2007; Crowley et al., 2000; Shin et al., 2005). T10 
and T22 are constitutively expressed in small intestinal enterocytes of C57Bl/6 but 
not β2M-/- mice and their engagement has previously been shown to up-regulate 




CD122 in vivo (Jensen et al., 2008; 2009). In addition, the gut microenvironment is 
rich in several cytokines that may be able to elicit some degree of phenotypic 
maturation independently of Btnl1. IL-15 is constitutively produced by epithelial 
cells and has been shown to drive up-regulation of T-bet and CD8αα and down-
regulation of CD5 in thymic precursors of TCRβ+CD8αα+ in vitro (Klose et al., 2014). 
Likewise, TGFβ and retinoic acid have been shown to promote up-regulation of 
CD8αα expression on αβ T cells in vivo and in vitro (Konkel et al., 2011; Reis et al., 
2014; 2013).  
Phenotypic maturation independent of TCR agonist engagement has been reported 
to occur in αβ T cells during systemic lymphopaenia. Specifically, when naïve 
CD8αβ T cells are adoptively transferred into a lymphopaenic host, they have been 
shown to transiently acquire a ‘memory-like’ CD122HICD44+ cell surface phenotype 
and slowly proliferate until they fill the available niche (Goldrath et al., 2000). Given 
that the neonatal gut grows particularly rapidly at the time of weaning, it is possible 
that the small intestinal IEL niche enters a transient lymphopaenic state, which 
could theoretically drive phenotypic maturation and slow proliferation of ‘residual’ 
Vγ7+ IEL in a Btnl1-independent manner. While there are several potential 
mechanisms that could co-operate to drive the phenotypic maturation of Vγ7+ IEL in 
vivo, it is important to emphasize that in the absence of Btnl1, the intestinal 
cytokine milleu, other Butyrophilin-like molecules and any other alternative ligands 
for cell surface receptors are wholly insufficient to sustain the extrathymic 
development and expansion of Vγ7+ IEL. 
7.2.2 Loss of Vγ7+ IEL is compensated for by TCRβ+CD8αα+ IEL 
Whereas loss of signature DETC in Skint1-mutant mice is compensated by an 
increase in polyclonal epidermal γδ T cells, loss of Vγ7+ IEL in Btnl1-/- mice is mostly 
compensated for by an expansion of TCRβ+CD8αα+ IEL (Barbee et al., 2011; 
Boyden et al., 2008; Lewis et al., 2006). TCRβ+CD8αα+ IEL share a similar gene 
expression profile to bulk γδ IEL, display a similar cell surface phenotype to Vγ7+ 
IEL (Table 1) but are thought to require thymic agonist selection for their 
development (Denning et al., 2007; Gangadharan et al., 2006; Lambolez et al., 
2005; Mayans et al., 2014; McDonald et al., 2014; Oh-hora et al., 2013; Pennington 




et al., 2003). Notably, the expansion of TCRβ+CD8αα+ IEL was not the root cause 
of Vγ7+ IEL depletion in Btnl1-/- mice as this phenotype was replicated in athymic 
NU/NU.Btnl1-/- mice that lack most αβ IEL. Instead, these two phenotypically similar 
populations are known to preferentially compensate for each other’s deficiency in 
vivo. Thus, TCRβ+CD8αα+ cells preferentially expand to compensate for γδ IEL 
deficiency in TCRδ-/- mice; and γδ ΙEL, which are mostly Vγ7+, likewise expand to 
compensate for αβ ΙΕL depletion in β2m-/- mice (Fujiura et al., 1996; Gapin et al., 
1999; Park et al., 1999).  
The capacity for these two IEL subsets to preferentially compensate for each other 
may be due to their selective concentration in the proximal small intestine (H. 
Suzuki et al., 2002); their expression of the CD8αα homodimer, which reduces 
activation-induced cell death (Cheroutre and Lambolez, 2008; Gangadharan et al., 
2006; Y. Huang et al., 2011); and/or their selective expression of counter-receptors 
for enterocyte determinants such as Btnl1 for Vγ7+ IEL. Indeed, such determinants 
for TCRβ+CD8αα+ IEL could include non-classical MHC class Ib molecules such as 
Qa-2, which would explain their deficiency in β2m-/- mice (G. Das et al., 2000). 
The similarities in gene expression profile, anatomical distribution and cell surface 
phenotype of Vγ7+ and TCRβ+ IEL raises the question of whether these cells can 
functionally compensate for each other’s absence. Whereas the study of DETC has 
greatly benefited from Vγ5-/-Vδ1-/- and Skint1-mutant mice that lack canonical DETC 
(Dalessandri et al., 2016; Lewis et al., 2006; Strid et al., 2011; 2008), there are no 
Vγ7-/- mice. As such, very few studies have clearly attributed the gastro-intestinal 
consequences of γδ T cell-deficiency (in TCRδ-/- mice) to Vγ7+ IEL. In this regard, 
the Btnl1-/- mouse provides the first opportunity to characterize the critical and non-
redundant contribution of Vγ7+ IEL to small intestinal physiology. By administering 
inflammatory, carcinogenic or infectious challenges to Btnl1-/- and TCRδ-/- mice in 
parallel, one should be able to pull out shared phenotypes that are direct 
consequences of signature intestinal γδ IEL deficiency (rather than an indirect 
consequence of systemic γδ T cell- or Btnl1-deficiency). Such studies are now on-
going and alongside studies of DETC, should help to define the critical 
contributions that these evolutionarily conserved immune cell populations make to 
host physiology. 




7.2.3 A temporal window for small intestinal Btnl1 activity 
To test whether enterocyte-expressed Btnl1 could rescue the extrathymic 
maturation of signature Vγ7+ IEL in Btnl1-/- mice, we developed an inducible 
transgenic system to re-introduce Btnl1 expression globally (R26-rtTA2-M2) or 
locally to intestinal enterocytes (villin-rtTA2-M2). Using this system we 
demonstrated that enterocyte expression of Btnl1 within the first 5 post-natal weeks 
was sufficient to rescue both the phenotypic maturation and numerical expansion of 
Vγ7+ and Vγ7+GL2+ IEL. These data confirmed that the impact of Btnl1 is indeed 
mediated in trans from small intestinal enterocytes and strongly support the notion 
that its expression is key to determining the lifelong composition and phenotype of 
intestinal γδ IEL. 
Interestingly, the capacity for enterocyte-expressed Btnl1 to elicit phenotypic 
change and numerical expansion was highly separable, with expansion being 
confined to a developmental window within the first 5 post-natal weeks. Hence, 
while induction of Btnl1 expression in adult (W7-W13) BiTg mice was associated 
with phenotypic changes such as up-regulation of CD122, Lag3 and Ki67, this was 
not accompanied by numerical expansion. Similar observations were also made 
after an extended period of Btnl1 induction (3-4 weeks). Given that phenotypic 
changes occurred in absence of detectable expansion, these data support the 
notion that Btnl1 elicits true phenotypic maturation of putative CD122LOThy1+ Vγ7+ 
IEL precursors, rather than just expanding a subset of cells that were 
CD122HIThy1- to begin with.  
The failure of Btnl1 to expand ‘residual’ Vγ7+ IEL in adult mice could be due to lack 
of available space within the small intestinal epithelial niche, which has instead 
been occupied by TCRβ+CD8αα+ IEL (‘niche hypothesis’). In this scenario, Vγ7+ 
cells may enter but not complete the cell cycle, or they divide but their daughter 
cells fail to ‘embed’ or adhere to available space. Alternatively, it is possible that 
IEL expansion requires a specific additional factor that is exclusively present in the 
neonatal gut (‘neonatal factor hypothesis’). However, the full reconstitution of Vγ7+ 
IEL from donor bone marrow in irradiated TCRδ-/- adult mice makes the ‘neonatal 
factor hypothesis’ less likely. Given that such reconstitution occurs in bone marrow 
chimeras, perhaps the irradiation conditions the small intestinal epithelium in such 




a way that enables full recovery of γδ IEL compartments. To test this, one could 
assess Vγ7+ IEL reconstitution in BiTg mice following irradiation, bone marrow 
transfer and simultaneous induction of Btnl1.  
Should the data acquired from these experiments support a ‘niche hypothesis’, 
further efforts should be made to dissect how the size of this niche may be 
regulated at the steady state, during inflammation and during recovery. Such 
studies may have profound implications for human pathology, as over-expansion of 
intestinal intraepithelial γδ T cells is associated with mucosal γδ T cell lymphomas, 
which show a particularly aggressive clinical course (Gaulard et al., 2003); and with 
coeliac disease, where expansion of γδ IEL has been proposed as a fast and 
accurate diagnostic test (Fernández-Bañares et al., 2014; Leon et al., 2002). In this 
context, the implication of Btnl-gene products in driving IEL expansion, and up-
regulation of CD122 merits their study in the context of small intestinal enteropathy, 
where IL-15 signalling is thought to promote IEL cytotoxicity and contribute to villus 
atrophy (Hüe et al., 2004). 
7.2.4 Implications for extrathymic development 
As discussed (see Chapter 1), several studies have suggested that intestinal γδ IEL 
develop extrathymically. This is because they are still detectable in athymic NU/NU 
mice (Guy-Grand et al., 1991); because their development is rescued in IL-7-/- mice 
by enterocyte-specific transgenic expression of IL-7 (Laky et al., 2000); and 
because TN cryptopatch lymphoid precursor cells can give rise to γδ IEL when 
adoptively transferred into thymectomized immunodeficient hosts (Saito et al., 
1998). However, the role for extrathymic development in euthymic mice was 
contested by studies that have failed to detect significant Rag expression in 
cryptopatches (Guy-Grand et al., 2003); and by studies that have dismissed the 
role of cryptopatches altogether (G. Eberl and Littman, 2004; Guy-Grand et al., 
2013). Albeit both of these arguments were in and of themselves later contested by 
proponents of extrathymic development (Ishikawa et al., 2007; Naito et al., 2008). 
Thus, this issue has remained unresolved for several years and most recent 
studies have not focussed on this developmental question (Hayday and Gibbons, 
2008). 




While our study has not addressed the anatomical location where TCR 
rearrangement takes place, we have identified Btnl1 as an extrathymic intestinal 
selecting element. We thus propose that depending on context (e.g. euthymic vs 
athymic mice), TCR rearrangements may take place intra- or extra-thymically (or 
both). However, once the Vγ7+ TCR is assembled, the selection of these T cells 
takes place outside of the thymus, during their selective interactions with Btnl1-
expressing small intestinal enterocytes (Figure 7.1). As the gut clearly has some 
capacity to support lymphopoiesis (Laky et al., 2000), extrathymic selection would 
enable the development and maintenance of this critical immune compartment in 
the absence of continued thymic output. Such a pathway may be necessary to 
replenish Vγ7+ IEL in later life when the thymus has undergone involution; and may 
be necessary to avoid negative selection in the adult thymus, as has been reported 
in mice rendered transgenic for self-reactive γδ TCRs (Lin et al., 1999). Hence, 
extrathymic selection may provide an important pathway for the lifelong 
maintenance of signature intestinal γδ IEL and merits further analysis. 




      
Figure 7.1 Model for the development of a signature Vγ7+ IEL compartment 
Development - Phenotypically immature Vγ7+ IEL precursors home to the small 
intestinal epithelium after TCR rearrangement, which in a young euthymic mouse 
may/may not occur in the thymus (G. Eberl and Littman, 2004); and in athymic 
mice or in elderly mice after thymic involution, may take place extrathymically in 
lymphoid organs such as cryptopatches, PP or MLN (Guy-Grand et al., 2003; 
Kanamori et al., 1996; Lambolez et al., 2002; Saito et al., 1998). Upon arrival at the 
small intestinal epithelium, Vγ7+ IEL progenitors engage in Btnl1-dependent 
interactions with villus enterocytes, which enables them to attain phenotypic 
maturity and representational predominance by postnatal W3, which roughly 
coincides with the time of weaning. 
Maintenance - Following perturbation to the small intestinal epithelium, this 
pathway may be necessary to enable full reconstitution of the signature Vγ7+ IEL 
compartment. Such reconstitution could be mediated by selective expansion of 
locally resident Vγ7+ cells and/or by selective maturation and expansion of newly 
arrived Vγ7+ IEL precursors. 




7.3 Mechanism of Btnl1-mediated selection 
The remarkable specificity of Btnl1 for Vγ7+ IEL suggested that the extrathymic 
selection of these cells was being driven via a TCR-associated pathway. 
Consistent with this, we showed that Btnl1 expressed together with Btnl6 rendered 
MODE-K cells capable of selectively stimulating Vγ7+ IEL in vitro, eliciting several 
consequences conventionally associated with TCR-mediated activation. These 
included up-regulation of CD25, enhanced transcription at the Nr4a1 gene locus 
and down-regulation of the TCR and CD122 (Hémar et al., 1995; José et al., 2000; 
Kim and Leonard, 2002; Yu and Malek, 2000). Stimulation of Vγ7+ IEL was 
dependent on cell-to-cell contact and was still detectable after Vγ7+ IEL had been 
purified by flow cytometry prior to co-culture. Furthermore, stimulation of Vγ7+ IEL 
was detectable within 6 hours of co-culture. Although a small proportion of Vγ7+ IEL 
up-regulated CD25 in a Btnl1+Btnl6-independent manner during co-culture with 
MODE-K.EV, this was mostly not associated with transcription at the Nr4a1 locus 
and could not be inhibited by PP2, suggesting it was driven via an alternative or 
TCR-independent pathway. Indeed, low-level background CD25 up-regulation was 
observed within every IEL subset irrespective of TCR chain usage during overnight 
co-cultures. Thus, MODE-K.L1+6 cells were both necessary and sufficient to elicit 
putative TCR-mediated stimulation of Vγ7+ IEL in vitro.  
7.3.1 Cell surface trafficking of Btnl gene products  
Previous studies have shown that the cell surface expression of Skint1 is very 
tightly regulated but is critically required for DETC maturation (Barbee et al., 2011; 
Salim et al., 2016). Consistent with this, phenotypic maturation of DETC was 
shown to be inhibited by adding soluble anti-Skint1-IgV blocking antibody to FTOC 
(Salim et al., 2016). Although our experiments have not demonstrated an absolute 
requirement for cell surface expression of Btnl1 or Btnl6 during IEL stimulation, we 
have shown that cell surface trafficking of these proteins is also tightly regulated 
and in the case of Btnl6, is dependent on co-expression of Btnl1. Given that 
MODE-K cells expressing Btnl1 or Btnl6 alone were unable to elicit stimulation of 
Vγ7+ IEL, it is possible that their heterodimerization and cell surface trafficking are 
critical for their impact in vitro. Furthermore, s Btnl1 reportedly exists in complex 




with Btnl6 in primary enterocytes, it is possible that its impact on Vγ7+ IEL in vivo is 
similarly mediated in co-operation with Btnl6 (Lebrero-Fernández et al., 2016). If so, 
we would expect Btnl6-/- mice to phenocopy Btnl1-/- mice with respect to Vγ7+ IEL 
depletion. To test this, Btnl6-/- mice are currently in the pipeline being bred to 
homozygosity. 
The capacity for Btnl1+Btnl6 to regulate Vγ7+ T cell selection in vivo and weak T 
cell activation in vitro evokes provocative comparisons with MHC, which directly 
engage TCRs to mediate both of these processes in αβ T cells. However, in the 
absence of TCR binding data for Btnl1 and Btnl6, we cannot conclude that these 
molecules are directly engaging the Vγ7+ TCR. Indeed, as members of the B7 
superfamily it is still possible that Btnl/Skint gene products serve as subset-specific 
co-stimulators that are necessary but insufficient for TCR activation. If this were the 
case, they would represent the first co-stimulators to engage lymphocyte counter-
receptors that segregate according to TCR variable chain usage (e.g. with Vγ7+ but 
not Vγ7- intestinal IEL). That notwithstanding, both models are consistent with Btnl1 
and Btnl6 regulating Vγ7+ IEL activation in vitro and Vγ7+ IEL selection in vivo, via a 
TCR-associated pathway.  
In an alternative model, it is still possible that Btnl1+Btnl6 are necessary for the 
recruitment of additional protein(s) that mediate TCR engagement. Such an 
‘indirect’ model for TCR stimulation was recently proposed for BTN3A1, which is 
unable to present pAg when over-expressed in hamster CHO cells in the absence 
of factors encoded in human chromosome 6 (so called ‘factor X’) (Karunakaran and 
Herrmann, 2014; Riaño et al., 2014). However, as chromosome 6 also contains 
BTN3A2 and BTN3A3, it is unclear whether this phenotype is due to an absence of 
heterodimerization, or whether there is a critical non-BTN3 gene encoded within 
the chromosome. This will need to be clarified because when any one of the three 
BTN3 isoforms is knocked down in a human pAgPC, its capacity to activate 
Vγ9+Vδ2+ T cells is significantly compromised (Rhodes et al., 2015). Thus, the 
mechanisms by which BTN/Btnl molecules exert their selective impacts on discreet 
subsets of γδ T cells is poorly understood and requires further research. 
To better characterise the mechanism of Btnl1+Btnl6-mediated Vγ7+ IEL stimulation, 
the next logical step would be to determine the importance of TCR specificity in 




these selective interactions. This could be tested by purifying CD25+ MODE-
K.L1+6-responsive Vγ7+ T cells and determining their TCR chain pairing by single 
cell PCR. TCRs cloned from ‘responder’ cells could then be tested for their capacity 
to confer MODE-K.L1+6-responsiveness to cell lines (e.g. Jurkat [human]; BWZ.36 
[murine]) expressing TCR signal reporter constructs (e.g. luciferase downstream of 
IL-2 promoter (Dolmetsch et al., 1998)). If this approach is successful, targeted 
mutagenesis should be employed to determine which region of the Vγ7+ TCR is 
most important for regulating their responsiveness to MODE-K.L1+6 (e.g. the Vδ 
chain versus Vγ7; or the CDR3 versus CDR2 or CDR1). To follow up these studies 
in vivo, ‘responsive’ and ‘non-responsive’ Vγ7+ TCRs can be transduced into donor 
bone marrow to compare their capacity to support Vγ7+ IEL development in an 
irradiated host. Similar experiments were recently performed to compare the 
lineage commitment of thymocytes expressing transgenic TCRs cloned from 
TCRβ+CD8αα+ versus TCRβ+CD8αβ+ IEL (Mayans et al., 2014; McDonald et al., 
2014). 
7.3.2 TCR hypo-responsiveness 
Our data suggest that Btnl1-mediated selection in vivo may be associated with 
attenuation of TCR responsiveness, in a striking phenocopy of Skint1-selection of 
DETC progenitors (Wencker et al., 2013). Specifically, we showed that TCR 
agonist antibody stimulation could elicit CD25 up-regulation in a greater proportion 
of Vγ7+ IEL that were recovered from Btnl1-/- mice, relative to those recovered from 
age-matched WT controls. TCR hypo-responsiveness has previously been 
reported for TCRβ+CD8αα+ IEL and for CD8αα+ γδ IEL but had not been 
specifically attributed to the Vγ7+ compartment (Malinarich et al., 2010; Wencker et 
al., 2013). Our data suggest this may be the case as non-Btnl1-selected Vγ7- γδ IEL 
were significantly more responsive to TCR agonist antibody stimulation than Vγ7+ 
IEL from the same WT mouse.  
Hypo-responsiveness to TCR stimulation is considered to be a key feature of IEL 
biology and has been suggested to represent a mechanism by which innate-like T 
cells developmentally accommodate their innate response mode(s) (Wencker et al., 
2013). In DETC, hyporesponsiveness may be necessary to prevent their 




inappropriate activation during the steady state, where they have been shown to 
constitutively engage keratinocytes forming contacts that are enriched in TCR, 
phospho-tyrosine, phosphoCD3ζ, and phospho-Zap70, suggestive of steady-state 
TCR signalling (Chodaczek et al., 2012). Such contacts are highly dependent on 
TCR specificity, may be responsible for driving DETC expansion in neonatal mice 
(Aono et al., 2000; Hara et al., 2000; Payer et al., 1991) and our unpublished data 
suggest they are highly dependent on Skint1, which is constitutively expressed by 
suprabasal keratinocytes (Boyden et al., 2008).  
Given what we know about DETC biology, it is possible that Vγ7+ IEL also engage 
villus enterocytes in Btnl1- and TCR-dependent points of contacts, which may drive 
their constitutive expression of chemokines and cytolytic effector molecules (Shires 
et al., 2001). Such Btnl1-dependent contacts may also be responsible for the pre-
existing GFP expression observed in Vγ7+ IEL freshly recovered from Nur77.gfp 
mice. Although we have not provided formal proof of these contacts in vivo, our 
observation that baseline GFP expression Vγ7+ IEL is mostly lost during overnight 
co-culture with MODE-K.EV but is re-induced when cells are cultured with MODE-
K.L1+6 is consistent with this model. Indeed, co-culture with MODE-K.L1+6 was 
uniquely associated with eliciting a CD25+GFP+CD122LO cell surface phenotype 
amongst Vγ7+ IEL. If constitutive TCR signalling occurs in both DETC and Vγ7+ IEL, 
it may be that attenuation of TCR responsiveness is necessary to prevent 
inappropriate activation of Vγ7+ IEL in the absence of challenge.  
How attenuation of TCR responsiveness is achieved is poorly understood but could 
feasibly involve the Btnl1-dependent up-regulation of co-inhibitory receptors (Table 
7.1). As the contribution of these co-inhibitory receptors to IEL biology is generally 
poorly understood, future work should seek to analyse the consequences of co-
inhibitory receptor deficiency during specific challenges to the skin (e.g. UV 
irradiation) or to the small intestinal epithelium (e.g. low dose methotrexate 
(Aparicio-Domingo et al., 2015)). In particular, it will be important for these studies 
to use conditional knock-out systems, such as the TCRδ-CRE and the Villin-CRE to 
assess the consequence(s) of co-inhibitory receptor deficiency in γδ T cells, 
alongside the consequence(s) of counter-receptor deficiency in the epithelium 
(Roth et al., 2009; B. Zhang et al., 2015). Data from these studies would be highly 
clinically relevant as many such receptors are targets for pharmacological blockade 




in clinic (Anderson et al., 2016). In this regard, it will also be interesting to see if 
their use in clinical trials is associated with specific gastrointestinal or cutaneous 
inflammatory side-effects. 
7.3.3 Putative regulatory role of the B30.2 domain  
As members of the BTN/Btn gene family, Btnl1 and Btnl6 both contain a 
cytoplasmic B30.2 (PRY/SPRY) domain (see Chapter 1). B30.2 domains are also 
found on TRIM proteins, where they are believed to regulate TRIM function by 
binding endogenous or exogenous molecules. For example, rhesus TRIM5α B30.2 
engages HIV capsid protein and targets it for proteasomal degradation, whereas 
TRIM21 B30.2 serves as an intracellular Fc receptor that activates innate 
intracellular neutralization pathways upon engagement of IgG-opsonised viral 
particles (Mische et al., 2005; Pertel et al., 2011; Rhodes and Trowsdale, 2007). 
Likewise, the B30.2 domain of BTN1a1/Btn1a1, the prototypic founder of the 
BTN/Btn gene family, engages intracellular xanthene oxidoreductase to promote 
milk fat globule secretion from lactating mammary gland epithelial cells (Franke et 
al., 1981; Jeong et al., 2009; Ogg et al., 2004). Thus it is possible that the biological 
activity of BTN/Btn/BTNL/Btnl gene products is also regulated by their engagement 
of cytosolic factors via their intracellular B30.2 domains. 
In support of this hypothesis BTN3A1 is believed to regulate the TCR-dependent 
activation of human circulating Vγ9+Vδ2+ T cells by binding intracellular phospho-
antigens (IPP/HMBPP) that are intermediary products of isoprenoid synthesis 
(Harly et al., 2012; Karunakaran and Herrmann, 2014; Rhodes et al., 2015; 
Sandstrom et al., 2014). Such pAgs accumulate endogenously in APCs during viral 
infection or cellular transformation, but may also be exogenously derived from 
microbial metabolism (H. Das et al., 2001; M. Eberl et al., 2003; Gober et al., 2003). 
Thus, this pathway links the engagement of an innate germline-encoded PRR 
domain (B30.2) to the activation of an adaptive (albeit innate-like) lymphocyte via 
its RAG-rearranged T cell receptor. While direct binding between BTN3 and the 
TCR has not been reproducibly demonstrated (Sandstrom et al., 2014; Vavassori 
et al., 2013), it is believed engagement of the intracellular B30.2 domain elicits 
conformational changes in the extracellular IgC/IgV domain that enable it to engage 
a lymphocyte counter-receptor (Sebestyen et al., 2016). Given these data 




regarding BTN3, it is tempting to speculate that Btnl1+Btnl6 mediate Vγ7+ IEL 
selection in vivo or Vγ7+ IEL stimulation in vitro via a TCR-dependent pathway that 
is regulated by engagement of the B30.2 domain.  
Future studies should therefore seek to better understand the role of B30.2 
domains in regulating the activity of Btnl1+Btnl6. Based on what has been 
published regarding BTN3A1 (Rhodes et al., 2015; Sandstrom et al., 2014; 
Sebestyen et al., 2016), we would predict that deleting or mutating the B30.2 
domain of Btnl1 and/or Btnl6 would abrogate the capacity of MODE-K.L1+6 to 
activate Vγ7+ IEL in vitro. Should this be demonstrated, the more challenging task 
will be to identify the nature of the molecule that engages the B30.2 domains of 
Btnl1+Btnl6. This could be a protein (e.g. XOR for Btn1a1), or a low molecular 
mass metabolite (e.g. pAg from isoprenoid synthesis for BTN3A1). It may or may 
not engage Btnl1+Btnl6 together as a heterodimer and may also regulate their cell 
surface trafficking. Whichever the answer, the MODE-K cell transductants 
presented in this thesis will certainly prove useful in testing the hypothesis and in 
providing a platform for further studies in vivo.  
Ultimately, defining the molecular regulator(s) of Btnl1+Btnl6 activity in vitro will 
provide us with a better understanding of the biological context in which these 
proteins function in vivo. Such studies may additionally help to explain why γδ IEL 
composition is regulated by organ-specific Btnl gene-products, rather than by pan-
epithelial molecules. In this regard, while it is interesting that the initial impact of 
Btnl1 in vivo overlaps with the time of weaning, our experiments using inducible 
transgenic mice and bone marrow transfer studies suggest that the capacity to elicit 
stimulation of Vγ7+ IEL persists into adulthood. To investigate the impact of 
weaning, we have tried to wean mice earlier than D21 but found that this did not 
accelerate Vγ7+ IEL maturation (data not shown). Recently it was suggested that 
Btnl1 protein is only detectable by immunohistochemistry from postnatal D14, 
which could explain the kinetics of Vγ7+ IEL maturation we observed in vivo 
(Lebrero-Fernández and Bas-Forsberg, 2016). As we now have our own Btnl1-
specific monoclonal antibody, we can try to replicate some of these studies using 
the Btnl1-/- mouse as a negative control. 




An additional consideration that should not be ignored is the possibility that the 
B30.2 domains of Btnl1 and Btnl6 signal back into the epithelial cells that display 
them (Bas et al., 2011). Such signals may or may not be dependent on interaction 
with Vγ7+ IEL and may constitutively regulate epithelial cell function or attenuate its 
response to inflammation. Evidence for the latter was provided by the finding that 
overexpressed Btnl1 can alter the MODE-K cell response to IFNγ (Bas et al., 2011). 
However, this has not been tested in primary enterocytes in vitro or in vivo as we 
have not had the appropriate tools. Together, the Btnl1-/- and inducible BiTg mice 
presented in this thesis provide these tools and future studies will investigate this 
potential biology. 
In summary, we believe that future studies of these genes should strive to identify:  
a) The non-redundant contributions of Vγ7+ IEL to host physiology. 
b) The role of TCR specificity in Btnl-driven Vγ7+ IEL stimulation in vitro/in vivo. 
c) The biological context in which Btnl gene products function in vivo and in 
vitro, along with the molecule(s) that regulates this function.  
d) Whether Btnl gene products directly influence epithelial cell biology in vivo 
and whether these impacts depend on constitutive or stress-inducible 
interactions with signature γδ IEL. 
7.4 Outlook: Potential Implications for human health 
7.4.1 Btnl3 and Btnl8 regulate human intestinal γδ T cells 
Btnl1, Btnl4, and Btnl6 are each encoded in an amplicon that lies adjacent to Btnl2 
on mouse chromosome 17. While no equivalent amplicon is found adjacent to 
human BTNL2, there is an amplicon encoding BTNL8 and BTNL3 adjacent to 
BTNL9 on human chromosome 5 (Figure 7.2). BTNL3 and BTNL8 are highly 
expressed In the human gastrointestinal tract (Uhlen et al., 2015), particularly 
within EpCAM+ epithelial cells, suggesting they may fulfil a similar biological 
function to murine Btnl1 and Btnl6 (Di Marco Barros et al., 2016). Indeed, our 
recent studies of BTNL3 and BTNL8 suggest that their trafficking to the cell surface 
is also highly regulated and requires concomitant expression of both molecules. 
While we were unable to test the developmental dependence of human gut γδ T 
cells on intestinal BTNL3 (L3) and BTNL8 (L8), we have tested whether expression 




of these molecules renders human embryonic kidney (HEK293T) cells capable of 
activating primary human gut-derived γδ T cells in vitro.  
These studies have revealed a striking conservation of biological function across 
human and mouse organ-specific BTNL/Btnl molecules in that they can selectively 
regulate signature organ-specific γδ T cell subsets. Specifically, we found that 
human gut-derived T cells that are stained with antibodies specific for TCRVγ2/3/4, 
but not with antibodies specific for Vγ5/3, Vγ8, or Vγ9, selectively down-regulate cell 
surface TCR and up-regulate CD25 during co-culture with HEK293T.L3+8 (but not 
during co-culture with HEK293T.EV, HEK293.L3 or HEK293.L8) (Di Marco Barros 
et al., 2016). Amplification and sequencing of TCRVγ chains among 
HEK293T.L3+8-responsive T cells identified a high prevalence of Vγ4 genes, 
suggesting that human Vγ4+ cells selectively responded to co-culture with 
HEK293T.L3+8. Emphasizing the specificity of this response to gut-derived γδ T 
cells, skin-derived γδ T cells, which showed bias towards Vγ3 expression, did not 
respond to HEK293T.L3+8. In conclusion, human intestinal epithelial BTNL genes 
appear to selectively regulate local intestinal γδ T cells expressing a particular 
TCRVγ-chain. These data demonstrate that human organ-specific BTNL molecules 
could similarly regulate the lifelong composition of human organ-specific γδ T cell 
compartments, with potential implications for human health. Future studies should 
therefore seek to determine whether BTNL3 and BTNL8 show up- or down-
regulation in human intestinal pathology that is associated with over-expansion of 
γδ IEL (e.g. Coeliac disease and mucosal γδ T cell lymphoma). 
7.4.2 Genetic associations of BTNs with disease 
There is significant interest in the putative role of Butyrophilin(-like) genes in the 
regulation of systemic immune responses (Abeler-Dörner et al., 2012; Arnett and 
Viney, 2014; Rhodes et al., 2016). In particular, BTNL2 has drawn significant 
attention to the extended BTN gene family because of its genetic association with 
human inflammatory diseases including sarcoidosis and ulcerative colitis (Pathan 
et al., 2009; Valentonyte et al., 2005). To investigate the biology underlying these 
associations, several studies have tested the impact recombinant Fc fusion 
peptides of several different BTN/Btn and BTNL/Btnl proteins, on the activation of 




αβ T cells in vitro. Using this approach, several studies have concluded that 
Butyrophilin(-like) molecules modulate TCR-driven activation of αβ T cells in vitro 
and may bind to the cell surface of activated but not resting αβ T cells, which is 
indicative of an activation-induced counter receptor (Ammann et al., 2013; Arnett et 
al., 2007; Nguyen et al., 2006; Sarter et al., 2016; Smith et al., 2010; Yamazaki et 
al., 2010). Consistent with an immunoregulatory role for one of these proteins, 
Btn2A2-/- mice are reported to display worse clinical scores during experimental 
allergic encephalitis and a reduced rate of tumour growth in vivo (Sarter et al., 
2016). The mechanism by which this immunoregulatory impact is mediated is not 
well understood but is thought to involve induction of CD4+ regulatory T cells.  
Aside from Btn2A1, which may regulate T cell activation by engaging DC-SIGN on 
APCs (Malcherek et al., 2007), no counter receptor has been identified for any 
other butyrophilin(-like) molecule. Thus, the mechanism by which αβ T cell 
activation may be regulated by these proteins in vitro or in vivo remains very poorly 
defined. Furthermore, as studies have largely used Fc fusion peptides of single 
butyrophilin(-like) molecules to test their function in vitro, it is unclear whether the 
reported immunoregulatory effects are physiological for proteins that may depend 
on heterodimerization for their function. In this regard, the study of BTN/Btnl genes 
in the regulation of γδ T cell development and activation has arguably identified the 
only physiological context(s) in which these proteins may function in vivo. Given 
that Skint1, BTN3A1/2/3, Btnl1/6 and BTNL3/8 are all directly implicated in the 
regulation of γδ T cell responses, it is tempting to speculate that the primary 
function of this gene family is to regulate discreet subsets of γδ T cells (Figure 7.3). 
Indeed, γδ T cell deficiency is often associated with exaggerated αβ T cell-mediated 
inflammatory responses (Hayday et al., 2000). Thus, it will be imperative for any 
future study of butyrophilin(-like)-deficiency in vivo to rule out the possibility that a 
γδ T cell compartment has been selectively ablated. Moreover, pathologies that 
have been genetically associated with members of the extended BTN gene family 
should be thoroughly assessed for potential γδ T cell involvement. 




      
 
Figure 7.2 Schematic of mouse and human BTNL2/Btnl2 and BTNL9/Btnl9 gene 
loci 
Btnl1, Btnl4, and Btnl6 are encoded in an amplicon adjacent to Btnl2 on mouse 
chromosome 17. BTNL8 and BTNL3 are encoded in an amplicon adjacent to 
BTNL9 on human chromosome 5. Schematic provided by Dr Vantourout. 
 
 
Figure 7.3 The emerging role of Butyrophilins in the regulation of γδ  T cells 
Phylogenetic tree of Butyrophilin gene family and the associated γδ T cell subsets 
they regulate. Adapted from: (Abeler-Dörner et al., 2012). 




7.4.3  On the regulation of T cell composition and implications for cancer  
The capacity of a non-lymphoid barrier tissue to actively regulate the composition 
of its locally resident lymphocyte compartment has profound implications for tumour 
immunosurveillance and auto-inflammatory disease; as such cells may ameliorate 
or exacerbate pathology. Indeed, histological data concerning the composition of 
lymphocytes infiltrating solid tumours has been shown to correlate with clinical 
outcomes (Fridman et al., 2012; Mlecnik et al., 2011) and has led to calls for 
histological ‘immune scores’ to be adopted for human tumour classification (Jerome 
Galon et al., 2012). Likewise, it is conceivable the composition of tumour-infiltrating 
lymphocytes could influence the efficacy of novel checkpoint inhibition therapies 
that are being trialled across a range of malignancies (Ansell et al., 2015; Hamid et 
al., 2013; Pardoll, 2012; Robert et al., 2015; Schadendorf et al., 2015; Weber et al., 
2015; Wolchok et al., 2013).  
Over recent years, γδ T cells have attracted considerable attention because of their 
capacity to rapidly respond to dysregulated or ‘stressed’ self, via the LSSR 
(Hayday, 2009). Indeed, tumour-associated γδ T cell gene expression signatures 
were recently reported to be the single greatest correlate with overall survival in an 
unbiased bioinformatics analysis of gene expression data across ~18,000 human 
tumours (Gentles et al., 2015). This thesis has presented genetic evidence to 
support the hypothesis that epithelial cells actively regulate the composition of their 
local lymphocyte compartments via their expression of organ-specific Btnl gene 
products. Given that most tumours derive from epithelial tissue, it is possible that 
regulators of immune composition may be up- or down-regulated according to what 
confers the greatest survival advantage to the tumour cell. Taking this into 
consideration, future analyses of tumour gene expression datasets should strive to 
characterize the landscape of Butyrophilin(-like) gene expression, to see if this 
shows any favourable correlation with the reported prognostic indicator of γδ T cell 
infiltration for overall survival. 
 





In this thesis, we sought to determine how the lifelong composition of signature γδ 
IEL compartments are established and maintained. In particular, we investigated 
whether Skint1-mediated DETC selection was an exceptional mechanism, or 
whether closely related Btnl gene products similarly regulate the composition of 
other signature γδ ΙΕL. From these studies, it is now clear that the development of 
the two signature murine γδ IEL compartments studied in any detail (DETC and 
intestinal Vγ7+ IEL) is in both cases driven by organ-specific, epithelial expression 
of butyrophilin-like genes, Skint1 and Btnl1(+Btnl6), respectively. These data 
provide the first demonstration that Skint1-mediated DETC selection is a 
generalizable mechanism by which Btnl products of epithelial cell differentiation 
serve to regulate the lifelong composition of local γδ IEL. Thus, Btnl gene products 
are the master regulators of intraepithelial γδ T cell composition. 
Through the analysis of WT pups, Btnl1-deficient mice, and inducible Btnl1 
transgenic mice, at least some of the consequences of epithelial Btnl1/Skint1-
mediated selection of IEL are now clear. First and foremost, ‘selected’ γδ T cells up-
regulate the IL-15Rβ (CD122) that is essential for the cells’ steady-state 
maintenance in small intestinal epithelium and epidermis. They also up-regulate the 
TCR and up-regulate several co-inhibitory receptors (e.g. TIGIT, Lag3), which most 
likely serves to limit IEL responsiveness to signalling via the TCR. Selected IEL 
proliferate, and suppress the expression of genes, notably Sox13, Sox4, Rorc, and 
Bcl11b that are commonly associated with the development γδ17 cells. These 
effects of Skint1 and Btnl1 coupled with their fine specificity for cells expressing 
defined TCRs results in the rapid emergence of signature T cell compartments 
uniquely associated with defined anatomical sites.  
Adopting a gain-of-function approach in vitro, we provided compelling evidence to 
support the notion that Btnl1 elicits Vγ7+ TCR-dependent events in co-operation 
with Btnl6 when co-expressed in MODE-K cells. Such heterodimerization has been 
shown to occur in primary enterocytes and could also be involved in Skint1-
mediated DETC selection and/or BTN3-mediated activation of human Vγ9+Vδ2+ T 
cells. Peptide:MHC complexes are known to have the capacity to elicit several 




potential impacts on developing αβ T cells These include positive and negative 
selection of αβ thymocytes, ‘agonist selection’ of regulatory T cells, and the 
activation or anergy of peripheral αβ T cell subsets. Throughout this thesis, we 
provide genetic evidence that Btnl1 drives the intestinal selection of Vγ7+ IEL in vivo 
and cell biological evidence that Btnl1+Btnl6 drives Vγ7+ IEL activation in vitro. 
While our data do not demonstrate a direct interaction between Btnl1+Btnl6 and the 
Vγ7+ TCR, they do demonstrate the capacity for Btnl1+Btnl6-mediated stimulation 
to elicit several consequences of TCR signalling, as was previously reported for 
Skint1-mediated selection. 
An exception to the parallels between Skint1- and Btnl1-mediated IEL selection is 
that the impact of Skint1 is initially mediated in the thymus, whereas that of Btnl1 is 
mediated in the gut. By demonstrating that enterocyte expression of Btnl1 in vivo 
drives selective phenotypic maturation and expansion of Vγ7+ IEL in BiTg mouse 
pups, we have established that the signature small intestinal γδ IEL compartment is 
shaped extrathymically, irrespective of where TCR rearrangement takes place. 
Thus, we are able to reconcile many conflicting reports and our data provide the 
foundations to resolve a long-standing debate.  
In conclusion, this thesis has provided a compelling answer to the question set out 
in its objective. Namely, that Skint1-mediated DETC selection is not exceptional 
and is likely to represent an evolutionarily conserved mechanism by which epithelia 
actively regulate the composition of their signature γδ IEL compartment. In 
answering this question, we have comprehensively described new experimental 
systems (e.g. Btnl1-/- mice, BiTg mice, MODE-K transductants) that will 
undoubtedly prove to be invaluable in future studies of Vγ7+ IEL function; and in 
future investigations regarding the mechanism of Btnl1+Btnl6-mediated Vγ7+ IEL 
stimulation. The conservation of BTNL3+8-mediated subset-specific stimulation of 
human intestinal γδ T cells (Di Marco Barros et al., 2016) heralds an exciting new 
chapter in human γδ T cell biology and brings us that little bit closer to defining the 





Chapter 8. Appendix 
8.1 Buffers 
Phosphate Buffered Saline (Gibco - 14190-094) 
 




175.3g NaCl  
88.2 sodium citrate-2H2O 
pH to 7.0 with HCl 
Top up to 1L with H2O 
 
10% Sodium Dodecyl Sulfate (SDS) 
Dissolve 100g SDS crystals in 900ml H2O, heat to 68oC 
pH to 7.2 with HCl 
Top up to 1L with milliQ water 
 
0.5M EDTA 
186.12g EDTA (Fisher Scientific) 
pH to 8 with sodium hydroxide 
Top up to 1L with water. 
 
70% ethanol 
70% Ethanol (Sigma) 
30% MilliQ water 
 
RPMI:DTT solution 
RPMI 1640 (Gibco) 
10% FCS (Gibco) 






IEL recovery medium 
RPMI 1640 (Gibco) 
10% FCS (Gibco) 
5ml Penicillin/Streptomycin (0.1mg/ml strep; 100 units/ml pen) 
 
Complete RPMI 
RPMI 1640 (Gibco) 
10% FCS (Gibco) 
5ml Penicillin/Streptomycin (Sigma; [net] = 0.1mg/ml strep; 100 units/ml pen) 
12.5ml 1M HEPES (Gibco) 
5ml 100X Non-essential amino acids (Invitrogen) 
5ml 100X Sodium pyruvate (Gibco) 
1ml 50mM β mercapto-ethanol (Gibco) 
IL-2 (10U/ml), IL-15 (10 ng/ml) (Immunotools), IL-3 (100U/ml), IL-4 (200U/ml) 
(R&D).  
 
F2.67 hybridoma culture medium 
DMEM +glutamine/+glucose/+pyruvate (Gibco) 
5% FCS (Gibco) 
5ml 100X Non-essential amino acids (Invitrogen) 
5ml Penicillin/Streptomycin (Sigma; [net] = 0.1mg/ml strep; 100 units/ml pen) 
1ml 50mM β mercapto-ethanol (Gibco) 
 
MODE-K Culture medium 
DMEM +glucose/+glutamine/+pyruvate (Gibco) 
10% FCS (Gibco) 
5ml Penicillin/Streptomycin (Sigma; [net] = 0.1mg/ml strep/100 units/ml pen) 
1:100 Hygromycin (Invitrogen; [net] = 0.5mg/ml) 
Puromycin (Sigma; [net] = 200ng/ml) 
 
Percoll 100% stock solution 
90ml Percoll (GE Healthcare) 







80% Percoll (100% stock solution) 
20% PBS  
 
Percoll 40% 
40% Percoll (100% stock solution) 
60% PBS  
 
Percoll 20% 
20% Percoll (100% stock solution) 








40mM Tris, pH8 
25mM EDTA, pH8 
100mM NaCl 
1% sodium dodwSDS 
Add 15µl (10mg/ml) Proteinase K (Sigma) to 360µl tail buffer at time of use 
 
Southern blot buffers 
Depurination buffer  
0.25M HCl 
 













1x Maleic acid buffer 
0.1M Maleic Acid  
0.15M NaCl  
pH 7.5 
 
Post Hyb Wash I 
2x SSC  
0.1% SDS  
 




Blocking buffer (10X) 
Dissolve blocking reagent to a final concentration of 10% in Maleic acid buffer. 
Bring to 1X by diluting 10X solution in Maleic acid buffer at time of use. 
 
Washing buffer 
Maleic acid buffer + 0.3% tween 
 








15% Picric acid solution 
pH to 7.3 
 
Block A: 
5% normal goat serum 
0.5% BSA 









100 ug/ml Rat gamma-globulin 
0.5% BSA 







8.2 Antibodies, cytokines, chemicals, materials and kits 
 
Antibodies 
CD3 APC Cy7 (17A2) BioLegend Cat#:100222 
CD3 PerCPCy5.5 (145-2C11) BioLegend Cat#:100328 
TCRβ Brilliant Violet 421 (H57-597) BioLegend Cat#:109229 
TCRβ APC (H57-597) BioLegend Cat#:109212 
CD122 PE (TMβ1) BioLegend Cat#:123209 
CD122 Brilliant Violet 421 (TMβ1) BD Cat#:562960 
CD122 APC (TMβ1) BioLegend Cat#:123213 
TIGIT PE (GIGD7) eBiosciences Cat#:12-9501-82 
CD45RB APC Cy7 (C363-16A) BioLegend Cat#:C363-16A 
Thy1.2 Brilliant Violet 510 (53-2.1) BioLegend Cat#:140319 
Lag3 PerCP-efluor 710 (C9B7W) eBioscience Cat#:46-2231-80 
CD5 PE (53-7.3) BD Pharmingen Cat#:553023 
CD24 FITC (M1/69) eBiosciences Cat#:11-0242-81 
CD24 PECy7 (M1/69) BD Pharmingen Cat#:560536 
CD8α PECy7 (53-6.7) BioLegend Cat#:100722 
TCR Vδ4 FITC (GL-2) BD Cat#:552143 
TCR Vδ4 PE (GL-2) BioLegend Cat#:134905 
CD8β PerCpCy5.5 (YTS156.7.7) BioLegend Cat#:126609 
CD25 PerCpCy5.5 (PC61) BioLegend Cat#:102030 
CD69 PECy7 (H1.2F3) BioLegend Cat#:104512 
CCR9 PECy7 (CW-1.2) BioLegend Cat#:128711 
CD44 PECy7 (IM7) BioLegend Cat#:103030 
TCRVγ7 (F2.67) Institut Pasteur Pablo Pereira N/A 
TCRVγ1 APC (2.11) BioLegend Cat#:141107 
TCRVγ4 APC (UC3-10A6) BioLegend Cat#:137708 
TCRδ BV421 (GL3) BioLegend Cat#:118119 
Ki67 FITC (B56/MOPC-21) BD Pharmingen Cat#:556026 
CD45 Qdot 605 (30-F11) eBiosciences Cat#:93-0451-42 
CD5 Brilliant Violet 510 (53-7.3) BD Cat#:563069 
TCRδ PeCy7 (GL3) BioLegend Cat#:118124 
CD161/NK1.1 Brilliant Violet 650 (PK136) BioLegend Cat#:108735 
CD4 Brilliant Violet 786 (GK1.5) BD Cat#:563331 
CD8α AlexaFluor 700 (53-6.7) BD Cat#:557959 
CD25 APC (PC61) BD Cat#:557192 
GITR PE  (DTA-1) BD Cat#:558119 
CD44 FITC (IM7) BD Cat#:553133 
CD62L PerCP-Cy5.5 (MEL-14) BD Cat#:560513 
KLRG1 BV421 (2F1) BD Cat#:562897 
CD11c BV786 (HL3) BD Cat#:563735 







F4/80 PerCPCy5.5 (BM8) BioLegend Cat#:123128 
Ly6G APC (1A8) BD Cat#:560599 
Ly6C AlexaFluor 700 (AL-21) BD Cat#:561237 
CD103 PE (M290) BD Cat#:557495 
CD317 Brilliant Violet 650 (927) BioLegend Cat#:127019 
MHCII/IA/IE FITC (2G9) BD Cat#:553623 
CD86 Pe-Cy7 (GL1) BD Cat#:560582 
CD3 Brilliant Violet 421 (145-2C11) BD Cat#:562600 
CD19 Brilliant Violet 421 (1D3) BD Cat#:562701 
CD161/NK1.1 (lin) Brilliant Violet 421 (PK136) BioLegend Cat#:108735 
IgG1 PE (A85-1) BD Cat#:550083 
B220 (CD45R) AlexaFluor 700 (RA3-6B2) BD Cat#:557957 
IgM Brilliant Violet 786 (R6-60.2) BD Cat#:564028 
IgD PerCPCy5.5 (11-26c.2a) Biolegend Cat#:405710 
GL-7 AlexaFluor 647 (GL7) BD Cat#:561529 
CD95 PECy7 (Jo2) BD Cat#:557653 
CD138 Brilliant Violet 650 (281-2) BioLegend Cat#:142517 
CD21/35 FITC (7G6) BD Cat#:553818 
CD23 Brilliant Violet 421 (B-ly6) BD Cat#:563929 
DYKDDDDK-PE (Flag) BioLegend Cat#:627310 
DYKDDDDK-APC (Flag) BioLegend Cat#:627308 
HA-DyLight 650 Thermo Fisher Cat#:26183-D650 
6x-Histidine-PE Abcam Cat#:Ab72467 
LEAF-P. Hamster IgG Isotype Control (HTK888) Biolegend Cat#:400933 
LEAF-P. anti-mouse CD3-e (2C11) Biolegend Cat#:100331 
CD3-uncongjugated (17A2) eBioscience Cat#:16-0032-85 
Goat anti-Rat IgG Alexa Fluor 555 ThermoFisher Cat#:A-21434 
Cytokines 
IL-2 Immunotools Cat#:12340024 
IL-15 Immunotools Cat#:12340155 
IL-3 R&D Systems Cat#:403-mL 
IL-4 R&D Systems Cat#:404-mL 
Chemicals, Enzymes, Media 
Dulbecco’s phosphate buffered saline (PBS) Gibco Cat#:14190-094 
Hank’s balanced salt solution (HBSS) Gibco Cat#:14175-095 
RPMI medium 1640 Gibco Cat#:21875-034 
Foetal calf serum (FCS) Gibco Cat#:10270-106 
Penicillin-Streptomycin (PenStrep) Sigma Cat#:P4333 
EDTA Fisher Scientific Cat#:D/0700/53 
HEPES Gibco Cat#:15630-056 
Non-essential amino acids (NEAA) Invitrogen Cat#:11140 
β mercapto-ethanol (50mM) Gibco Cat#:31350-010 
β mercapto-ethanol Fisher scientific Cat#:M/P200/05 







DMEM Gibco Cat#:41966-029 
Hygromycin Invitrogen Cat#:10687010 
Puromycin Sigma Cat#:P8833 
Percoll GE Healthcare Cat#:17-0891-01 
DL-Dithiothreitol (DTT) Sigma-Aldrich Cat#:D0632 
Bovine Serum Albumin Sigma Cat#:A4503 
BrdU Sigma-Aldrich Cat#:B5002 
Zombie NIRTM Fixable Viability Kit Biolegend Cat#:423106 
Live/Dead Fixable Blue Dead Cell Stain Kit Thermo Fisher Cat#:L23105 
Superscript II Invitrogen Cat#:18064014 
Platinum SYBR Green qPCR SuperMix-UDG Thermo Fisher Cat#:11744500 
Proteinase K Sigma Cat#:P2308 
RedTaq DNA polymerase Sigma Cat#:D4309 
Isopropanol Fisher Chemical Cat#:P/7500/PC17 
Ethanol Sigma Cat#:32221 
Accutase PAA Cat#:L11-007 
Picric acid Sigma Cat#:197378 
Normal goat serum Jackson 
ImmunoReseach Cat#:005-000-001 
Triton X-100 Fisher Scientific Cat#:T/3751/08 
Rat γ globulin Jackson ImmunoResearch Cat#:012-000-002 
Southern Blot DIG-reagents/kits 
DIG PCR Probe Synthesis Kit Roche Cat#:11636090910 
DIG Easy Hyb Roche Cat#:11603558001 
DIG Blocking reagent Roche Cat#:11096176001 
DIG Luminescent Detection Kit Roche Cat#:11363514910 
DNA Molecular Weight Marker II (DIG-labelled) Roche Cat#:11218590910 
Other Kits 
Click-iT EdU Alexa Fluor 647 Flow Cytometry 
Assay Kit Invitrogen Cat#:A10202 
Foxp3 Staining Buffer Set eBioscience Cat#:00-5523-00 
RNAscope 2.0 HD Reagent Kit-Brown ACD Cat#:320497 
Mouse TCS Purification System  abcam Cat#:ab128749 
EZ-Link Sulfo-NHS-LC Biotinylation Kit Thermo Fisher Cat#:21435 
Alexa Fluor 647 protein labelling kit Thermo Fisher Cat#:A20173 
KAPA Stranded RNA-seq Kit with RiboErase 
(HMR) Roche Cat#:07962282001 
RNeasy Plus Micro Kit Qiagen Cat#:74034 








LS-Columns Mitlenyi Biotech Cat#:130-042-401 
Red Blood Cell Lysis Buffer Sigma Cat#:R7757 
V-bottom 96-well plate Fisherbrand Cat#:FB56414 
U-bottom 96-well plate Corning Cat#:353077 
24-well transwell plate Corning Cat#:CLS3452 






8.3 Spleen and Mesentric lymph node immunophenotyping 
panels 
T Cells 
Population Description by markers 
Total T cells CD45+ , CD5+ , TCRδ+ or CD4+ or CD8+ 
Total γδ T cells CD45+ , TCRδ+,  
Effector γδ T cells CD45+ , TCRδ+ , CD44+ , CD62L- 
Resting γδ T cells CD45+ , TCRδ+ , CD62L+ 
KLRG1+ γδ T cells CD45+ , TCRδ+ , KLRG1+ 
CD5+ γδ T cells CD45+ , TCRδ+ , CD5+ 
Total αβ T cells CD45+ , CD5+ , TCRδ- , CD4+ or CD8+ 
Total CD8+ T cells CD45+ , CD5+ , TCRδ- , CD4- , CD8+ 
Effector CD8+ T 
cells 
CD45+ , CD5+ , TCRδ- , CD4- , CD8+ , CD44+, CD62L- 
Resting CD8+ T 
cells 
CD45+ , CD5+ , TCRδ- , CD4- , CD8+ , CD44+ , CD62L+ 
Naive CD8+ T cells CD45+ , CD5+ , TCRδ- , CD4- , CD8+ , CD44- , CD62L+ 
KLRG1+ CD8+ T 
cells 
CD45+ , CD5+ , TCRδ- , CD4- , CD8+, KLRG1+ 
Total CD4+ T cells CD45+ , CD5+ , TCRδ- , CD4+ , CD8- 
CD4+ T helper cells CD45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25- , GITR- 
Effector CD4+ T 
helper cells 
CD45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25- , GITR- , 
CD44+ , CD62L- R sting CD4+ T 
helper cells 
5  , 5+ , TCRδ- , CD4+ , CD8-, CD25- , GITR- , CD62L+ 
KLRG1+ CD4+ T 
helper cells 
CD45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25- , GITR- , 
KLRG1+ Total Tr g  CD45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25+ , GITR+ 
Effector Tregs CD45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25+ , GITR+ , 
CD44+ , CD62L- Resting Tregs 5  , 5+ , TCRδ- , CD4+ , CD8- , CD25+ , GITR+ , 
CD62L+ KLRG1+ Tregs 45+ , CD5+ , TCRδ- , CD4+ , CD8- , CD25+ , GITR+ , 
KLRG1+ NKT cells 
Total NKT cells CD45+ , CD5+ , TCRδ- , CD161+ 
Total CD4- NKT cells CD45+ , CD5+ , TCRδ- , CD161+ , CD4- 
Effector CD4- NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4- , CD44+ , CD62L- 
Resting CD4- NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4- , CD62L+ 
KLRG1+ CD4- NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4- , KLRG1+ 
Total CD4+ NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4+ 
Effector CD4+ NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4+ , CD44+ , CD62L- 
Resting CD4+ NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4+ , CD62L+ 
KLRG1+ CD4+ NKT 
cells 
CD45+ , CD5+ , TCRδ- , CD161+ , CD4+ , KLRG1+ 
NK cells 
Total NK cells CD45+ , CD5- , TCRδ- , CD4- , CD8- , CD161+ 
Effector NK cells CD45+ , CD5- , TCRδ- , CD4- , CD8- , CD161+ , CD44+ , 
CD62L- Resting NK cells 45+ , CD5- , TCRδ- , CD4- , CD8- , CD161+ , CD62L+ 









Total B cells CD45+ ,B220+ , CD138- 
B1a cells CD45+ ,B220+, CD138- , CD5+ 
Total B2 cells CD45+ ,B220+, CD138- , CD5- 
Marginal zone B 
cells 
CD45+ ,B220+, CD138- , CD5- , GL-7- , CD95- , IgM+ , IgG- , 
CD21high , CD23+ 
Transitional 1 B cells 
CD45+ ,B220+, CD138- , CD5- , GL-7- , CD95- , IgM+ , IgG- , 
CD21- , CD23- 
Transitional 2 B cells 
CD45+ ,B220+, CD138- , CD5- , GL-7- , CD95- , IgM+ , IgG- , 
CD21- , CD23+ 
Follicular B cells 
CD45+ ,B220+, CD138- , CD5- , GL-7- , CD95- , IgM+ , IgG- , 
CD21low , CD23+ 
Plasma cells CD45+  B220low , CD138+ 
Memory B cells CD45+ ,B220+, CD138- , CD5- , GL-7- , CD95- , IgM- , IgG+ 
Germinal centre B 
cells 
CD45+ ,B220+, CD138- , CD5- ,  GL7+ , CD95+ 
Early germinal 
centre B cells 
CD45+ ,B220+, CD138- , CD5- ,  GL7+ , CD95+ , IgM+ , IgG- 
Late germinal centre 
B cells 
CD45+ ,B220+, CD138- , CD5- ,  GL7+ , CD95+ , IgM- , IgG+ 
Myeloid 
Total myeloid cells CD19- , CD3-, NK1.1-,  
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